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The expression of major histocompatibility complex (MHC) class II gene products is tightly
regulated and is normally confined to professional antigen presenting cells (B cells, dendritic cells,
monocytes). However many cells can be induced to express MHC class II molecules, for example
human T cells do not express class II but synthesize and express high levels upon activation. In
sheep, a percentage of resting T cells express class II and upon activation there is increased
expression of the different MHC class II molecules (Dutia et at, 1993a). The significance of the
increased class II expression after activation of T cells is unclear.
In this study the expression of MHC class II molecules on T cells from various immunological
compartments of the sheep was examined. Monoclonal antibodies (mAbs) were characterized which
react specifically with the homologues of human DRa andDQa molecules. The expression of these
antigens was established on B cells and T cell subsets derived from peripheral blood, efferent lymph
and afferent lymph. B cells from each of the lymphocyte sources expressed both DRa andDQa
antigens. Variable expression on T cells was found. Each of the T cell subsets expressed both DR and
DQ molecules at much higher levels in afferent lymph. DR expression on peripheral blood
lymphocytes and efferent lymphocytes was higher than DQ on each of the T cell subsets. Afferent
lymphocytes represent memory type cells and class II DR expression on these T cells may mark
activation status.
Expression of the class II subtypes was also examined on in vivo activated T cells and correlated
with expression of activation markers. Increased expression of class II molecules was coincident
with the increased expression of activation markers in each of the T cell subsets with the exception of
y5 cells. The lack of correlation on y5 T cells may be a reflection on the type of antigen used. Levels
of DQ expression on CD4 positive cells after activation showed a more dramatic increase than levels
of DR expression.
Cytokine profiles of concanavalin A (Con A) activated-T cells (DR positive) were examined and
compared with that of DR negative T cells. The data reveal that IL-6 mRNA production correlated
with DR expression. IL-6 was induced after activation of the total T cell population and was not
induced in the DR negative T cells. No detectable differences in IL-4, IL-10 and ylFN mRNA profiles
were observed between the total T cell population and the DR negative T cells.
The increased expression of class II molecules after in vivo activation coincided with the
increased expression of activation markers. Correlation with activation markers did not provide
further insight into the possibility that DR and DQ molecules may fulfill different functional roles
whereas examination of cytokines secreted revealed that DR expression correlated with IL-6
production after Con A activation. This is indicative of a functionally distinct immunoregulatary role
for DR positive T cells. The differential expression of class II molecules may fulfill distinct
functions in regulating the outcome of T cell activation and the resultant effector function.
Using the MACS cell separation technique, a novel lymphocyte population was identified in sheep.
These lymphocytes were CD3 positive suggesting they are of the T cell lineage, however they did not
express markers for CD4, CD8 or y§ T cells. This null cell population represent approximately 5%
of the efferent lymphocytes.
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CHAPTER 1 Introduction
The demonstration that peptide fragments bound directly to major
histocompatibility complex (MHC) molecules (Babbitt et al, 1985) provided the
first evidence that MHC molecules interact with processed antigen independently of
TCR engagement. Since then much has been learnt on antigen presentation by the
MHC. The following review concentrates on the processing of antigen for
presentation by MHC class II molecules and the functional outcome of antigen
presentation.
1.1 The Major Histocompatibility Complex
1.1.1 Genes and proteins of the MHC
Self/nonself discrimination was first demonstrated by the rejection of
foreign tissue grafts in mice (Gorer,1936). The genetic loci involved in this
rejection process were subsequently mapped to a region known as the major
histocompatability complex (reviewed in Klein,1986). The MHC is located on
chromosome 17 in mice and on chromosome 6 in humans. Three classes of MHC
molecules have been identified in the MHC complexes of both mouse and man, classes
I, II and III (reviewed in Campbell and Trowsdale,1993; Trowsdale,1993). The
class I and class II regions encode polymorphic cell surface molecules involved in
immune recognition of antigens. The class III region encodes genes for the
complement proteins C2, C4, and (3 factor, as well as genes for TNFa and (3 and the
heat shock protein (Hsp) 70. Other genes with no obvious association with the
immune system have also been identified within the class III region.
In humans the class I loci contains around 20 genes, only three of which, the
HLA-A, B, and C loci, produce polymorphic products that are clearly involved in
antigen presentation. The other genes encoded in the HLA-E, F, G, H, I and J regions
are characterized by limited polymorphism, restricted tissue distribution and low
cell surface expression. The classical class I molecules associate with [52 -
microglobulin in the presentation of endogenously derived proteins such as those
from viruses. This allows the class I restricted CD8 T cells to screen for the
expression of non-self material (reviewed in Monaco,1992).
The class II region in humans (HLA-D) is composed of three loci HLA-DP,
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DQ and DR that are directly involved in antigen presentation. The HLA-DM
molecules have also recently been found to play a critical role in antigen
presentation (Morris et al, 1994). Additional loci such as HLA-DN and DO are
considered to be involved with antigen processing and transport to the endoplasmic
reticulum (ER) (Ting and Baldwin,1993). TAP1 and TAP2 (for transporter
associated with antigen processing) genes located in the class II region encode
transporter proteins important for class I peptide translocation, while the closely
associated LMP1 and LMP2 (for low molecular weight polypeptide) genes encode
proteins similar to subunit proteins of proteasomes (Monaco and McDevitt,1982).
Each of the DP, DQ and DR loci contain class II A and B genes which encode a and p
chains of the class II heterodimers. Class II molecules are usually associated with
the presentation of exogenous proteins.
The major feature of the MHC is the polymorphism of some of the class I and
class II genes. In general class I molecules are somewhat more polymorphic than
class II molecules although some of the class I molecules exhibit little
polymorphism.
1.2 The Class II region
The human HLA-DP and DQ subregions contain pairs of polymorphic A and B
genes. In the DP region both members of a DPA/DPB gene pair are pseudogenes.
Within the DR region a single non-polymorphic a chain can be associated with the
product of several DRB genes, the number of which varies between haplotypes
(Bodmer et al, 1990). In mouse the functional class II genes are grouped into two
subregions (IA, IE) which code for EaEp andAaAp class II molecules. Genes
homologous to the HLA-DN have also been identified (Karlsson and Peterson,1992).
In the IO region the Op protein product has been identified (Karlsson et al, 1 991)
and the IOA gene found to be homologous to HLA-DN (Karlsson and Peterson,1992).
In situ hybridization has localized the MHC gene region of sheep (Ovar-D) to
chromosome 20 (Mahdy et al, 1989). Genes equivalent to the HLA-DR, DQ and DN
homologues have been identified. No DPA genes were identified (Scott et al,1 987;
Deverson et al, 1991). Using two unrelated sheep, 7 A and 24 B genes have been
detected using human/murine cDNA probes (Deverson et al, 1991). The A genes
were identified as DR-like, DQ-like and DN-like, the B genes could not be
determined because of extensive cross-hybridization. From these cloned genes a
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DRA and a DRB gene have been identified and shown to be expressed on transfection
into mouse L cells (Ballingall et al, 1992). Two DQA genes, a DQB gene and a DRB
pseudogene have also been sequenced (Scott et al, 1991 a&b). Alleles within the
DRA, DQA1, DQA2 and DQB regions have been identified (Fabb et al, 1993; van
Oorschot et al, 1994). These regions in sheep are thus polymorphic. The protein
products of DR and DQ molecules have been identified using mAbs (Puri and
Brandon,1987; Dutia et al,1994). One DQa, DRa, DQp and two DRp molecules have
so far been found to be expressed (Ballingall et al, 1992; Dutia et al, 1993&4). A
distinguishing feature of the ovine class II region which differs from the HLA class
II region is the presence of a DY region (Wright et al, 1994). The DY region is
represented by an A/B gene pair.
1.2.1 Gene regulation
Class II molecules are expressed primarily on B cells, thymic epithelia,
macrophages and dendritic cells (reviewed in Kappes and Stominger,1988; Benoist
and Mathis,1990; Glimcher and Kara,1992). The expression of class II is under
tight developmental control on these cells. For example, class II expression is
absent on murine pre-B cells but appears in mature B cells, the differentiation of B
cells into plasma cells is accompanied by a loss in class II expression. Ovine B cells
have also been shown to lose expresssion of class II on terminal differentiation into
plasma cells (Dutia et al, 1993a). Expression of class II is also subject to
regulation by cytokines. Macrophages, endothelial cells and astrocytes can be
induced to express class II by ylFN (Wong et al, 1984; Manyak et a/,1988; Celada
and Maki,1991).
Expression is controlled at the level of transcription, and specific cis-acting
sequences have been recognized in the proximal promoters of the MHC class II genes.
These are the highly conserved X, Y and W/Z boxes. Each of these promoter
elements appear to be involved in the regulation of both constitutive and inducible
class II gene expression (reviewed in Glimcher and Kara, 1992). An additional
promoter element has been identified on the DRA gene. The DRA gene contains an
octamer motif which appears to be involved in B-cell specific gene expression as
mutation of this element reduces the expression of DRa (Tsang et al, 1 990).
Upstream J elements have been found in HLA-DPA and HLA-DQB promoters that are
necessary for constitutive and y IFN induced gene expression (reviewed in Ting and
Baldwin,1993). A number of nuclear binding proteins have been identified that
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bind to these class II X, Y or W/Z box sequences with varying affinities for the
different class II box sequences (Ono et a/,1991; Ting and Baldwin,1993). In vivo
analysis of class II promoters has demonstrated that the regulated expression of
class II genes is accompanied by changes in promoter occupancy implying that
promoter accessibility is likely to be the major determinant of class II expression.
Thus changes in transcription of class II genes are associated with changes in factor
binding at the promoter in vivo (Kara and Glimcher,1 993).
Bare lymphocyte syndrome (BLS) is a rare genetic disease which causes
severe immune combined immunodeficiency due to a complete lack of expression of
class II molecules. Using B cell lines established from BLS patients two types of
HLA class II regulatory mutants have been distinguished at the molecular level. One
type is characterized by the lack of binding by factor RF-X to the X box on the HLA
promoter (Reith et al, 1988). Unoccupied promoters have also been identified in
vivo (Steimle et al, 1993). In the second type of BLS no defects in promoter
occupancy have been identified and the defect is due to the absence of CIITA
transactivator gene expression (Steimle et al, 1994). The defect in these cell lines
is fully corrected by the CIITA gene. Control of both constitutive and inducible class
II expression is also mediated by the transactivator CIITA gene. Steimle and co¬
workers showed that CIITA expression is induced by ylFN. Furthermore, a
functional CIITA gene is sufficient to activate expression of class II genes in class II
negative cells in the absence of ylFN. Thus CIITA acts as a general regulator of both
inducible and constitutive class II expression. As there is no evidence of CIITA
binding directly to a class II promoter, it was suggested that CIITA may act as a
tissue specific co-activator (Steimle et al, 1994).
1.2.2 Structure of MHC class II molecules
Early structural studies showed that the human class II molecules are ap
heterodimers in which both chains span the cell membrane (Springer et al, 1977).
The heterodimer is composed of the a chain non-covalently linked to the p chain.
The a subunits have an approximate molecular weight of 33-35kD and the p
subunits of 25-30kD. The extracellular region is divided into two domains of 90-
100 amino acids each, a transmembrane region of 20-25 amino acids and a short
intracellular region of 12-15 amino acids. The membrane proximal domains (a2
andp2) each contain an internal disulphide bond and are structurally very similar
to immunoglobulin domains. The membrane distal domains (a1 and pi) have no
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such homology and associate to form a structure that constitutes the peptide binding
region of the molecule (reviewed in Kappes and Strominger,1988;
Cresswell,1994). From the x-ray crystallographic analysis of class II (Brown et
al, 1993) the peptide binding structure consists of eight strands of anti-parallel 3
sheets with 2 anti-parallel a helical regions overlaying them. There is a deep cleft
between the a helices which accommodates the peptide. In addition, the majority of
allelic polymorphisms in both mouse and human class II molecules are located
within the a1 or 31 domains (Bell et al, 1985). Similar MHC class II proteins have
been described in sheep. As in mice and humans, sheep a and 3 chains are
glycosylated with complex N-linked oligosaccharides (Puri et al, 1987a ;Dutia et
al, 1990a).
1.2.3 Biological expression of MHC class II gene products
Class II expression occurs constitutively on classical antigen presenting
cells (APCs) such as Langerhan's cells of the skin, dendritic cells, macrophages,
monocytes and B cells in all species so far examined (Kappes and
Strominger,1988). In humans, specific epithelial cells (skin keratinocytes,
intestinal epithelium, thymic epithelium, kidney tubular cells, vascular
epithelium), astrocytes and melanocytes transiently express class II molecules.
The level of class II expression is not static in these cells but can be up-regulated
or down-regulated by a large number of external stimuli. The major regulator of
class II expression is ylFN. TNFa is also an inducer of class II gene expression and
in macrophages and monocytes it acts synergistically with ylFN. In a variety of cell
lines derived from malignant solid tumours, class II expression is inducible with
ylFN or mitogens (reviewed in Benoist and Mathis,1990; Glimcher and
Kara,1992).
Striking differences between species in the expression of MHC class II on T
cells are described in the literature. The synthesis of class II molecules has been
demonstrated directly on human T cells (Oshima and Eckels,1990a), rat T cells
(Reizis et al, 1994; Broeren et al, 1995) and sheep T cells (Hopkins et al, 1993).
In human and rat T cells class II expression only occurs following activation, while
in the sheep a proportion of T cells are class II positive and show increased
expression following activation. All equine (Crepaldi et al, 1986), feline (Rideout
et a!A 992) and canine (Doveren et al^ 986) T cells express class II molecules
constitutively. In the cat increased expression of class II has been demonstrated on
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T cells following viral infections (Rideout et al,t 992).
In contrast, the expression of class II molecules on mouse T cells is
controversial. Several groups have reported the phenotypic expression of MHC
class II determinants on mouse T cells both in vitro (Singh et al, 1984; Bevan and
Chisholm,1986) and in vivo (Gautam efa/,1991). However others have
demonstrated that class II molecules on mouse T cells may be passively adsorbed
from antigen-presenting stimulator cells (Lorber et al, 1982). Reizis et al
(1994), recently reported that a significant amount of class II proteins on the
surface of activated rat T cells is acquired by passive adsorption, nonetheless active
synthesis was found to take place in the same cells. Thus active expression and
passive acquisition of class II proteins may occur simultaneously in murine T cells.
On mature human B cells there is co-ordinate expression of DP, DQ and DR
loci (Nunez et al, 1984). On human T cells the products of DR, DP and DQ loci are
not co-ordinately expressed and there are differences between CD4 and CD8 T cell
populations in levels of expression (Diedrichs and Schendei,1989; Oshima and
Eckels,1990a). Similarily in sheep there is differential expression of class II
molecules on T cell subsets. In foetal sheep blood there is no expression of class II
on either CD8 or 78 T cells with a very low level of expression on CD4 T cells. In
adult peripheral blood and efferent lymph a significant proportion of T cells
express DR but not DQ while in afferent lymph all three T cell subsets express both
DQ and DR (Dutia et al, 1 993a).
1.3 MHC Polymorphism
Diversity in MHC expression affects immunological potential in several
ways. Polymorphisms in MHC molecules influence the ability of MHC to bind a
given peptide. Consequently individuals expressing different MHC alleles select
different peptides of a given antigen for presentation. Thus MHC polymorphism
influences the spectrum of peptide antigens against which an individual can initiate
an immune response. There is also an association of MHC phenotypes with
susceptibility to certain diseases. This may be a consequence of the selective nature
of the binding groove ensuring certain alleles are capable of binding pathogenic
peptides. For example in coeliac disease the antigen gliadin has a strong association
with HLA-DQ*0501 and HLA-DQ*0201. Gliadin reactive T cells have been shown
to be restricted to these two alleles (reviewed in George et al,1 995). Other
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diseases associated with HLA alleles include insulin dependent diabetes mellitus and
pemphigus vulgaris. With these diseases it has been demonstrated that it is
polymorphic variations in MHC molecules themselves, rather than hypothetical
disease genes closely linked to MHC loci that contribute to the disease propensity.
Autoimmune disease (eg. multiple sclerosis, rheumatoid arthritis, pemphigus
vulgaris, insulin dependent diabetes mellitus) associations implicate HLA-DQ more
frequently than DR alleles in predisposition to disease (Altmann et al, 1 991).
Residues critical for peptide binding have been associated with susceptibility to
autoimmune diseases (Hammer et al, 1995). Two polymorphic positions in the MHC
class II (3 chain are critical for selective peptide binding and the development of
autoimmunity (position 71 of DRpand position 57 of DQp). In autoimmune diseases
associated with DR4 alleles, the charge at position DRp71 controls the charge at
peptide position P4 (relative to the first anchor P1). In rheumatoid arthritis (RA)
patients, RA peptides have a negative charge at P4 whereas pemphigus vulgaris
peptides have a positive charge at the same position (Wucherpfennig and
Strominger,1995). It appears that polymorphic residues critical in peptide
binding are associated with susceptibility to the development of autoimmune disease.
1.4 MHC class II assembly and antigen presentation by antigen
presenting cells (APCs)
1.4.1 Assembly and transport of Class II, the role of invariant chain
MHC class II molecules are assembled in the endoplasmic reticulum (ER)
(Kvist et al, 1988) and only the functional unit of the a(3 heterodimer leaves the ER
(Sant efa/,1991). During biosynthesis of class II a third chain, the invariant
chain (li) associates transiently with the class II a(J chains. The invariant chain
was so named because of its lack of allelic polymorphism between different strains
of mice. The li is not MHC linked, li rapidly forms noncovalently associated
trimers in the ER (Marks et al, 1990) and class II a(3 dimers associate with these
trimers to form nonamers (Roche et al, 1991). In the human there are 4 primary
forms of li, called p33, p35, p43 and p45. The N-terminal cytoplasmic extension
found on human li p35 and p43 forms, constitute a strong ER retention signal
(Bakke and Dobberstein,1990). It is thought that the formation of mixed trimers
of li which will include either p35 or p43 will exert their retention signal and as a
consequence all non-class II associated li is retained within the ER
(Cresswe!i,1994). Upon association of the class II a and(3 subunits with invariant
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chain the ER retention signal is negated (Machamer and Cresswell,1982). How this
assembly inhibits li chain mediated retention is unknown.
Association with li is not an absolute requirement for assembly and surface
expression of the ap heterodimer. Using cell lines expressing class II ap subunits
but not li, class II expression on the cell surface was demonstrated (Sekaly et
al, 1986). Later experiments have revealed that li facilitates assembly and
transport of the ap heterodimer (Anderson and Miller,1992). Evidence from li
knockout mice further supports an important functional role for li in class II
assembly and transport. Invariant chain knockout mice have impaired class II
expression, dramatically reduced numbers of CD4+ T cells and spleen cells that are
defective in their ability to present antigens to T lymphocytes (Bikoff et al, 1 993).
Furthermore li knockout mice have an unstable class II configuration affecting
processing and presentation of native protein antigens, whereas peptides are
presented very efficiently (Acolla et al, 1995). Thus it would appear that li does in
fact facilitate antigen processing.
After assembly of the ctpli complexes, they move out of the ER and through
the Golgi stacks. When they reach the trans-Golgi they deviate from the typical
exocytic pathway and move to an endocytic pathway (Neefjes et al,t 990). The li is
thought to drive class II molecules into the endosomal system. It has been
demonstrated that li augments class II surface expression by improving class II
egress from the ER (Layet and Germain,1991). Lotteau et al (1990), identified a
targetting signal on the cytoplasmic tail of li which directs traffic to the endosomes.
li association also prevents the association of peptides with class II
molecules before they are delivered into the endosomal system (Cresswell,1994).
As the accepted function of class II molecules is presentation of exogenous antigen to
T cells the association of li with the dimer in the ER prevents the binding of
endogenous peptides. The li possesses a short internal segment (the class II
associated invariant chain peptide, CLIP) that interacts with the binding groove
such that binding cannot occur (Germain,1994). Polymorphic differences may
affect the assembly of li with allelic variants of class II (Bikoff et al, 1995). In the
absence of li the AabApb haplotype chains were expressed as free Aab andApb
chains, however other allelic products assembled efficiently and were
conformationally similar to wild type heterodimers.
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Thus the li fulfills three important functions in the biosynthesis of class II
molecules, it guides the folding of class II molecules, it targets delivery of class II to
the endocytic route and it prevents premature binding of antigenic peptide to class II
molecules.
1.4.2 The endosomal route
After leaving the ER the assembled apli complex traverses the Golgi.
However unlike most membrane glycoproteins, the class ll-li complex is not
immediately expressed on the cell surface. The pathway involved is unclear but
early endosomes, late endosomes and lysosomes have all been implicated in various
cell types. Precisely where in the endosomal/lysosomal system peptides bind and
the mechanisms which regulate the process are unknown.
It was originally the work of Jensen (1990) that showed enhanced peptide
binding to purified class II molecules in solution at acidic pH. At acidic pH the li
chain derived CLIP peptide dissociates more rapidly (Riberdy et al,~\ 992). Mellins
et al( 1990), studying a cell line lacking the capacity to present intact antigens to T
cells documented that its class II molecules dissociated into a andp monomers on
SDS gel electrophoresis. The association between failure to present antigen and loss
of MHC class II dimer stability suggested that peptides were important for stable
dimer state. From these observations it has been proposed that at neutral pH, the
class II molecule cannot undergo the conformational change needed to attain the
antigen bound state, even in the presence of peptide. At lower pH, the class II
molecule is more flexible and receptive to antigen. When neutralization occurs
class II molecules with bound peptide are locked in this state trapping the associated
peptide (Sadegh-Nasseri and Germain,1992). The class II DM molecule has also
been shown to play an essential role in antigen presentation (Morris et al, 1 9 94).
DM is though to maintain peptide free class II molecules by keeping the class II
binding pocket free of CLIP (Stebbins et al, 1995).
In APCs a different population of vesicles distinct from endosomes or
lysosomes have been identified (Amigorena et al, 1994). These class II associated
vesicles (CM V) are a specialized subset of the endosomal compartment.
Morphological studies on CIIV in B cells reveal spherical structures with abundant
internal membrane vesicles or infoldings (Amigorena et al, 1994). Schmid and
Jackson(1994), have proposed the following route of intracellular antigen
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presentation in APCs. Newly synthesized ocpli complexes leave the Golgi and enter
early endosomal compartments. Degradation of the li occurs in this acidic and
mildly proteolytic environment. Class I! complexes are diverted to the CIIV where
most of li is degraded and class II molecules are receptive for antigenic peptide. The
CIIV mature into a high density compartment in which peptide loaded class II
molecules accumulate. Receptor bound antigens are targeted to the CIIV from early
endosomes to generate a diverse array of antigenic peptides. When peptides are
loaded onto class II molecules, the aggregated complexes dissociate and the peptide-
class II complex is transported to the cell surface for presentation to T cells.
Recent evidence from Amigorena et al (1995) supports this theory. It was found
that the CIIV hosts the final steps in the dissociation of li from class II molecules and
the loading of antigen derived peptides into newly synthesized a(3 dimers.
Through the conventional endosomal pathway presumably any cell can
present different antigens to T cells. The CIIV in APCs may provide a particularily
efficient means of presenting antigen. Much has yet to be learnt of the transport
molecules, chaperones and carrier proteins involved in the route of class II
movement from the site of loading to the cell surface.
1.4.3 Antigen processing and presentation
While the antigens presented by class II molecules are generally
characterized as exogenous, it is required that they be internalized for processing
in the endosomal route. This was demonstrated in the studies of Gell and Benacceraf
(1959). They were the first to show that whilst B cells primarily recognize
determinants found on native molecules, T cells can recognize both native and
denatured forms of the antigen. It has since been established that antigens require
some form of processing prior to presentation to T cells. This processing involves
internalization of antigen and reappearance on the cell surface in association with
class II for recognition by T cells.
Professional APC utilize different strategies for antigen capture. B cells
present their antigen to T cells in a very efficient manner. Antigen specific
immunoglobulin molecules on the surface of B cells can serve as a means for the cell
to specifically take up and concentrate the antigen. This antigen can then be
processed and re-expressed on the surface of B cells in association with class II.
Because of their specificity and concentrating effect B cell presentation can occur at
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concentrations much lower than those required by macrophages and dendritic cells
(reviewed in Lanzavecchia,1990). In comparison to B cells, macrophages and
dendritic cells acquire antigen in a non-specific manner. Macrophages are highly
phagocytic and are likely to ingest antigen spontaneously. Fc receptors on
macrophages enhance processing by binding and internalizing antigen-antibody
complexes while complement receptors on macrophages help in the phagocytosis of
complement opsinized cells (reviewed in Unanue and Allen,1987). The dendritic
cell is a much more potent stimulator of T cells and has the unique capacity to
induce primary immune responses. Dendritic cells appear to exist in an immature
stage in non-lymphoid organs (e.g. Langerhans cells in the skin) where they ingest
antigen. Dendritic cells utilize mannose receptors, Fc receptors and pinocytosis to
capture antigen. After antigen uptake dendritic cells move to T cell areas of
lymphoid organs where they mature into antigen presenting cells. Increased
expression of adhesion molecules and presentational molecules (class II and CD1)
allow them the potential to interact with both a(3 andy5 T cell subsets (reviewed in
Bujdoso et al, 1990).
After binding to receptors on the plasma membrane, ligand-receptor
complexes cluster in clathrin coated pits that subsequently invaginate, pinch off the
membrane and form vesicles. The vesicles are then delivered to the endosomal
route. Enhancing the rate of endocytosis of protein antigens by APC has been found
to increase the efficiency with which they are processed for class II T cell
recognition. The surface immunoglobulin of B cells can increase the efficiency of
antigen presentation 3 fold (Lanzavecchia,1985). Fc receptors expressed on APC
may also enhance processing by binding and internalizing antigen-antibody
complexes (Cresswell,1994).
A fraction of naturally occurring class II associated peptides originate from
cytoplasmic proteins. Cytosolic proteins may enter lysosomes through a process of
autophagy, the engulfment of cytosolic material or even organelles (Dunn,1990).
Following fusion of autophagocytic vesicles with lysosomal elements, cytosolic
proteins are broken down and presented by class II molecules. Another route
proposed for the presentation of cytosolic proteins is transport via heat shock
proteins. Molecules of the Hsp 70 family have been implicated in a shuttle
mechanism for the provision of processed antigen to class II in endocytic
compartments (DeNagel and Pierce,1991). Hsp molecules bind peptide or degraded
protein and thus prevent their complete degradation in the proteolytic environment
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of lysosomes. Thus peptide from endogenous and exogenous antigen may be generated
at the same location and available for binding to class II. This fits with studies on
the purified peptides from class II molecules which reveal that almost all are
endocytically acquired (Hunt et al, 1992; Chicz et al, 1993).
The length of the peptide presented to the T cell varies from 13-25 amino
acids. The x-ray crystal structure of human HLA-DR1 (Brown et al, 1 993)
revealed that the class II binding groove is open at both ends with an overall linear
contact length of 15 residues. This differs from the class I peptide binding groove
which is blocked at either end. Severe restrictions are imposed on the size of
peptide class I can accommodate (8-10 residues), longer peptides are forced to
bulge out in the middle (Guo et al, 1992). The class II binding site allows peptide to
protrude from it and consequently longer peptides can bind. The structure of the
complex of DR1 and the antigenic peptide of influenza hemaglutinin shows that the
peptide binds as a straight extended chain with a pronounced twist (Stern et
al, 1994). This confirmation allows most of the peptide residues to participate in
the surface presented to the T cell receptor. Peptide residues at positions P4, P6,
P7 and P9 (relative to the first anchor P1) appear to contribute to the specificity
of peptide binding to different DR molecules (Stern et al, 1994). Twelve of the
hydrogen bonds involve residues conserved in most human and mouse class II
alleles. This suggests a universal method for peptide binding by class II proteins.
Several promiscuous peptides, capable of binding to different class II alleles, have
been identified (Sinigaglia et al, 1988; Panina-Bordignon et al, 1 989)
Class II molecules make several contacts with the peptide side chains to
increase the overall binding affinity of the bound peptides. Side chain contacts
differ between different alleles and determine the peptide sequence specificity for
each class II allele (Sinigaglia and Hammer,1995). In vitro studies demonstrate
that peptide-class II complexes have a long half-life (22hours). This is dependent
on the length and sequence of the bound peptide. The half-life is not decreased by the
presence of an excess concentration of other peptides which have greater affinity.
Peptides which stabilized class II molecules in the presence of SDS conferred longer
half-lives (Nelson efa/,1994).
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1,5 The functional outcome of antigen presentation by MHC class II to
T cells
1.5.1 T cell activation
Once peptide-MHC complexes have been exported to the cell surface they
function by interacting with the clonally distributed receptors of T lymphocytes
(TCR). The process of lymphocyte activation is highly complex and involves
integration of many signals that together determine the outcome. In addition to the
TCR several co-receptors on the APC are involved. Some of these interactions
function to strengthen the adhesion of the APC and the T cell while others provide
important costimulatory signals. As a consequence of signal transduction events
that follow stimulation, T cells produce a variety of cytokines. The cytokines
produced regulate the subsequent development of the immune response by
influencing proliferation, differentiation, migration and function of immune
effector cells.
1.5.2 The ligand for peptide-MHC class II complex
T cells recognize antigen through their T cell receptors in the form of
peptide fragments bound to MHC. Each TCR has a binding affinity directed to a
specific peptide-class II complex. This unique binding affinity arises from the
structure of the combined variable domains within the a and (3 chains making up
individual TCR molecules. Mature T cells with af3 TCR come in two major classes,
expressing either CD4 or CD8. CD4 T cells recognize peptide fragments bound to
class II molecules while CD8 T cells recognize peptide fragments bound to class I
molecules (Swain,1983). MHC class I and class II act as restriction elements in
the antigen specific activation of CD8 and CD4 T cells respectively. The TCR and
CD4/CD8 molecules diffuse independently on the plane of the T cell membrane and
are brought together by co-recognition of the same peptide-MHC complex
(reviewed in Springer,1990). The CD4 molecule interacts with the membrane
proximal regions of class II that are relatively invariant while the TCR binds the
polymorphic peptide binding region (reviewed in Janeway,1992). A measure of
affinity of TCR for peptide-MHC complexes has come from competition experiments
using soluble MHC complexed with specific peptides. This affinity with a Kd of
5x1 0~5M is several orders of magnitude lower than that of most antibodies for
their protein antigens suggesting that co-stimulation events are important in T cell
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activation (Jorgensen et al, 1 992).
1.5.3 Peptide antagonists
Recent observations on T cell responses following TCR interaction with
altered peptide ligands have highlighted the complexity of TCR signalling. Using
altered peptide ligands which bind to defined MHC class II molecules, peptides have
been identified which bind to the TCR and block the induction of normal signals. The
variant peptides act as antagonists blocking positive responses to the wild type
peptide presented by competent APCs (DeMagistris et al, 1992). T cell anergy can
be induced by variant peptides even in the presence of effective co-stimulation. In
addition to peptide variants blocking the T cell response to immunogenic peptide,
peptide variants also block the T cell response to superantigens. As superantigens
bind at a different site to peptide, this effect appears to occur through the TCR. This
finding also eliminates the possibility that TCR antagonism is the result of
competition between peptides for binding sites (Evavold et al, 1993). Thus the TCR
appears to be able to alter effector function selectively. Conformational changes in
the receptor itself may play a critical role in TCR signalling (Janeway,1995).
1.5.4 Signalling through the TCR
The TCR is found on the surface of all T cells. It is a complex of oligomeric
structures composed of 6/7 different subunits. These are divided into three distinct
groups of proteins, the receptor chains, the CD3 chains and the £ chains. The
immunoglobulin-like clonotypic chains responsible for ligand binding are present
as heterodimers. There are two forms of receptor: ap and y§. in sheep, ap T cells
are found on most mature T cells while y8 T cells consitute a major T cell population
in sheep 3-4 months old (Mackay,1991). The CD3 chains encompass 3 distinct
subunits y, 5 and e. The final group is the Cdimers, three proteins comprise the C
family. Of all these proteins the CD3e has been identified as having signalling
capabilities (LeTourneur and Klausner,1992) while the cytoplasmic tail of £ chain
appears to be essential for antigen stimulated signalling (l-rank et al, 1990).
CD4 and CD8 molecules are also important in signalling. The first indication
that CD4 and CD8 play an active role in TCR mediated cell signalling came from
studies demonstrating that anti-CD4 and anti-CD8 mAbs inhibited mitogen-induced
activation in the absence of MHC ligands (Janeway,1988). The cytoplasmic
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domains of both CD4 and CD8 bind the tyrosine kinase p56lck (Turner et at, 1 990)
leading to tyrosine phosphorylation of the £ chain of the TCR unit (Veillette et at,
1989). The proportion of cellular Ick associated with CD4 is 10-20 fold higher
than associated with CD8. Furthermore, aggregation of CD4 results in a more than
10-fold induction in the kinase activity of cellular Ick, while aggregation of CD8
has barely detectable effects. It appears that CD4 and CD8 have distinct roles in
regulating antigen receptor signalling during T cell activation (reviewed in Julius
et al, 1993). Antigen presented by class II is brought into proximity with the TCR
through binding the same ligand and the interaction of CD4 with TCR appears to be
critical for Ick activation (Janeway,1992). The potentiation of T cell activation by
CD4/CD8 is manifest as a 30-300 fold reduction in ligand density required for T
cell activation.
Stimulation through the TCR activates the tyrosine kinases p59fyn, p56lck
and ZAP-70 (Chan et al, 1992). Subsequently phospholipaseC-yl is activated by
tyrosine phosphorylation, it cleaves phosphatidyl-inositol bisphosphate to the two
active second messengers inositol 1,4,5-trisphosphate and diacylgiyceroi. These
second messengers induce a sustained rise in intracellular calcium and activation of
protein kinase C. The increased levels of calcium and the activation of protein
kinase C in turn synergize to activate transactivating factors required for cytokine
gene transcription (reviewed in Schwartz,1992).
The transcription of cytokine genes in activated CD4 T cells is blocked by the
immunosuppressive drug cyclosporin A (CsA). Calcineurin, one of the enzymes
activated following increased intracellular calcium is a primary target of CsA
(Schreiber and Crabtree,1992). This suggests that calcineurin plays an essential
role in regulating transcription of cytokines. NF-ATp (nuclear factor of activated T
cells) is a substrate for calcineurin and it appears to be involved in the regulation
and induction of several cytokine genes (Rao,1994). Other nuclear complexes
known to regulate cytokine gene expression include NF-kB, AP-1, AP-3 and
octamer binding factors (Fraser et alj 993).
The crystallization of the FILA-DR molecule revealed that the molecule
crystallized as a dimer (a dimer of the heterodimer) such that the two molecules
are parallel and orientated in the same direction (Brown et al, 1993). Dimers of
heterodimers have also been observed in immunoprecipitates of class II molecules
(Schafer and Pierce,1994). There has been much speculation on the role of
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superdimers in TCR signalling. One hypothesis is that the close approximation of
two TCRs brought about by simultaneous recognition of two peptide-MHC ligands in
each superdimer may modulate the TCR response. At increasing ligand density,
there is an increased possibility that both molecules of the dimer are peptide
associated and by physical proximity of all participating subunits a strong TCR
signal would be elicited. At lower ligand density crosslinking of the two receptors
may occur but only one may bind activating peptide and thus a reduced activation
signal elicited. Thus through MHC class II dimer presentation of antigen the TCR
may signal CD4 T cells in different ways (Janeway and Bottomly,1994).
The interaction of TCR with MHC-peptide complex appears to be one of low
affinity and short duration. This phenomenon has recently been explained by the
finding that a small number of peptide-MHC complexes can serially trigger a much
larger number of TCRs leading to an amplified and sustained signal. The high off-
rate of TCR allows a single MHC-peptide complex to engage many TCRs. One MHC-
peptide complex can trigger up to 200 TCRs. This is correlated with down-
regulation of the TCRs that were specifically triggered, the bystander TCRs being
essentially unaffected (Valitutti et al, 1995). The long half-life of peptide
associated class II favors the potentiation of increased TCR signalling.
1.5.5 Signalling through the APC-MHC class II
In addition to their function in presentation of antigen to CD4 T cells, class II
molecules transduce signals which regulate APC cell function. The capacity of MHC
class II molecules to deliver signals that modulate APC cell function has been
demonstrated with studies using anti-class II mAbs and superantigens.
Superantigens bind with high affinity to MHC class II molecules and act as
superantigens by bridging TCR molecules on T cells and class II molecules on APCs.
Using these methods to crosslink class II molecules sustained LFA-1 adhesion on
human B cells has been reported (Fuleihan et al, 1991). In addition, engagement of
class II on B cells induces proliferation and immunoglobulin production (Mourad et
al, 1989). On monocytes induced secretion of IL-1 has been reported
(Palacios,1985). Furthermore during T-B cell interaction, engagement of the TCR
with class II - antigen complex delivers a signal to the B cell which requires the
cytoplasmic domain of the class II molecule and results in surface CD80 (B7)
expression (Nabavi et al, 1992). The CD40 ligand may be another molecule on
activated T cells which induces CD80 (B7) expression by B cells (Ranheim and
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Kipps,1993). Signal transduction through class II on B cells leads to two distinct
signal transduction phenotypes depending on the B cells activation status.
Crosslinking class II on non-primed murine B cells leads to rapid increases in
cAMP levels and translocation of protein kinase C to a detergent insoluble fraction.
These events mediate the induction of CD80 expression. Crosslinking class II on
primed B cells leads to protein tyrosine kinase activation and calcium mobilization
(Cambier et al, 1991). The activation of protein tyrosine kinase triggers a wave of
secondary activation events for MHC class II mediated effector functions such as
adhesion and induction of cytokines. Both signalling pathways play important roles
in T-B cell collaboration (reviewed in Wade et al, 1993; Scholl and Geha,1994).
In addition to T cell receptor interaction with MHC class II antigen
complexes, a successful outcome of T-B cell collaboration requires participation of
additional transmembrane receptor ligand pairs. Some of these are constitutively
expressed while others like CD80 are induced by class ll/TCR interactions.
1.5.6 Co-receptors
Adhesion molecules enhance signal transduction between the T cell and the
APC by increasing occupancy of the TCR. CD2, LFA-1 (CD11a\CD18) and their
ligands LFA-3 (CD58) and ICAM-1 (CD54) respectively, are the major adhesion
molecules that contribute to the T cell- APC binding avidity. Engagement of the TCR
by mAbs has been shown to upregulate the affinity of LFA-1 for its counter receptor
(Dustin and Springer,1989). Class II molecules can similarily transduce
intracellular signals that activate LFA-1 molecules (Mourad et al, 1 990).
Enhanced expression of CD2, LFA-3 and LFA-1 has also been reported on activated T
cells (Sanders et al, 1988; Mackay et al, 1990). Increasing cellular adhesion
between APC and T cell augments the T cell response.
Two costimulatory molecules with a unique role in T cell activation have
been identified. These are B7 (CD80) and heat stable antigen (Hsa). They provide
co-stimulatory signals which are essential for T cell proliferation and
differentiation but do not by themselves induce any response in T cells. However
when the T cell has its receptor ligated and engages the B7 and Hsa ligands the T cell
will proliferate and differentiate. T cells which do not receive co-stimulatory
signals are thought to die (Webb et al, 1990) or to become anergic (Jenkins et
al, 1988). Thus an encounter with antigen can lead to two distinct outcomes which
17
are dependent on costimulatory signals.
CD80 was first identified on activated B cells, and expression was shown to
be upregulated during B cell activation (Freeman et al, 1989). It has since been
documented that CD80 expression is not limited to activated B cells but is more
generally characteristic of APCs (Linsley and Ledbetter,1993). Crosslinking with
CD28 induces rapid tyrosine phosphorylation of proteins and these signals appear to
be distinct from those delivered via the TCR. CD80 has also been identified as a
ligand for CTLA-4 receptors found only on antigen experienced T cells (Linsley et
al, 1991b), which bind CD80 with a 20 fold higher affinity than CD28 (Linsley and
Ledbetter,1993). A second CTLA-4 ligand has now been identified (B7.2) which
may also be important in naive CD4 T cell activation. Crosslinking antigen
receptors on naive CD4 T cells does not induce proliferation whereas this event will
induce proliferation on antigen-experienced T cells (Luqman and Bottomly,1992).
However naive T cells will proliferate when the CD80 molecule on APC is ligated by
CD28 expressed on the T cell (Linsley et at,t 991 a).
Hsa is a small glycoprotein which can also stimulate naive CD4 T cells (Liu
et al,1992a). Hsa is expressed on B cells, activated T cells, monocytes,
granulocytes, Langherhan's cells and thymocytes. It has been found that both
CD28/CTLA-4 and Hsa are required for optimal CD4 T cell activation (Liu et
al, 1992b).
CD45 is another molecule that plays a critical role in T cell activation
though it is not a co-stimulatory molecule. Purified CD45 has tyrosine specific
phosphatase activity (Tonks et al, 1988). The cytoplasmic region of CD45 consists
of two protein tyrosine phosphatase domains which regulates the tyrosine
phosphorylation and activity of both p56lck and p59fyn in T cells. Studies on
several CD45 deficient T cell lines have demonstrated that the signal transduction
process initiated by TCR ligation is interupted in the absence of CD45. This implies
that the inability to signal through the TCR in CD45-deficient lymphocytes is due to
improper regulation of tyrosine phosphorylation (Trowbridge and Thomas,1994).
T cells change their CD45 isoform expression during and subsequent to activation.




Signal transduction events that occur during antigen recognition by T cells
produce a variety of cytokines. It is the co-ordinate production of cytokines which
is crucial for the regulation of an immune response. In 1986, Mosmann and
Coffman described a panel of murine CD4 T cell clones that revealed distinct
patterns of cytokine production and effector function. This led to the subdivision of
effector CD4 T cells into distinct subsets based on their cytokine profiles (reviewed
in Janeway et al, 1988; Mosmann and Coffman,1989; Kelso et al, 1991).
The IL-2, ylFNandTNFp producing clones were designated Th1 type and the
IL-4, IL-5, IL-6 and IL-10 producing clones Th2. Cells of both types can produce
IL-3, TNFa and GM-CSF. It has since become clear that the type of immune
response generated following antigen challenge is dependent on the pattern of
cytokines produced. The different patterns of the two types of Th cells leads to
distinct effector functions. Th1 cells are adept at macrophage activation and
immunoglobulin selection for lgG2a and lgG3 isotypes. These isotypes mediate
antibody-dependent cytotoxity and complement activation. Th2 cells favor
activation of mast cells and eosinophils. They also stimulate B cell growth
differentiation and isotype switching to cells producing IgE and lgG1. In general,
Th1 cells generate cellular immunity against intracellular pathogens while Th2
cells promote the development of humoral responses that direct effector functions
using specific antibodies against extracellular pathogens.
This mouse Th1/Th2 classification has since been validated for humans
using antigen specific human CD4 T cell clones (Romagnani,1991). CD4 T cell
clones that exhibit Th1 or Th2 like profiles accumulate in tissues or peripheral
blood of patients in disease states. Most CD4 Th clones specific for antigens of the
nematode Toxocara canis exhibited a Th2 profile of cytokine secretion whereas the
majority of Th cell clones generated from the same donors specific for purified
protein derivative (PPD) from Mycobacterium tuberculosis showed a Th1 profile
(reviewed in Romagnani et al, 1994). A distinction from mice is the production ot
IL-10 by both human Th types (Del Prete et at,A 993).
The polarization of Th1 and Th2 responses is influenced by the cytokine
milieu in which they develop. The initial event that determines cytokine producing
phenotype is the differentiation of naive precursor cells (Thp) under the influence
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of factors present at the time of primary stimulation. Naive Thp cells produce IL-2
which acts as an autocrine growth factor. Thp cells progress into the intermediate
ThO stage in which cytokines of both Th1 and Th2 are produced. In the murine
system these cells then terminally differentiate into Th1 or Th2 type cells under
the influence of cytokines produced upon repeated antigen stimulation (Street et
al, 1990).
Once induced, the subsequent expansion of Th subsets is facilitated and
regulated by subset specific cytokines (reviewed in Trinchieri,1993; Paul and
Seder,1994). The dominant cytokines responsible for Th1 and Th2 differentiation
are IL-12 and IL-4 respectively. IL-12 produced by macrophages in response to
bacteria or parasites is an obligatory factor for Th1 generation and proliferation.
IL-12 acts directly on Th1 cells and indirectly by inducing ylFN production by T
and NK cells. ylFN has a positive feedback effect by positively inducing further IL-
12 production from macrophages. The effect of ylFN in enhancing IL-12 may be
mediated by its ability to block endogenous IL-10 production by macrophages
(Chomarat et al, 1993). The presence of ylFN and the subsequent down-regulation
of IL-4 promotes the development of CD4 Th1 cells (Hsieh et al, 1993). On the
other hand IL-4 is required for the development of a Th2 response by inhibiting IL-
2 receptor expression and ylFN production. The Th2 cell products, IL-10 and IL-4
have a negative feedback effect by inhibiting IL-12 production (D'Andrea et
al, 1993). In order to determine whether IL-12 and IL-4 directly initiate Th1 and
Th2 development in naive T cells, Hsieh et al {1993) showed that naive CD4+ T
cells derived from mice transgenic for an anti-ovalbumin TCR, were induced by
ovalbumin, to develop into Th1 type cells in the presence of IL-12 and Th2 type
cells in the presence of IL-4.
Macrophages, NK cells and mast cells have all been implicated in the directed
development of the Th phenotype (Kullberg et al, 1992). NK cells are a major
source of ylFN in vivo (Gately et al, 1994). In addition to CD4 T cells, mast cells
have been shown to synthesize significant quantities of IL-4 (Bradding et al, 1993).
NK cells and macrophages produce ylFN for Th1 development, while mast cells
provide IL-4 for Th2 type responses. y8 T cells may also contribute to the cytokine
milieu that influences the differentiation of antigen specific CD4 T cells. y8 T cells
have been shown to produce cytokines appropriate to the Th response much earlier
than CD4 cells following infection (Ferrick et al, 1995). Macrophages, mast cells,
NK cells and y8 T cells appear to play a significant role in directing the immune
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response.
The influence of IL-4 and IL-12 in the development of functional T helper
subsets in vivo has been established using the mouse model of Leishmania major
infection (Heinzel et al, 1989). Strains of mice that are highly susceptible (Balb-
c), develop poor cell mediated immunity to the parasite and produce Th2 type
cytokines. In contrast, resistant mouse strains such as C3H develop Th1 responses.
Susceptible Balb-c mice can become resistant when treated with anti-IL-4
antibodies (Sadick et al, 1990) or administering IL-12 (Heinzel et a!,\993) near
the time of parasite innoculation. Recently it has been reported that treatment with
IL-12 in combination with a leishmanicidal drug induces healing in L. major
infected mice. This healing was associated with a switch from Th2 to Th1 response
(Nabors et al,~\ 995).
The immune response is directed by cytokines, however locally active
hormones (Daynes et al, 1991) antigen dose and antigen specific recognition can
also control the functional outcome of immunity. Peptide density on APCs has been
predicted from MHC haplotype and the cell mediated immunity was found associated
with the haplotype displaying low ligand density (Murray et al, 1994). Ligand
density may be important in controlling the functional outcome of the Th response.
The Th1/Th2 analysis has also been extended to CD8 T cell clones which
similarily subdivide on their cytokine secretion patterns (Salgame et al, 1991).
This was demonstrated for CD8 T cells specific for Mycobacterium leprae derived
from skin biopsies of patients with leprosy. Th1 CD8 clones were derived from
healed lesions of patients with tuberculoid leprosy. Th2 CD8 T cell clones were
derived from patients with lepramatous leprosy. Similarily CD8 T cell clones
generated from Kaposi's sarcoma skin lesions of patients with AIDS secrete IL-4
and IL-5 but not ylFN and show diminished cytolytic activity (Del Prete et
al, 1994). Mouse and rat CD8 T cells in in vitro culture have also been shown to
produce IL-4 when stimulated with IL-2, IL-4 and ConA/anti-CD3 (reviewed in
Kemeny efa/,1994; Seder and Le Gros,1995).
1.6 Antigen presentation by MHC class II on T cells
Antigen presentation has been considered a specialized function of
professional APCs (macrophages, B cells and dendritic cells) that constitutively
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express class II. The functional significance of class II expression on activated
human T cells is unclear. The ability of T cells to present soluble antigens is
limited by the lack of an efficient mechanism of antigen capture but T cells have
been shown to present peptide antigens in vitro.
Receptor-mediated interactions with antigens are required by T cells to
capture and present soluble antigens effectively. This has been demonstrated for
mouse immunoglobulin bound to the T cell surface, gp120 of HIV which binds CD4
(Lanzavecchia et al, 1988) and for hepatitis B virus which binds to the transferrin
receptor (Franco et al, 1992). Peptides or whole antigen covalently coupled to
anti-CD4 mAbs have also been shown to be taken up processed and presented by T
cells (Wyss-Corray et al, 1991). Thus T cells are not processing deficient but
their antigen presenting capacity is limited by their inefficiency in capturing
soluble antigens.
Though presentation of whole antigen by T cells is dependent on antigen
capture, T cells are able to present denatured antigens or peptides. The highly
purified native myelin basic protein (MBP) cannot be processed and presented by T
cell clones, however T cells can present peptides of MBP to stimulate epitope
specific autologous T cell clones (LaSalle et al, 1991). This has also been
demonstrated for influenza virus haemaglutinin specific T cell lines (Hewitt and
Feldman,1989). The inability of T cells to process whole antigens would imply that
T cells have no APC function in vivo. T cell peptide presentation may represent an
in vitro phenomenon of T cell clones binding excess peptide directly to class II
molecules (LaSalle et al,1991). There has been a report of uptake of soluble
antigen by pinocytosis (Barnaba et a/,1994), but these experiments did not include
controls to exclude uptake independent presentation. Using physiologically activated
class II positive sheep T cells in contrast to in vitro T cell lines no induction of
antigen-specific T cell proliferation was found even when using digested antigen
(Hopkins et al, 1993). Overall activated class II positive human T cells have the
ability to present antigens when bound to receptors on the T cell. The significance
of their ability to present peptides is controversial.
That activated T cells present antigens has been demonstrated in humans
(Lanzavecchia et al, 1988) and sheep (Hopkins et al, 1993) by their capacity to
stimulate allogeneic T cells in mixed lymphocyte reactions (MLR). This can be
expected as the alloantigen forms an integral part of the polymorphic structure of
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the class II molecule. LaSalle et al (1991), showed that T cells can present the
autoantigen, myelin basic protein (MBP) peptides, to autologous T cells in an MHC
class II restricted fashion. The activation of autoreactive T cells may lead to the
induction of autoimmune diseases. Much of the recent work on the functional
significance of class II on activated T cells suggest an immunoregulatory function in
T-T cell interactions. Broeren et al (1994), have reported direct evidence of T
cell regulation of activated T cells presenting TCR fragments in the rat. It was
demonstrated that T cells process and present their own TCR proteins to anti-TCR
peptide specific MHC class II restricted CD4+ T cells. T cell regulation of activated
T cells also underlies the principal of T cell vaccination, in patients with multiple
sclerosis (MS) there is an increased frequency of activated MBP reactive T cells
(Allegretta et al, 1990). Vaccination of MS patients with irradiated autologous MBP
reactive T cells induces an MHC restricted T cell response to the MBP-reactive T
cells (Zhang et al, 1993). It was postulated that this response was regulated by a
clonotypic network whereby peptides of the TCR variable region were presented by
T cells themselves. Indeed the up-regulation of class II on T cells is coincident with
internalization/down-regulation of the TCR (Valitutti et al, 1995). Therefore the
presentation of TCR fragments on activated T cells may maintain peripheral
tolerance.
This phenomenon may also be linked to the anergizing signals reported for
antigen presenting T cells. T cells primed with superantigen or by peptide
presenting T cells become unresponsive to further antigenic stimuli (O'Hehir and
Lamb,1990; LaSalle et al, 1992) whereas activation by B cells does not alter the
function of the reactive clones. Antigen presentation by T cells appears to down-
regulate the immune response and results in clonal anergy. Thus T-T cell
interactions may have important immunoregulatory function in the maintenance of
peripheral tolerance through the induction of clonal anergy.
Activated human T cells express the costimulatory molecule B7 after
repeated stimulation in vitro. B7 is also found on isolated T cells from HIV infected
individuals (Wyss-Corray et al, 1993). However not all activated T cells express
detectable amounts of B7 (Pichler and Wyss-Corray,1994). The significance of B7
expression on T cells has yet to be ascertained.
The signal transduction capabilities of T cell class II has also been examined.
Odumef al (1991) have shown that mAb to MHC class II molecules induce activation
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of tyrosine kinases and mobilization of intracellular calcium in activated human
class II positive T cells. Crosslinking class II with submitogenic amounts of anti-
CD3 induces IL-2, IL-3, ylFNandTNFa secretion by T cells (Spertini et al, 1992).
A more recent study, has shown that crosslinking class II molecules on human T
cells enhances IL-2 sensitivity. It was further shown that DQ as opposed to DR mAb
were unable to trigger this effect (Odum et al, 1 993).
The differential expression of class II isotypes on activation of T cells with a
predominance of DR followed by DP and DQ has also been documented (Oshima and
Eckels,1990a). Class II isotypes are differentially expressed on human T cells and
appear to have different sensitivities to IL-2 based on their proliferative response,
suggesting different roles in the regulation of T cell responses. Similarily in sheep
there is a predominance of DR expression over DQ. Using T cells drawn from the
various immunological compartments, variations in their cell surface phenotype
correlated with activation states such that DQ is thought to be a marker of recent
activation events while DR is a marker of memory (Hopkins et al, 1993).
In summary class II molecules on human T cells have been shown to
participate in MLR, autoantigen presentation, anergy induction and signal
transduction. The most exciting possibility is the presentation by a T cell of
idiotypic TCR peptides in the context of its own MHC class II molecules which may
form a basis for specific anti-idiotypic T-T cell interactions.
1.7 Immunological memory
It has long been recognized that the immune system holds a memory response
to previous encounters with antigen. Individuals who survive diseases such as
measles, mumps, chickenpox and whooping cough rarely suffer twice. The first
contact clearly imprints some memory so that the body is prepared to repel any
later invasion by that organism, a state of immunity is established. Compared to
primary encounter with antigen, the secondary response is more rapid and
effective. The memory response is dependent on T and B cells, the cells which
recognize the antigen. Both T and B cells maintain and are responsible for the
generation of memory. In this section the memory response of T lymphocytes is
discussed.
Much research has been conducted on delineating cell surface markers which
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relate to the activation state of the T cell. Initial studies in humans found that T
cells could be divided into distinct populations based on expression of two isoforms
of CD45, CD45RO and CD45RA\B\C (in human,mouse and rat) and adhesion
molecules (reviewed in Mackay,1993). T cells that expressed CD45RA expressed
low levels of adhesion molecules while CD45RO T cells expressed increased levels of
adhesion molecules. Furthermore, T cells bearing the low molecular weight
(CD45RO) isoform represented primed T cells and transferred specific responses
based on their ability to proliferate to recall antigen (Sanders et al, 1988). Thus it
was established that CD45RA marked naive antigen inexperienced T cells while
CD45RO delineated the memory T cells. Analysis on the distribution of these
phenotypes throughout life found that the memory phenotype was rare in young life
but became more conspicuous with age (DePaoli et al, 1988; Ernst et al, 1 990).
This led to the belief that the change in CD45 isoform expression represented an
antigen driven unidirectional maturation event.
This concept has since been challenged by findings that CD45 isoform
expression can readily interconvert. It was first discovered that T cell populations
of the low molecular weight isoform transferred into athymic nude rats reverted to
the high molecular weight isoform (Bell and Sparshott,1990). Several other
studies have substantiated this finding. Mitogen stimulated CD45RO human T cell
lines re-express the CD45RA isoform in vitro with time (Warren and
Skipsey,1991). More recent data from Sparshott and Bell (1994) demonstrates
that there is rapid interconversion of CD45R isoforms (<6 hours). Their evidence
suggests that CD45RC expression in the rat reflects a dynamic state in which T cells
switch back and forth between a resting (CD45RC+) and a more active state
(CD45RC"). This has led to the current understanding, that there are no markers
of memory but only markers of activation. On encounter with antigen T cells
become activated, acquire markers, proliferate and become hyperreactive to
antigen. After a brief phase, the stimulated cells revert to a resting phase and lose
the markers but remain present in expanded numbers (Mitchison,1992; Sparshott
and Rell,1994).
Though CD45 can readily interconvert, it still has value in defining
different cell phenotypes. Evidence from CD45 deficient T cell lines demonstrate
that CD45 is an absolute requirement for TCR signalling (reviewed in Trowbridge
and Thomas,1994) and there is further evidence demonstrating that CD45 isoforms
regulate signal transduction through the TCR differentially (Chui et al, 1994). The
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use of CD45 expression in conjunction with adhesion molecule expression provides
a better definition of T cell phenotypes. T cells which have not encountered antigen
since their exit from the thymus, express high levels of CD45RA/B/C (in human,
mouse and rat respectively) L-selectin and low levels of CD44. Effector T cells
which have been stimulated by antigen express a reciprocal phenotype with low
levels of CD45RA/B/C (or high CD45RO) low levels of L-selectin and high levels of
CD44. In addition effector/memory type cells have higher levels of several
adhesion molecules such as ICAM-1, LFA-1, CD2, LFA-3 and VLA-4 (Sanders et
al, 1988; Mackay et al, 1990).
An interesting approach recently reported (McHeyzer-Williams and
Davis,1995) uses the T cell receptor sequences of responder cells as a memory
marker. It was shown that certain sequences predominated in the secondary
response while others disappeared, suggesting a selective preservation or expansion
of specific T cell clones. The change in repertoire seen may represent a selection
for T cells expressing a receptor with greater specificity for the antigen-major
histocompatibility complex i.e. the memory response.
1.7.1 Lifespan of naive and memory T cells
The lifespan of both naive and memory T cells is controversial (reviewed in
Gray,1993; Matzinger,1994; Sprent and Tough,1994). Because the cell surface
markers used to define phenotypes are variably regulated, it is difficult to assess
the precise functional phenotypes of T cells. For example when bromodeoxyuridine
(BrdU), a DNA precursor is administered to thymectomized mice a proportion of
the naive phenotype (CD45RB, L-selectin, Pgp-1) T cells were found to divide
(Tough and Sprent,1994) implying that the surface phenotype of T cells does not
correlate exactly with functional phenotype. However, because there is no
definitive marker for memory/naive T cells, the cell surface phenotypic division is
still used to define the temporal activation status of T cells.
Adoptive transfer experiments have demonstrated that naive phenotype I
cells can survive for long periods in the host (Sprent et a/,1991). Tough and
Sprent's (1994) studies on thymectomized mice found with BrdU labelling that the
naive phenotype T cells remain in interphase for prolonged periods. Thus it has
been suggested that naive T cells are potentially long-lived. The longevity of these
virgin cells allows the immune system to continue to mount primary responses to
26
new antigens even in advanced age.
If memory resides in long-lived cells, the presence or absence of antigen
should be irrelevant. However in experiments transferring memory phenotype
cells without antigen, these cells lost their function after a couple of months. In
these adoptive transfer experiments memory type T cells were dependent on the
presence of antigen for survival (Gray and Matzinger,1991). Investigations on the
lifespan of both CD45RO and CD45RA T cells in patients after radiotherapy show
rapid loss of unstable chromosomes from the CD45RO but not the CD45RA pool
(Michie et al, 1992). Immunological memory appears to reside in a population
with a more rapid rate of division. Memory phenotype T cells in the sheep
(CD45R) have also been noted as short-lived (Mackay et al, 1990). Tough and
Sprent's studies using BrdU labelling in thymectomized mice, found that a
proportion of the memory phenotype T cells divided rapidly while others remained
in interphase for weeks. Long-term memory T cells have been shown by recent
findings that murine cytotoxic T cells, which confer protection to viral antigen,
survive for years in the apparent absence of persisting antigen (Lau et al, 1994;
Hou et al, 1994). These results favor a model whereby both short term memory and
long term memory T cells exist. Short term memory cells require constant
restimulation to ensure survival of memory while long term memory cells survey
the tissues until they make contact with specific antigen. Short term memory T
cells may be maintained by the slow release of antigen from dendritic cells, keeping
these cells in a constant state of activation. It is also possible that CD8 T cells
exhibit long term memory while CD4 T cells require constant antigen stimulation
for longevity.
1.7.2 Migration of memory and naive T cells
Because the frequency of antigen specific lymphocytes is low, continuous
migration through the tissues of the body enhances the likelihood of cells of
appropriate specificity coming into contact with individual antigen (reviewed in
Picker, 1992; Gray, I 993; Mackay, 1993).
Much of this work has been carried out using the ovine cannulated lymphatic
model. This model allows access to in vivo fractionated cell populations from
distinct lymphoid compartments. The vast majority of lymphocytes migrate
through the body by passing from the blood to secondary lymphoid tissues (lymph
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nodes, Peyers patches, gut associated lymphoid tissue) by way of specialized high
endothelial venules (HEVs) (Hall,1974). Lymphocytes return to the blood via the
efferent lymph ducts and the thoracic duct. Small numbers of lymphocytes also
leave the blood in peripheral tissues. Cells that enter tissues eventually accumulate
in the afferent lymphatic ducts. Within this system different migration routes have
been proposed for naive and memory phenotype I lymphocytes (Mackay,1991).
T cells draining the skin into the afferent lymphatics are mostly memory
type. This is consistent with observations that T cells with the memory phenotype
are highly enriched in inflammatory sites (Pitzalis et al, 1988). Inflammatory
stimuli result in large numbers of memory type lymphocytes crossing inflamed
endothelia (Pitzalis efa/,1991; Picker,1993). T cells within efferent lymph
derived from the blood via high endothelial venules (HEVs) predominantly express
the naive phenotype (Mackay et al, 1990). More recent studies show a tissue
specific migration route of activated T cells to the skin and gut (Mackay et al, 1 992
a & b). Thus it appears that naive cells enter lymph nodes through high endothelial
venules, while cells with the memory phenotype leave the blood at other sites and
enter the lymph nodes through lymphatic drainage from these tissues. In the lymph
nodes antigens arrive via the afferent lymph and presentation to naive T cells by
dendritic cells and macrophages occurs (Bujdoso et al, 1989). Thus naive T cells
are able to screen a large drainage area in a short time. In contrast the migration of
memory T cells in non-lymphoid tissues allows them to carry out their effector
function directly and reach the lymph nodes via the afferent lymph. The trophism
exhibited by memory T cells allows them to survey tissues that possibly frequently
encounter the specific antigen.
Primary antigen challenge to lymph nodes produces only minor changes in
lymph flow and cell output. In contrast secondary challenge results in cell
shutdown and increased lymphocyte output (Hall and Morris,1965; Mackay et
al, 1990; Hopkins et al,~\ 993). Presumably antigen delivered on primary
challenge is presented by dendritic cells and macrophages to the naive T cells in the
node thus establishing a memory response to the specific antigen. The increased
traffic in secondary challenge is correlated by increased traffic of the memory
phenotype T cells and blastogenesis of B cells. This increased traffic of memory
type T cells serves to place functionally potent T cells at sites of antigen deposition.
A number of lymphocyte and endothelial cell adhesion molecules have been
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identified which define where cells adhere and migrate. The adhesion molecules
which facilitate differential migration include the selectins (L-selectin, E-selectin
and P-seiectin) and their ligands, the immunoglobulin superfamily cell adhesion
molecules (ICAM-1, ICAM-2, VCAM-1) and the integrins (LFA-1, the a4, a5, a6
and (51, p2, p7 heterodimers). The a4pi integrin has been found to be one of the
principal adhesion molecules for lymphocyte extravasation to inflammatory sites
(van Kooyk and Figdor,1993). In sheep, skin memory phenotype T cells express
high levels of the a6 and p1 integrins in contrast low levels are expressed by gut
memory phenotype T cells ( Mackay et al, 1992a&b). L-selectin on the other hand
has been implicated in lymphocyte binding to lymph node HEV (Gallatin et
al, 1983). Naive T cells are L-selectin positive enabling them to enter lymph node
through the blood while memory T cells lack this receptor and reach the lymph node
through afferent lymph (Mackay,1991).
A multistep hypothesis (Butcher,1991) proposes that lymphocyte
extravasation is the result of (a) primary adhesion (activation independent), (b)
lymphocyte activation and (c) activation dependent adhesion. Various
chemoattractants and cytokines have been implicated as activation factors in this
process.
1.8 Aim of thesis
The aim of the work presented in this thesis was to investigate the functional
significance of class II expression on sheep T cells. A proportion of resting T cells
express class II and on activation there is increased expression of the products of
both DR and DQ genes on T cells. This is evident in each of the T cell subsets (CD4,
CD8and y8). The function of class II positive T cells is not fully understood.
Firstly, it was necessary to define subgroup specific MHC class II molecules.
The NH2-terminal amino acid sequence of the molecules recognized by two
monoclonal antibodies (mAbs) was carried out to confirm their locus specificity.
This allowed their comparison with homologues identified in humans and mice.
Using defined mAbs the differential expression of class II on lymphocyte subsets was
analysed in the various immunological compartments of the cannulated sheep.
Expression following in vivo activation was also examined.
Class II antigens (DR,DQ) on sheep T cells may be described as activation
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markers, however their relationship with other markers of activation is unknown.
Work was conducted to correlate class II antigen expression on sheep T cells with
other known activation markers. A separation technique was employed to
fractionate the T cell populations into CD4+, CD8+ and y8+ (T19) T cell pools.
Activation marker expression and class II antigen expression was then correlated
directly on each of these subsets by two colour flow cytometry.
The different products of the MHC class II loci on T cells have been shown to
vary in their signal transduction capabilities (Odum et al, 1993). Signal
transduction events that occur during antigen recognition by T cells produce a
variety of cytokines. The cytokines secreted subdivide T cells into Th1 or Th2
types. This subdivision can delineate their functional role. For further insight into
the function of the class II isotypes on T cells, cytokine profiles of DR+ T cells was
compared with that of DR" T cells.
Thus by analysing class II expression with relation to other markers of
activation combined with the analysis of cytokine patterns of the different class II
antigens, it was hoped to achieve a greater understanding of the functional
importance of MHC class II positive T cells.
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CHAPTER 2 Materials and Methods
2.1 Materials
2.1.1 Chemical reagents and plasticware
Materials used in the preparation of this thesis were supplied by Sigma
Chemical Company, Poole, Dorset, U.K. and BDH Laboratory Supplies, Poole,
England unless otherwise stated. Nunc, Denmark supplied the sterile tissue culture
ware. All radioisotopes were supplied by Amersham International pic.,
Buckinghamshire, England.
2.1.2 Animals
Blackface sheep were obtained from the Moredun Research Institute,
Edinburgh. They were kept in cages and given food and water ad libitum. Animal
surgery was performed by Dr John Hopkins and all animal inoculations and blood
sampling were performed by suitably licensed colleagues.
2.1.3 Media for cell culture
Cell cultures were maintained in RPMI 1640 (Gibco Biocult, Uxbridge,
U.K.) supplemented with 2mM L-glutamine, 100 U/ml benzyipenicillin and 100
U/ml streptomycin, 500 mM 2-mercaptoethanol, 2.5mM Hepes and 10% foetal
calf serum (Flow Laboratories, Hertfordshire, U.K.). Wash media was RPMI
containing 1% foetal calf serum.
2.1.4 Monoclonal antibodies
The monoclonal antibodies (mAbs) used were from stocks held within the
department. A summary of the mAbs used and their specificites for the sheep is
given in Table 2.1
2.2 Methods
2.2.1 Immunizations and secondary in vivo challenge of animals
Sheep were antigenically primed by intradermal injection of 1 mg
ovalbumin in complete Freunds adjuvant and by subsequent injections of 1mg
ovalbumin in sterile PBS. Secondary in vivo challenge of primed animals 4-6
weeks after primary immunizations was by intradermal injection of 100gg
ovalbumin given in 1 ml sterile PBS containing 1% patent blue dye into several
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sites around the drainage area of cannulated lymphatic vessels.
Table 2.1 Monoclonal antibodies recognizing ovine (ov) leukocyte molecules.
mAb Specificity isctypc Reference
ST197 ovT 1 9 (WC1) lgG2b Maddox, 1986
CC15 ovT 1 9 (WC1) lgG2a Clevers et al, 1990
ST4 ovCD4 igGi Maddoxet al, 1985
SBU-T4 ovCD4 igG2a Maddoxefa/, 1985
E95 ovCD8 IgM Maddoxefa/, 1985
SBU-T8 ovCD8 lgG2a Maddoxefa/, 1985
VPM 8 ovlgG1 lgG1 Jones, 1988
VPM30 ovB cell IgM Naessens & Howard, 1991
VPM 19 ovMHC class 1 igGi Hopkins et al, 1990
SW73.2 pan MHC class II (3 Rat lgG2b Hopkins et al, 1986
VPM54 ovMHC DRa chain lgG1 Dutia et al, 1994
VPM36 ovMHCDQa chain lgG1 Dutia et al, 1 994
HMT3.1 anti-human CD3 igGi Kubo et al, unpublished
F1 0/1 50/39 ovLFAl igGi Mackay et al, 1990a
L1 80/1 ovLFA3 IgGi Hunig, 1985
IL-A1 11 anti-bovine CD25 igGi Naessensef al, 1992
73B ovCD45RA igGi Mackay et al, 1990a
35A-1 ovCD2 igGi Giegerich et al, 1 989
25-32 ovCD44 igGi Mackay et al, 1988
25-91 ovCD5 igGi Mackay et al, 1 985
218 ova4 integrin lgG2b Sanchez-Madrid et al, 1983
Du 1 -29 ovL-selectin lgG1 Mackay et al, 1 992
VPM64 ovFcylll igGi Gupta, 1994
VPM65 ovCD14 lgG1 Gupta, 1994
VPM21 ovBDV igGi Dutia et al, 1 990b
VPM22 ovBDV lgG2b Dutia et al, 1990b
MS121 ovIgGA lgG2a unpublished
2ySH ovlgG2 rat lgG2b unpublished
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2.2.2 Collection of lymph
Surgical techniques for the cannulation of efferent lymphatic vessels were
as described by Hall (1967). Pseudoafferent lymphatic cannulations were as those
described for the prefemoral lymphatic except that the node had been excised at
least 6 weeks previously. During this time the afferent vessels anastomose with the
efferent duct remaining after removal of the node (Hopkins et al,~\ 986).
Cannulations were allowed at least 3 days to stabilize following surgical procedures.
Lymph collections were made from fully conscious animals into sterile siliconized
bottles containing 200 units heparin.
2.2.3 Preparation of cells
2.2.3.1 Peripheral blood leukocytes (PBL)
Peripheral blood leukocytes were isolated from heparinized blood by NH4CI
lysis as described by Mishell and Shiigi (1980). 10 mis of blood was added to 35
mis lysis buffer (0.16M NH4CI, 0.017M Tris, pH7) warmed to 37°C.
Clarification of the solution indicates lysis of the red blood cells. The cells were
centrifuged at 200g for 5 minutes and washed twice in PBS. Peripheral blood
leukocytes were also prepared by defibrinating blood end over end with glass beads.
The defibrinated blood was then layered over Lymphoprep (Nygaard, Oslo,Norway)
and centrifuged at 850g for 20 minutes. When dealing with large quantities of
defibrinated blood, red blood cells were lysed by hypotonic shock before layering
over lymphoprep. 10mls of blood was added to 15mls sterile water and
immediately reequilibrated with the addition of 1.5 mis of 10X sterile PBS.
2.2.3.2 Lymphocytes
Lymphocytes from efferent and afferent cannulations were washed twice in
PBA (1 %BSA, 0.1% Na-azide,PBS) by centrifugation at 200g for 5 minutes for
use in immunofluorescent analysis and washed twice in wash media for use in in
vitro proliferation assays.
2.2.3.3 Alveolar macrophages
Lungs recovered from the abattoir were rinsed with ice-cold Hanks Buffered
Salt Solution (HBSS),(1mM CaCI2,5mM KCI, 0.5mM KH2P04, 0.5mM MgCI2,
0.5mMMgSO4, 0.14M NaCI, 1mM Na2P04, 5mM Glucose, 0.02M Hepes, 0.01%
phenol red, pH7). Using a funnel down the trachea, HBSS was poured into both
intact lungs and the lungs gently massaged to release macrophages. Cells were
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harvested by centrifugation at 800g for 15 minutes at 4°C, washed twice with HBSS
and resuspended in 10mls RPMI. Erythrocytes were lysed by hypotonic shock,
15mls water was added to the cell suspension, followed immediately by 1.5mls 10x
PBS to restore isotonicity. The cells were washed, resuspended in culture media at
2x1 06/ml in T75 flasks and allowed to adhere to the plastic flasks for 2 hours in
the incubator. Non-adherent cells were poured off and replaced with fresh culture
media and stimulated with bacterial lipopolysaccharide (from Salmonella abortus
equi) at 10pg/ml. Cells were directly harvested into RNAzol B at various time
points following stimulation.
2.2.3.4 Cell fixation
Cells were suspended at 1x108 per ml in PBA. An equal volume of 1%
paraformaldehyde was added to the cell suspension, incubated for 5 minutes then
washed.
2.2.4 Immunochemical Techniques
2.2.4.1 Caprylic acid precipitation
Immunoglobulin was isolated from ascitic fluid by caprylic acid treatment
(Russo et at, 1 983). 25jil glacial acetic acid was added per ml of ascites to bring
the pH to 5.0. 50|il of caprylic acid was added per ml of ascites and stirred at room
temperature for 30 minutes, centrifuged at 13000g for 5 minutes then placed at
4°C for 30 minutes to remove the solidified caprylic acid. The purified Ig was then
dialysed into several changes of 0.1 M sodium bicarbonate buffer pH 8.4. Protein
concentration was determined by spectrophotometer, whereby a reading of 1
absorbance unit at 280nm is the equivalent of 715 pigIgG.
2.2.4.2 Biotinylation
Purified Ig was coupled to biotin (biotinamidocaproate N-
hydroxysuccinimide ester) (1mg/ml in DMSO) at a biotin/IgG ratio of 75pg/mg.
The suspension was rotated end over end for 4 hours at room temperature. The
biotinylated Ig was dialysed against PBS containing 20% (v/v) glycerol and titrated
for flow cytometric use.
2.2.4.3 Immunodiffusion
This technique was based on that developed by Ouchterlony (1967). 1%
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(w/v) agarose in PBS-0.05% (w/v) Na-azide gels were prepared. Sera was added
to the central well and ovalbumin at 0.5mg/ml added to the outer wells. The plates
were incubated in a humid chamber overnight. Plates were examined and stained
with Coomassie Brilliant Blue G250.
2.2.4.4 Cytospin and Leishmann Staining
Cells at a concentration of 104/1 0 0pi were spun onto glass slides at
1200rpm. Slides were allowed to air dry and then stained with Leishmann stain for
1 minute followed by a wash in Leishmann buffer pH6.8. Slides were allowed to air
dry then mounted in DPX.
2.2.5 Immunofluorescence Staining
2.2.5.1 Immunofluorescent staining and flow cytometry
Antibodies supplied as saturated supernatants were used undiluted, whereas
antibodies obtained from ascitic fluid were diluted in PBA to give optimal
fluorescent intensity. The optimal working dilution of the various conjugates was
determined by titrating against optimal dilutions of the primary antibody so that the
mean and mode of fluoresence distribution coincided.
For single colour immunofluorescent staining, 106 cells were incubated
with 5Ojul of mAb at appropriate dilution for 30 minutes at room temperature.
Unbound antibody was removed by washing in PBA. Cells were resuspended in 50pl
of FITC anti-mouse Ig (Scottish Antibody Production Unit, Carluke, U.K.). After a
30 minute incubation the cells were analysed per sample with dead cells excluded on
the basis of forward light scatter.
Dual colour immunofluorescence requires that each antibody is detected by a
distinct fluorochrome. Immunoglobulin prepared from ascitic fluid of the anti-cell
phenotype antibodies (CD4, CD8, VPM30 and CC15) was biotinylated. These
biotinylated mAbs were detected using streptavidin-phycoerythrin (SA-PE)
(Amersham.UK). The second antibodies were used in conjunction with the relevant
Ig subclass-specific FITC conjugated anti-mouse Ig antiserum (The Binding Site,
Birmingham, UK).
Cells were stained simultaneously with 25pl of the appropriate dilution of
both antibodies. After 30 minutes incubation at room temperature, cells were
washed twice and incubated for a further 30 minutes with dilutions of SA-PE and
FITC-antiimmunoglobulin before finally washing twice and analyzing. Dual staining
using SW73.2 required that each staining step be done sequentially, first staining
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with SW73.2, followed by an anti-rat-PE conjugate (Serotec, Oxford, U.K.),
followed by second antibody and anti-mouse FITC conjugated antisera.
2.2.5.2 Immunofluorescent analysis
All fluorescence analysis was carried out using a Becton Dickinson FACScan
cell analyzer. Live gating using forward scatter (FSC) and side scatter (SSC)
parameters were used to distinguish the different cell populations in afferent
lymph, efferent lymph and blood. The gate used for small lymphocytes is shown in
Figure 2.1. The fluorescence profile of a population of cells is presented as a
histogram of fluorescent intensity versus relative cell number. Linear
amplification was used for the physical parameters (FSC,SSC) and logarithmic
amplification used for the fluorescence parameters (FL1,FL2). FL1-FL2 and FL2-
FL1 compensation was used to optimize the two-colour analysis. Antibody positive
cells were gated by reference to biotinylated normal mouse Ig at 10pg/ml or
irrelevant anti-rat or mouse antibody followed by FITC conjugated anti-serum IgG.
Calculations of percentage positive cells were obtained by subtracting any residual
percentage staining on the gated negative control from all positive staining.
2.2.6 Cell purification
Magnetic activated cell sorting (MACS) was used to either negatively or
positively select cells. The cellular content of afferent lymph, efferent lymph and
PBL from which cell populations were isolated is shown in Table 2.2.
2.2.6.1 MACS selection for flow cytometric use
When separating cells for flow cytometric use, cells were first fixed in
0.5% paraformaldehyde (described in 2.2.3.4). Cells were counted and suspended
in PBA and the appropriate titre of biotinylated mAb for 40 minutes. Cells were
then washed and resuspended at 107cells/90)xl plus 10pl MACS streptavidin
microbeads and incubated for 15 minutes before washing again.
Cells were applied in suspension to the ferromagnetic stainless steel wool
column in a strong magnetic field. Columns were incubated with 1% BSA for 15-
60 minutes prior to use to saturate non-specific binding sites. Cell suspensions
were allowed to pass through the column under the force of gravity and the speed of
elution altered by changing the size of elution needle. For negative selection a low
flow speed is necessary (~1ml/min) whilst for positive selection the flow rates are
less critical. Positively selected cells were repassaged through the column four
times to achieve high purity. The effluent was collected as the negative fraction and
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labelled cells were eluted outside the MACS magnetic field with the needle removed
from the column, as the positive fraction.
Figure 2.1
Forward scatter (FSC) and side scatter (SSC) profile of afferent lymph cells and





The percentage of CD4+, CD8+, T19+ and B cells in efferent lymph, afferent lymph
and PBL is shown.
EFFERENT AFFERENT PBL
CD4+ 48.7±3.1 (n = 7) 54.7±3.8 (n = 7) 36.8±1 5.0 (n=5)
CD8+ 1 G.2±2.8 (n=7) 11.1+2.4 (n = 9) 11.0±6.5 (n=5)
T19+(y6) 8.0±3.1 (n=7) 9.1 ±1.3 (n=7) 7.1 ±2.7 (n=4)
B cell 14.8 + 7.3 (n=5) 1 6.3±7.8 (n=7) 26.7±6.0 (n = 6)
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The purity of the cell populations was assesed by (1) immunofluorescently
labelling with monoclonal antibodies specific for various subset markers followed
by isotype specific second layer reagents or (2) by incorporating streptavidin
conjugated phycoerythrin (SA-PE) with the MACS streptavidin microbead
incubation step at 5pl SA-PE per ml of cell suspension.
2.2.6.2 MACS selection for in vitro use
The same method was used except that cells were not fixed but kept on ice
during this procedure. Tissue culture wash media was used throughout.
2.2.7 Transmission Electron Microscopy
Ovine T lymphocytes were fractionated into a CD4, CD8, yd and B cell
positive fraction and a CD4, CD8, yd and B cell negative fraction using the MACS
(described in 2.2.6.1). Cells were prepared for electron microscopy by the staff at
the Veterinary Preclinical Department, University of Edinburgh. Cells were fixed
overnight in 0.1 M sodium cacodylate pH7.3 and 3% glutaraldehyde buffer. Cells
were washed three times in 0.1 M sodium cacodylate pH7.3 and treated with 1%
osmium tetroxide made up in 0.1 M sodium cocodylate pH7.3. Samples were
dehydrated through graded acetone solutions and embedded in araldite. Ultrathin
sections were cut, stained with 50% uranyl acetate (in ethanol) and Reynolds lead
citrate for examination in a Phillips TEM 400 operating at 100kV.
2.2.8 Proliferation assays
2.2.8.1 Ovine peripheral blood mononuclear cells (PBMC)
PBMC prepared from both antigen primed and non-primed sheep were
resuspended in culture medium and 105 cells cultured in 96-well round bottomed
microtest trays (Gibco) with various concentrations of antigen (ovalbumin).
Cultures were made to a final volume of 200pl and established in triplicate.
Concanavalin A (Con A) at 5pg/ml was used as a positive control and human serum
albumin (HSA) at the same concentrations as ovalbumin as a negative control. The
proliferation assays were incubated for 5 days at 37°C in 5% C02. 3H-thymidine
at 1pCi/well was added for the last 4 hours of culture. Cultures were harvested
onto glass filter using a Harvester-96 (Tomtec, CT,USA) and the 3H-thymidine
incorporation was measured by beta spectroscopy.
38
2.2.8.2 Proliferation assays for cytokine analysis
2.2.8.2.1 Proliferation with Con A
Leukocytes collected from blood or efferent lymph were cultured in T25
flasks at 2 X106 cells/ml with 5pg/ml Con A. Cells were harvested at various time
points and cell pellets lysed directly for RNA extraction. In some experiments the
lymphocytes were first fractionated using the MACS into MHC class II DR positive
or negative T cell subpopulations .
2.2.8.2.2 Proliferation with ovalbumin
Using efferent cells for proliferation assays, autologous PBMC were
irradiated to act as antigen presenting cells. PBMC prepared from ovine blood were
suspended in RPMI and 1% FCS at a concentration of 2x106cells/ml and irradiated
using a cobalt-caesium source. The amount of radiation that prevented subsequent
proliferation of PBMC was 3000 rads. Total efferent cells were MACS selected into
MHC class II DR positive and negative fractions and 107 cells set up in culture with
an equal number of irradiated PBMC. Ovalbumin was added at 500pg/mi. Cells
were harvested at various time points after stimulation and lysed directly for RNA
extraction.
2.2.9 Purification of MHC class II for amino acid sequencing
2.2.9.1 Column Preparation
Immunoglobulin was purified by caprylic acid precipitation as described
previously (2.2.4.1) and dialysed into several changes of 0.1 M phosphate buffer
pH7.2. The protein concentration was determined by spectrophotometry and
coupled to Affigel 10 (Bio-Rad, Hertfordshire, U.K.) for 4 hours at 4°C. Unbound
sites were blocked with 1M ethanolamine pH8.0 for 1 hour. The antibody linked
Affigel 10 was then washed with TNT (20mM Tris-HCI pH 8.0, 150mM NaCI, 0.5%
Triton X100).
2.2.9.2 Lysate Preparation
Ovine class II was purified from sheep spleen (obtained from the local
abattoir). Spleen tissue was teased from the capsule, homogenized in ice cold HBSS
using an electric blender. Cells were pelleted by centrifugation at 800g for 15
minutes and lysed in TNT containing 0.2mM phenyl methyl sulphonyl flouride
(PMSF). Nuclei were removed by centrifugation for 15 minutes at 800g. The
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lysate was clarified by centrifugation for 90 minutes at 3000g followed by
filtration through glass fibre filters (Millipore, Ireland). The lysate was pumped
onto a normal mouse Ig Affigel 10 column followed by either a VPM36 or a VPM54
Affigel 10 column. The column was washed through with TNT buffer followed by
15mM triethanolamine-HCI, pH 8.0, 0.5% sodium deoxycholate and eluted with
15mM triethanolamine-HCI pH11.3, 0.5M NaCI, 0.5% sodium deoxycholate. Eluted
fractions were neutralized with respect to pH by addition of 0.5M triethanolamine
pH7.9. Protein containing fractions were identified by spectrophotometor at
280nm and peak fractions pooled. The columns were reequilibrated with PBS-
0.05% sodium azide.
2.2.9.3 Isolation of monomers for amino acid sequencing
Isolation of the individual a and p chain monomers of MHC class II was
accomplished with the Applied Biosystems Model 230A HPEC, an automated
micropreparative electrophoresis system. Separation was achieved on 10%
polyacrylamide gels [30% (w/v) acrylamide, 0.8% (w/v) piperazine
diacrylamide(PDA)] in Tris-phosphate pH7.5. The separated eluted a chains of
VPM36 and VPM54 were centrifuged onto a polyvinylidene difluoride (PVDF)
membrane using Prospin cartridges (Applied Biosystems, Warrington, U.K.).
Sequencing was carried out at the SERC Protein Sequencing Facility, University of
Aberdeen, U.K. on an Applied Biosystems pulsed liquid analyser.
2.2.10 Protein Chemistry
2.2.10.1 Preparation of cell samples for SDS polyacrylamide gel electrophoresis
(SDS-PAGE)
Cells were counted and pelleted by centrifugation at 800g for 5 minutes and
lysed in TNT containing 0.2mM PMSF at a concentration of 5x 107ce I Is/ml, for 30
minutes on ice. Nuclei were removed by centrifugation at 13000g for 10 minutes.
The supernatant was then acetone precipitated by the addition of 5 volumes of ice-
cold acetone-1mM HCI and overnight incubation at -20°C. The precipitate was
recovered by centrifuging for 10 minutes at 13000g.
2.2.10.2 SDS-PAGE
Proteins were separated according to size by electrophoresis using the
method of Laemmli (1970). Protein fractionation was on polyacrylamide gels with
a Tris-glycine buffer containing SDS using the Bio-Rad mini-protean II system
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apparatus. The separating gel consisted of 12% polyacrylamide [30% (w/v)
acrylamide,0.8% (w/v) bisacrylamide], 375mM Tris-HCI pH 8.7, 0.1% (w/v)
SDS with 0.05% (w/v) ammonium persulphate and 0.05% (v/v) TEMED added to
polymerize the gel. This gel was then overlaid with a stacking gel consisting of 3%
polyacrylamide 125mM Tris-HCI pH 6.8, 1% SDS, 0.05% ammonium persulphate
and 0.1% TEMED. Samples were mixed with an equal volume of sample buffer
[0.125M Tris-HCI, pH 6.8, 20% (v/v) glycerol, 2% (w/v) SDS, 0.04% (w/v)
bromophenol blue], boiled for 3 minutes then added to stacking gel. A set of
proteins of known molecular weights (Pharmacia, Herts, U.K.) were used as size
markers. Gels were run at 200V until the dye front reached the bottom of the gel.
2.2.10.3 Silver staining of gels
Gels were fixed in 50% (v/v) methanol, 10% (v/v) acetic acid for 15
minutes, 5% methanol, 7% acetic acid for 30 minutes and then 10% (v/v)
glutaraldehyde for 30 minutes. Gels were then washed thoroughly in several
changes of deionised water over several hours. After washing, gels were stained
with 0.1% (w/v) silver nitrate solution for 15 minutes, rinsed briefly with water
then developed with a 3%(w/v) sodium carbonate 0.02% (v/v) formaldehyde
solution. Colour development was stopped by the addition of solid citric acid. Gels
were rinsed well, fixed in 10% llfofix (llford, Cheshire) for 1 minute, washed
then dried at 80°C under vacuum.
2.2.10.4 Immunoblotting
After electrophoretic separation on SDS-PAGE, proteins were transferrred
to nitrocellulose membrane (Hybond C, Amersham) using a semi-dry electroblotter
(Ancos, Denmark). The gel was placed on top of the membrane and sandwiched
between blotting paper soaked in blotting buffer (48mM Tris, 39mM glycine, 20%
methanol) current at 120mA was applied for 45 minutes. Following transfer,
marker tracks were stained with 0.5% amido black and the remaining membrane
blocked in 5% (w/v) non-fat dried milk powder (Cadburys, Stafford, U.K.) in PBS
before overnight incubation in primary antibody. Blots were washed in several
changes of PBS-1% non-fat dried milk powder over 60 minutes at room
temperature. Bound primary antibody was detected by incubating for 60 minutes
with an anti-mouse whole IgG molecule biotin conjugate (Boehringer Mannheim,
East Sussex, U.K.) followed by alkaline phosphatase conjugated to streptavidin
(Boehringer Mannheim). Excess reagent was removed by several changes of buffer
over 60 minutes at room temperature. The immunoblots were developed with
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0.17mg/ml nitro-blue tetrazolium and 80|ag/ml 5-bromo-4-chloro-3-
indolylphosphate in 0.1M Tris-HCI pH9.5 and 3.5mM MgCI2- Colour development
was stopped by washing in water.
2.2.11 Molecular Biology Techniques
In the manipulation of nucleic acids care was taken in keeping preparations
free of nucleases. All handling was done wearing gloves, sterilized ware was used
and solutions kept on ice. Dimethylsulphoxide (DEPC) treated water was used for
RNA work (0.2% (w/v) DEPC added to water, incubated for 2 hours, then
autoclaved).
2.2.11.1 Purification of RNA
Total RNA was prepared by the method of Chomczynski and Sacchi (1987)
modified by Cinna/Biotecx (RNAzol B method, Biogenesis Ltd., Bournemouth, U.K.).
The cell pellets were lysed directly by the addition of RNAzo! B (1 ml/107cells).
RNA was solubilized by passing the lysate 5-6 times through the pipette.
Chloroform was added to 10% and samples shaken vigorously for 15 seconds before
placing on ice for 5 minutes. The suspensions were centrifuged at 13000g for 15
minutes and the upper aqueous phase transferred to a fresh tube with the addition of
an equal volume of ice cold isopropanol. Samples were stored on ice for a minimum
of 15 minutes, when using low numbers of cells the isopropanol step was carried
out overnight. The RNA was precipitated with another 15 minute centrifugation.
The RNA was then washed using 75% ethanol. RNA pellets were finally resuspended
in 50pl DEPC treated water and stored at -70°C. The concentration of RNA was
estimated by measuring the absorbance at 260nm of aliquots diluted 1:100 in water
and applying the equation RNA=A260x 100 x 40ng/ml. Absorbance readings at
280nm were also measured to check the sample purity. Pure preparations of RNA
have A260/A280 ratios of 2.0. If the ratio is less than this value, the sample is
contaminated with protein or phenol and the calculated concentration of nucleic acid
is not then reliable. The integrity of the RNA was checked by agarose gel
electrophoresis when sufficient quantities of RNA was recovered.
2.2.11.2 Synthesis of cDNA
Single stranded DNA was synthesised by the method of Gubler and Hoffman
(1983) from total RNA using a commercial kit (1st strand cDNA synthesis system,
Amersham). Reactions were carried out according to manufacturers instructions
using 1pg amounts of RNA per reaction. Oligo dT was used to prime from the 3'
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poly(A)tail of mRNA. Incorporation of 1pCi a32P-dCTP in this reaction allowed the
yield of cDNA to be estimated. The reactions were allowed to proceed at 42°C for 1
hour.
2.2.11.2.1 Estimation of the amount of radioactivity incorporated into nucleic acid
On completion 10% of the reaction mix was diluted 10 fold and an equal
volume spotted onto filter discs (Millipore, Herts, U.K.) in duplicate. One set of
discs were washed in an ice-cold solution of 5% TCA followed by ice cold ethanol and
finally in ice cold acetone. The discs were allowed to dry thoroughly. Scintillant
was added and the percentage incorporation of radioactivity was measured using an
LKB liquid scintillation counter. The unwashed filter measures the total
radioactivity in the sample while the washed filter measures only the incorporated
nucleic acid. The percentage of input radioactivity incorporated into DNA can be
calculated, thus allowing the calculation of mass of cDNA synthesized. The yield of
cDNA from each reaction was calculated as follows
cDNA synthesized= A x B ng
C
where A= the residue molecular weight of 1mole dNTP (350)
B= the total amount of dNTP incorporated
4 x %incorporation
nmoles of unlabelled dCTP incorporated
C= the weight of input RNA
2.2.11.2.2 Purification of cDNA for polymerase chain reactions (PCR)
The cDNA synthesised was diluted to 10Opil with TE buffer (10mM Tris-
HCI, pH8.0, 1mM EDTA pH8.0) and phenol(pH8.0):chloroform (1:1) extracted.
The aqueous phase was further extracted with chloroform. The cDNA was
precipitated with 16% 4M Ammonium acetate and 64% ethanol at -20°C for a
minimum of 2 hours. The DNA was precipitated at 13000g for 10 minutes and
resuspended at 1 ng/jul from the estimation described above.
2.2.11.3 Probes and Primers
Oswel DNA Service, Edinburgh, supplied all primers and probes. The
sequence for all the primers and probes used in this thesis are listed in Table 2.3.
Primers were designed not to have detrimental intra-annealing or inter-annealing
characteristics.
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Table 2.3 Sequences of primers and probes.
Primer/probe sequence Code Size of
Cytokine (S=sense, A=anti-sense ,P=probe) Name PCR
product



































IL-10 S 5' -ATG CCACAGGCTGAG AACC 3'








2.2.11.4 Polymerase chain reactions
PCR reactions were set up in laminar flow hoods using aerosol barrier
pipette tips (BioRad). Reaction mix volumes were 10Ojal overlaid with mineral oil.
Reactions were performed using both buffers and enzyme supplied by Biogene Ltd,
Bedfordshire, England. Reaction conditions were as follows 75mM Tris-HCI
pH9, 20mM ammonium sulphate, 0.01% (w/v) Tween, 2.5mM MgCI2, 100pM
dNTP's, 0.05-0.12pM of each primer and a standardized amount of substrate cDNA.
An equal volume of water was added as a negative control. Prior to the addition of
the enzyme the reaction was heated at 80°C for 5 minutes, then 0.33 of a unit of
enzyme was added diluted in water. Automatic thermal cycling was performed on
either a Techne PHC-1 machine or a Hybaid Omnigene machine using block control.
PCR reactions involved 40 cycles of denaturation at 95°C for 36 seconds, 36
seconds at 53°C annealing temperature followed by an extension for 1.5 minutes at
75°C with a final extension at 75°C for 3 minutes. 10% of the DNA synthesized was
analysed on agarose gel electrophoresis.
2.2.11.5 Slot-blotting of PCR products
In a separate laboratory to that used for the preparation of samples for PCR,
the products of PCR reactions were denatured and blotted onto nylon membrane
(Hybond-N+, Amersham). 10pl of amplified DNA harvested at various cycle points
was added to 10Opil 0.4M NaOH -10mM EDTA in a 96 well microtitre plate and
incubated for 10 minutes. The plate was then placed in a boiling waterbath for 3
minutes. Samples were transferred to nylon membrane previously soaked in water
for 10 minutes via a Bio-Rad (BIODOT) manifold. 500pl of SDW was passed
through the filter under vacuum followed by sample and finally washed through
with 500pl of 0.4M NaOH-10mM EDTA. The DNA was immobilized onto the
membrane by baking at 80°C for 1 hour.
2.2.11.5.1 Prehybridization and hybridization of slot-blot
Membranes were prehybridixed in 5mls hybridization solution [2xSSC
(0.15M NaCI, 0.15M NaCitrate, pH7), 10x Denhardts, 1% SDS, 200pg/ml salmon
sperm DNA and 120pg/ml yeast RNA] in a Hybaid hybridization oven at 45°C. The
appropriate probe was added to 3mls of fresh hybridization solution and membranes
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were hybridized in the oven for a minimum of 3 hours at 45°C. Membranes were
washed twice at room temperature in 2xSSC for 5 minutes with a final higher
stringency wash in 0.5X SSC at 50°C for 1 hour. The blots were saran wrapped and
exposed to XAR-5 scientific imaging film (Kodak) at room temperature and
processed.
2.2.11.6 Agarose gel electrophoresis of DNA
DNA samples were assessed by electrophoresis through 1-2% (w/v)
agarose gels. Agarose was melted in TAE buffer (40mM Tris acetate pH7.8, 1mM
EDTA) containing 0.5ng/ml ethidium bromide. Prior to loading samples, samples
were mixed with 0.25 volumes of loading buffer [0.25% (w/v) bromophenol blue,
0.25% (w/v) xylene cyanol, 15% (w/v)ficoll, 5xTAE]. Gels were cast as
horizontal slab gels and run in 1xTAE at 70V using an LKB 2013 miniphor
electrophoresis unit. Gels were generally run for 1 hour and samples analysed
using a UV transilluminator and photographed using a Mitsubishi video copy
processor. Estimates of molecular size and mass of DNA bands were made by
comparing their mobility with those of known standards (NBL, Northumberland,
UK) run in parallel.
2.2.11.7 Agarose gel electrophoresis of RNA
RNA gels were carried out under denaturing conditions. Samples were
fractionated by electrophoresis on 25cm long horizontal slab gels of 1.5% agarose
containing 18% formaldehyde and 20mM Na phosphate pH7. Samples were heated to
70°C for 15 minutes with 3 volumes denaturing buffer (60% deionised formamide,
24% formaldehyde, 20mM Na phosphate pH 7) then a 1:5 dilution of dye mix (
30% ficol, 0.05% bromophenol blue, 100mM phosphate pH7, 100|ag/ml ethidium
bromide) was added before samples were loaded into individual wells and
fractionated by electrophoresis initially for 15 minutes at 60V in Na phosphate.
The buffer was then circulated and run at 40V overnight. Gels were further stained
in 1pg/ml ethidium bromide for 1 hour prior to UV transillumination.
2.2.11.8 Southern Blot
DNA fragments contained within agarose gels were transferred to nylon
membrane (HybondN+, Amersham) using techniques based on the method of
Southern (1975). Before capillary transfer to the membrane the DNA in the gels
was depurinated in 0.4M NaOH for 20 minutes. Gels were then laid on a wick of
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Whatman 3MM filter paper, connected to a resevoir of 0.4M NaOH and overlaid with
a Hybond N+ membrane prewetted in water. The transfer of DNA was effected by a
continual upward migration of buffer for 16 hours achieved by overlaying the
membrane with 2 sheets of 3MM paper, topped with a wad of paper towels and
compressed with a weight. DNA was immobilized by baking at 80°C for 1 hour.
2.2.11.9 Radiolabelling of DNA
DNA oligonucleotides were end-labelled using the radioactive isotope 32P.
The following was added to an eppendorf tube : 1pl of oligonucleotide, (OD 5-
20/ml), 2.5pl 10x kinase buffer(0.8M Tris pH7.5, 0.1M MgCI2, 0.1M DTT),
1 8pl sterile water, 30pCi 32Py-dATP and 1U polynucleotide kinase (Epicentre
Technologies). The tubes were incubated at 37°C for 1 hour, the enzyme was then
inactivated at 65°C for 15 minutes and the total volume brought to 200^1 with
sterile water.
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CHAPTER 3 The characterization of Ovar DR a and DQ a
MHC class II molecules and their expression on T cells.
3.1 Introduction
The class II region in humans (HLA-DR) is composed of 3 loci HLA-DR,
HLA-DQ, HLA-DP that are directly involved in antigen presentation. The HLA-DM
loci encodes molecules which play a critical role in the antigen processing and
transport to the endoplasmic reticulum (Morris et al, 1994). The additional loci
HLA-DN, -DO are also thought to be involved in antigen processing within the cell
(Ting and Baldwin,1993). In the mouse the functional class II genes are grouped
into two subregions (IA,IE) which are homologous to DQ and DR respectively
(Kappes and Strominger,1988). Mice also have homologues to HLA-DM and DN
(Karlsson and Peterson,1992). The functional subregions of class II contain A and
B genes which encode a and p proteins. The class II molecules expressed on the cell
surface exist as a heterodimer of the a (32,000) and p (28,000) glycoprotein
chains non-covalently linked.
In recent years many studies have been carried out on the genetic
arrangement of the ovine class II region (Ovar-D). Gene cloning and Southern blot
hybridization studies indicate that Ovar-D region contains subregions homologous to
the HLA-DR, DQ and DN regions of humans. No DP or DM regions have been
identified (Scott et at, 1987). Alleles within the DRA, DQA1, DQA2 and DQB regions
have been identified (Fabb et a!,\993: van Oorschot et al, 1994), these regions in
sheep are thus polymorphic. A feature of the sheep class II region which differs
from the HLA class II region is the presence of a DY region (Wright et al, 1 994).
The DY locus is represented by an A/B gene pair. Use of monoclonal antibodies has
identified expressed DQa,DQp, DRa and two DBp class II molecules in the sheep
(Dutia et al,~\ 994).
The constitutive expression of MHC class II gene products is tightly
regulated and is normally confined to professional antigen presenting cells.
However, many cell types can be induced to express MHC class II molecules
(reviewed in Glimcher and Kara,1992). For example, resting human T cells do not
express class II but synthesize and express high levels upon activation. Oshima and
Eckels (1990a), have shown differential expression of the class II locus products
during activation of human T cells with a hierarchial dominance for DR, DP and DQ
isotypes. In sheep, a percentage of resting T cells express class II and upon
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activation increased expression occurs. Differential expression of the class II
isotypes has also been reported in sheep (Dutia et al, 1993a). The significance of
the increased class II expression on activation of T cells is unclear.
On professional APC's class II expression serves to present antigens to T
cells. On T cells the role of class II in presentation of antigen is not as clearcut. The
antigen presenting capacity of class II on T cells has been found to be limited by
their inefficiency in capturing antigens (Lanzavecchia et al, 1988; Franco et
al, 1992; Wys-Coray et al, 1991). Only antigens that directly bind to cell surface
determinants are presented. Though presentation of whole antigen by T cells is
dependent on antigen capture, human T cells have been shown to present denatured
antigens or peptides. This has been demonstrated in vitro , using T cell clones
(LaSalle et al, 1991; Hewitt and Feldman,1989). It is possible that this may
represent an in vitro phenomenon as when physiologically activated class II
positive sheep T cells were used, Hopkins et al {1993), found no induction of
antigen proliferative response to digested antigen. The ability of T cell class II to
present antigens is somewhat limited, however antigens are presented.
Presentation of antigens has been demonstrated in humans (Lanzavecchia et
al, 1988) and in sheep (Hopkins et al, 1993) by their capacity to stimulate
allogeneic T cells in MLR.
In addition to their function as antigen presenting structures, class II
molecules on APCs can function as signal transduction elements. On murine and
human B cells, crosslinking class II molecules induces protein tyrosine
phosporylation, increased cytosolic free calcium and activation of protein kinase C
(reviewed in Julius et al, 1993). Class II expression on T cells may also have a
role other than antigen presentation. On activated human T cells, mAb to class II
molecules induces activation of tyrosine kinases and mobilization of intracellular
calcium (Odum efa/,1991). Induced secretion of IL-2, IL-3, ylFNandTNFa by T
cells with class II and CD3 molecules crosslinked has also been reported (Spertini
et al,1992). A more recent study has shown that the different class II isotypes
show different sensitivities to IL-2 induction (Odum et al, 1993). DR as opposed to
DQ molecules have enhanced sensitivity to IL-2. Class II isotypes are selectively
expressed on human T cells and their differing sensitivities to IL-2 induction
suggest differing immunoregulatory roles.
The data presented in this chapter forms an introduction to class II isotype
49
expression on sheep T cells. Data in successive chapters will focus on the functional
significance of class II positive ovine T cells. To study the expression of MHC class
II on ovine T cells it was necessary to define sub-group specific MHC class II mAbs.
Amino-terminal sequencing of the antigens recognized by two mAbs was carried out
to confirm their locus specificity and allow their comparison to homologues in
humans. Using the defined mAbs, the differential expression of class II subtypes in
lymphocyte subsets was analysed from various immunological compartments. Ovine
T cells circulating in afferent and efferent lymph have been identified
phenotypically as memory and naive type cells respectively, while T cells of the
peripheral blood contain a mixture of both phenotypes (Mackay et al, 1990). By
analysing the expression of class II in each of these compartments an overall
picture of class II expression on phenotypically distinct T cells can be assessed. Use
of the cannulated sheep lymphatic model allows access to in vivo fractionated cell
populations from the distinct lymphoid compartments.
The differential expression of class II products following in vivo activation
of efferent T cells was also examined. The efferent duct of a single peripheral
lymph node can be cannulated and lymph collected over extended periods of time.
Antigen challenge to the lymph node drainage area allows the subsequent analysis of
draining in vivo activated T cells. Because primary antigen challenge is not
associated with kinetic and phenotypic alterations in class II expression by ovine T
cells (Hopkins et al, 1993), only responses after secondary antigenic challenge
were studied.
The aims of the work described in this chapter were
(a) to determine the NH2-terminal amino acid sequence of the class II a chain
recognized by the mAbs, VPM54 and VPM36 in order to establish their MHC class II
locus specificities,
(b) to correlate the expression of class II subtypes with expression of T cell subset
specific surface markers, in afferent lymph, efferent lymph and peripheral blood
from sheep, and
(c) to analyse the expression of class II subtypes on CD4+, CD8+ and T19+ T cells
after in vivo activation of efferent lymph.
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3.2 Results
3.2.1 Selection of DR and DQ mAbs.
VPM36 and VPM54 were selected for these studies as DQ and DR a chain
specific mAbs respectively. VPM36 has been described by Dutia et al (1 990).
Further data on the reactivity of both mAbs was published recently (Dutia et
al, 1993a & 1994). In order to establish conclusively the MHC class II locus
specificities of these mAbs, NH2-terminal amino acid sequence analysis of the
purified a chains was carried out.
3.2.2 Purification of VPM36 and VPM54 a chains.
Sheep MHC class II molecules were purified from sheep spleens. The MHC
class II heterodimers reacting with VPM36 and VPM54 were purified by
immunoaffinity chromatography following the detergent solubilization of
splenocytes. Separation of the a and (3 chains was accomplished using an automated
micropreparative electrophoresis system (HPEC, ABI,Warrington,U.K.). This
instrument enables the collection of samples fractionated by SDS-PAGE. Sheep a
and p chains differ in molecular weight by approximately 2kDa. Conditions of
electrophoresis were optimized to achieve such resolution as to separate these
chains. This entailed varying the size of gels and the percentage of polyacrylamide
used for the preparation of gels. 10% (10cm x 2.5cm) polyacrylamide gels proved
optimal. Figure 3.1(A) is an elution trace of low molecular weight markers run on
the HPEC under the conditions described. From this elution trace a range was
predicted for fraction collection following the electrophoresis of class II molecules.
An elution profile of a class II antigen is given in Figure 3.1(B). A silver stained
SDS-PAGE gel of recovered (3 (28kDa) and a (32kDa) chains from the heterodimer
is given in Figure 3.1 (C). The individual fractions collected depict a stepwise
increase of bands showing the changes due to glycosylation. From this data the a
chain fractions (13-15) were selected, transferred to PVDF membranes using a
Prospin cartridge and sent for sequencing.
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Figure 3.1
HPEC preparative separation of low molecular weight markers (A) and partially
purified VPM54 antigen (B). The markings on the trace represent fractions
collected. When analysed by slab-gel (C) fractions 7-15 show recovery of the
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3.2.3 Amino acid sequence of VPM36 and VPM54 a chains.
The sequence of the a chain recognised by VPM36 compared with human and
mouse a chain sequences is given in Figure 3.2a. The amino acid sequence
recognised by VPM36 is close to that of the amino acid sequence derived from cDNA
sequenceofhumanDQa and mouse l-Aa (Travers and McDevitt,1 987).
Comparisons with the amino acid sequences predicted from published cDNA
sequences for Ovar-DQA1 and DQA2 (Fabb et al, 1993) indicate that the antigen
recognized by VPM36 is more homologous to the predicted product of DQA1.
However there is no conclusive data on the reactivity of VPM36 with the individual
DQA gene products. VPM36 mAb may recognize both DQA gene products.
The sequence data of the a chain recognised by VPM54 is given in Figure
3.2b along with an ovine DRa sequence (VPM38) determined by NH2-terminal
amino acid sequencing (Dutia et al, 1993a) and an amino acid sequence predicted
from cDNA sequence (Fabb et al, 1993). Each are homologous to human DRa and
mouse l-Ea. VPM54a sequence is identical to the Ovar-DRa derived sequence
published by Fabb et al, (1993) in the first 20 amino acids.
In conjunction with the ELISA data and 2-dimensional immunoblot data
(Dutia et al, 1993a & 1994) it can be concluded that VPM36 and VPM54 represent
DQa and DRa sheep MHC class II locus products.
3.2 4 Expression of MHC class II in vivo.
Using a pan class II mAb (SW73.2) it has been shown that class II is
expressed on resting T cells (Hopkins et al, 1986). To examine the expression of
the individual locus products on functionally distinct lymphocytes, the staining of
VPM36 and VPM54 on lymphocytes from different immunological compartments
was analysed.
DQ and DR expression on CD4+, CD8+ and T19+ and B cells in afferent
lymph, efferent lymph and peripheral blood was examined by two colour flow
cytometric staining. Live gating on small lymphocytes excluded any contributions
from blasting cells. Staining with these antibodies on T cells does not identify a
discrete population rather a continuum indicating varying intensities of expression.
The staining pattern is given in Figure3.3. Both DR and DQ locus products were
expressed on T cells at varying levels in each of the immunological compartments
examined. B cell expression of class II was relatively homogenous in each
compartment with all B cells expressing both DR and DQ.
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Figure 3.2
(a) NH2-terminal sequence analysis of class II a chain recognized by VPM36
compared with human DQ, mouse l-A a and the predicted Ovar DQa1 andDQa2 chain
sequences.
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(b) NH2-terminal sequence of the class II a chain recognized by the mAb VPM54
compared with the NH2-terminal sequence of a sheep DRa (VPM38), sheep DRa
sequence predicted from DNA, human DPa, human DRa and mouse l-Ea.
VPM54a ikedhviiqaefylnpeesaa-m
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i-Ea ike e h v iioaefyl l p. d k r
Sequences underlined indicate identity with the sequences determined using VPM36
and VPM54, . indicates a gap inserted to maximise alignment, - indicates that
residues could not be determined. Alternative residues indicate different allelles
except for VPM36a and VPM38a where alternative residues indicate that more than
one residue was present.
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The percentage of T cells stained with MHC class II mAbs from a number of
sheep are tabulated in Table 3.1. Data analysed from 5 sheep show DQ expression on
8% CD4+ T cells, 12% CD8+ T cells and 4% T19+ T cells in efferent lymph. DR
was expressed on 18% CD4+ , 20% CD8+ and 12% T19+ efferent T cells
(Table3.1). Data on VPM54 and VPM36 staining on T cell subsets and B cells of
afferent lymph and peripheral blood was obtained from two sheep. In the afferent
lymph, levels of both DQ and DR expression were higher than in efferent lymph for
each of the T cell subsets. DR and DQ expression on PBMC showed a similar pattern
to that of efferent lymph on each of the T cell subsets. Two DQA genes both of which
appear to be expressed are found in some but not all sheep (Scott et al, 1991). The
reactivity of VPM36 with both gene products is not known. Thus two sheep is too
small a sample size for interpretation of DQ expression. Only one DRA gene has
been identified, however for statistical significance the sample size was again too
small.
3.2 5 In vivo antigenic challenge.
On activated human T cells DR cell surface densities are modulated over time
while the density of DP and DQ molecules remain more constant. To assess the
situation in ovine T cells, VPM54 and VPM36 staining on T cell subsets in efferent
lymph at various time points following a secondary immune response was examined.
Cells of the efferent lymph are described as phenotypically naive (Mackay et
al, 1990) and so it was of interest to examine class II expression after activation.
Changes in expression levels of class II do not occur during primary immune
responses (Hopkins et al, 1993) and only secondary responses were examined.
The secondary response to ovalbumin was examined in 3 sheep.
Representative data on VPM36 and VPM54 staining of T cell subsets is shown in
Figure3.4. Using the cannulated model of the sheep for functional studies regular
lymph collection was difficult. As a consequence it was not possible to obtain data at
equal time intervals for each animal examined.
Lymph cells were stained with anti-phenotypic cell surface mAb and either
VPM54/VPM36 mAb. Live gating using FSC/SSC parameters was used to delineate
small lymphocytes. Increased levels of DR and DQ expression were observed in each
of the T cell subsets over 9 days. The levels returned to resting levels by day 12.
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Figure 3.3
Two colour flow cytometry analysis of lymphocytes from adult sheep peripheral
blood (PBMC), afferent lymph and efferent lymph stained with anti-class II
subgroup specific mAbs VPM36 and VPM54 and the anti-phenotypic mAbs, anti-
CD4 (a), anti-CD8 (b), anti-T19 (c) and anti-B cell (d). The anti-phenotypic
mAbs were coupled to biotin and detected with streptavidin-labelled phycoerythrin
and the anti-class II mAbs detected with isotype specific FITC labelled anti-mouse
ig-
CD4 + T CELLS
PBMC AFFERENT LYMPH EFFERENT LYMPH
LOG FLOURESCENT INTENSITY (ANTI-CLASS H)
CD8 + T CELLS
PBMC AFFERENT LYMPH EFFERENT LYMPH
LOG FLOURESCENT INTENSITY (ANTI-CLASS II)
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(C) T19 + T CELLS
PBMC AFFERENT LYMPH EFFERENT LYMPH
LOG FLOURESCENT INTENSITY (ANTI-CLASS II)
LOG FLOURESCENT INTENSITY (ANTI-CLASS II)
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Table 3.1
Percentage of T cells from different lymphoid compartments expressing MHC class
II DQ and DR molecules.
PBMC AFFERENT EFFERENT
LYMPH LYMPH
(n = 2) (n=2) (n = 5)
CD4+ DQ 1 7.3±3.0 1 7.9±3.9 7.8±2.0
TCELLS DR 1 9.5±3.6 50.1 ±2.1 1 7.9±2.2
CD8+ DQ 1 2.1 ±3.3 37.3±1 7.5 1 2.4±3.1
TCELLS DR 1 7.5±1.3 51.5±1.1 20.5±2.4
T19 + DQ 4.5±3.2 1 9.3±5.0 4.0±2.0
TCELLS DR 7.5±5.4 32.1 ±11.2 1 2.2±6.0
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Figure 3.4
Expression of DR and DQ on T cell subsets following a secondary immune response.
Flow cytometry histograms of dual stained efferent lymph cells isolated at daily
intervals during the response. Gating on CD4+ (a, pg 58), CD8+ (b, pg 58) and
T19+ (c, pg 59) T cells, single histograms were obtained. Each panel shows cells
stained with anti-class II DR (VPM54), DQ (VPM36) and the irrelevant antibody
negative control (VPM21). The figures represent the percentage positive cells

















































































Near doubling levels of DR expression occured on each of the T cell subsets, however
much more dramatic levels of increase were observed for DQ expression. Levels of
DQ expression trebled on CD4+ T cells, and doubled on CD8+ and T19+ T cells.
3.3 Discussion
In this chapter, the characterization of DR and DQ specific mAbs and analysis
of antigen expression on resting and activated T cells is described. This data forms
an important introduction for the work described in successive chapters.
The characterization of a DRa and a DQa specific mAbs was accomplished by
NH2-terminal amino acid sequencing of their antigens. Purification of class II
monomers was successfully achieved with the HPEC. Using the HPEC, the individual
class II monomers were recovered in fluid phase, transferred onto PVDF membrane
and were available for sequencing directly. In comparison, recovery after manual
electrophoresis, blotting and staining is typically low and often NH2-termina!ly
blocked, making it difficult to obtain sufficient protein for sequencing. The HPEC
proved to be a more successful method in purifying proteins for NH2-terminal
amino acid sequencing.
The amino acid sequence of the class II a chain antigen recognized by VPM36
in conjuction with 2-dimensional immunoblot analysis (Dutia et al, 1993a)
confirms that VPM36 recognizes the ovine homologue of DQa. In humans there are
2 DQA loci one of which is not transcribed. In contrast, the 2DQA loci identified in
sheep are both expressed (Scott et al, 1991). Studies with two Ovar-DQA locus
specific probes have revealed extensive polymorphism in both genes (Scott et
al,t 991; Fabb et al, 1993). The presence of the 2 DQA genes has been shown to
vary between haplotypes in sheep, a significant proportion of sheep (63/571
tested) do not possess a DQA1 gene (Fabb et al, 1993). Whether VPM36 recognizes
a single or both DQA gene products is not known. In this study, all the sheep
examined expressed the DQA gene products recognized by VPM36. However, in
afferent lymph the levels of VPM36 expression in each of the T cell subsets was
much lower than that previously reported using the same mAb (Dutia et al, 1993a).
This may be due to variations in the number of DQA genes possessed by the sheep
that are recognized by VPM36. The results shown for VPM36 expression on
afferent lymph were derived from two sheep, this is too small a sample size when
looking at the expression of polymorphic genes.
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A single DRA gene with very few alleles has been identified in sheep (Fabb
et al, 1993). This is consistent with human and murine data. NH2-terminal
sequence data of the a chain from VPM54 antigen demonstrates unequivocally that
this chain is CVarDR-like. Only one difference between the amino acid sequence
determined and that predicted from DNA sequence occur in the first 23 amino acids
(Fabb et al, 1993; Ballingall et alA992). This may be a real difference or an
error incurred in amino acid sequencing. The residue at this position from the
sequence determined from ovine DNA is the same in both human and mouse sequences
implying that these are conserved regions. This would indicate that the difference is
due to a mistake incurred in amino acid sequencing. However, the published NH2-
terminal sequence of an a chain recognized by a different mAb (VPM37) (Dutia et
al, 1993a) has exactly the same difference at this residue which suggest this is real
difference.
The level of DR expression reported here is inconsistent with that reported
by Dutia et al (1993a), when using VPM38 as a DRa chain specific mAb. Much
higher levels of staining were observed (30% CD4+, 38.4% CD8+ and 19% T19+).
Both of these mAbs recognize homologous antigens as determined from NH2-
terminal amino acid sequence data. That the differences are due to varying antibody
binding capacities are precluded as both antibodies show similar intensities of
staining on all B cells. Perhaps the differences in levels of expression between both
mAbs may be due to differences in background staining.
DQ and DR molecules were found to be expressed on all T cell subsets from
afferent lymph, efferent lymph and peripheral blood. Afferent T lymphocytes
expressed increased levels of both VPM36 and VPM54 antigens when compared with
efferent and peripheral blood T lymphocytes. In vivo activation of efferent
lymphocytes resulted in increased expression of both DR and DQ molecules, DQ
showing a more marked induction on CD4+ T cells.
The significance of these events is unclear and will be addressed in the
adjoining chapters. In afferent lymph both DR and DQ were highly expressed on T
lymphocytes when compared with efferent lymph and peripheral blood. Cells
circulating in the afferent lymph of sheep have been phenotypically described as
memory type (Mackay et al, 1990). Is class II expression on T cells a marker of
memory? Furthermore, upon in vivo activation of efferent T cells, both DR and DQ
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expression was induced, DQ showing a more marked induction on CD4+ T cells, Does
DQ expression correlate with a recent activation event as has been suggested by
Dutia et al (1993a)? These questions will be addressed in Chapter 5 by correlating
class II expression with other known markers of activation.
In sheep, as in humans, class II molecule expression is associated with
activation of the T cell. Activation of the T cell results in the production of
cytokines, whose coordinate production regulates the immune response. The pattern
of cytokines secreted can subdivide T cells into Th1/Th2 types which have distinct
effector functions. To examine whether expression of class II subtypes after
activation influences the pattern of cytokines secreted, class II isotype expression
will be correlated with cytokine expression. This will be addressed in chapter 6.
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CHAPTER 4 Isolation of T cell subsets.
4.1 Introduction
In the previous chapter it was shown that T cell expression of class II
increases after in vivo activation in antigen primed sheep. The biological
significance of this event is not understood but it is possible that class II antigens on
T cells are markers of activation status. However, the relationship of class II
expression with other known activation markers is largely unknown. By isolating T
cell subsets, the expression of class II molecules and activation markers can be
analysed on each T cell subset. Two colour flow cytometric staining on the purified
T cell subsets would allow the direct correlation of class II isotype expression with
a range of available activation markers. This required the evaluation of a suitable
cell separation technique. A cell separation technique was also required for the
proposed studies on cytokine expression. The isolation of T cell subsets expressing
different class II isotypes would allow the correlation of class II isotype expression
with cytokine synthesis using molecular biological techniques. Thus the
relationship between class II isotype expression and cytokine synthesis could be
correlated.
Examples of gross separations of immunological cells include adherence to
plastic surfaces which largely removes phagocytic cells and passage down nylon-
wool columns which greatly enriches lymphocyte populations for T cells (Julius et
al, 1973). Using sheep red blood cells, CD2 positive T cells from other species can
be separated by rosetting (Shaw et al, 1986). The panning technique developed by
Mageef al (1977) can be used to select cells expressing phenotypic markers by
panning on dishes coated with specific mAbs. These methods have various
disadvantages including low sensitivity and poor quality of separation. On the other
hand, flow cytometry is a powerful method for isolation of subpopulations out of
complex cell mixtures. The overwhelming advantage of flow cytometry over other
methods is that it is extremely sensitive. However, it is limited by a small
separation capacity (approximately 107 particles per hour). Magnetic beads coated
with immunoreactive molecules have emerged as an efficient alternative to flow
cytometry. Dynabeads (Dynal, UK) are widely used. More recently, a newer
method based on similar principles to Dynabead has been developed, the magnetic
activated cell sorter (MACS) (Miltenyi et al, 1 990).
The most important innovation of the MACS is the ability to couple to the cell
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surface biodegradable microbeads which have the size of cellular macromolecules
(50-150nm diameter). Cells are sequentially labelled with biotinylated mAbs and
streptavidin-conjugated magnetic microbeads. The magnetically stained cells are
passed over a ferromagnetic column in the field of a powerful magnet. Labelled cells
stick to the magnetized matrix and are separated from the unlabelled cells which
flow through. The magnetic fraction can be eluted by removing the column from the
magnetic field. This allows both negative and positive separations. The purity of
the selection procedures can be assessed by flow cytometric analysis. The advantage
of MACS over Dynabeads is that the beads are smaller and biodegradable, plus the
presence of microbeads does not affect flow cytometry.
In this chapter, the use of MACS in the selection of T cell subsets is
described. T cell populations were both positively and negatively selected and the
quality of the separations evaluated. Negative selection identified a novel population
of cells and some characterization of these cells was carried out.
4.2 Results
4.2.1 MACS - negative selection
The aim of these experiments was to purify CD4+ and CD8+ T cell
populations from lymph. Negative selection using the MACS was the method of
choice. Through negative selection the selected cells are free of antibody
attachments and are thus suitable for dual cytometric analysis to allow direct
correlation of class II expression with activation markers on the T cell subsets.
Efferent lymph contains B cells, y8 T cells, CD4+ andCD8+ T cells. Using
biotinylated mAbs reactive with B cells (VPM 30), the T19 molecule of y5 T cells
(CC15), the CD4+ T cell subset (SBU-T4) and the CD8+ T cell subset (SBU-T8),
purification of CD8+ or CD4+ T cells by negative selection was attempted. The
biotinylated mAbs were bound by the streptavidin associated magnetic beads and
removed using the MACS. The quality of the selection procedure was then
determined by flow cytometry gating on small lymphocytes. Following negative
selection for CD4+ T cells ~73% of the recovered population were of the CD4+
phenotype. The remainder did not express VPM30 antigen, T19 antigen or SBU-T8
antigen. Likewise for CD8+ selections -52% CD8+ cells were stained. Thus there
appeared to be a fifth population of cells present in efferent lymph which did not
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express CD4, CD8, T19 and B cell markers. The higher numbers of contaminating
cells with CD8+ selection reflects the higher throughput of cells needed to select out
equal numbers of CD8+ cells. This contaminating population of cells was negative
when stained with a general anti-mouse FITC sera, thus excluding the possibility
that the magnetic beads were not at saturation level.
4.2.2 Artefacts of MACS selection?
To discern whether this contaminating population of cells was an artefact of
the MACS method the following experiments were conducted.
To confirm that the level of CD4 selection is a real phenomenon and not an
artefact of the technique, CD4+ T cells were pre-labelled with FITC and then
negatively selected. Lymph cells were first stained with anti-CD4 conjugated FITC
and were then negatively selected using VPM30, SBU-T8 and CC15 mAbs. The
negatively selected cells were analysed directly on the FACS . Again the purity of
the selection was low (65%) (Fig4.1). As all the FITC stained CD4 cells were
recovered in the negative fraction, it is possible that the contaminating cells
represent a novel population.
To negate the possibility that antibody capping from the cell surface was
occuring, cells were fixed in paraformaldehyde to crosslink surface antigens.
Lymph cells were fixed in 0.5% paraformaldehyde and the CD8+ cells negatively
selected. Following separation, the negative population of cells was stained for each
of the phenotypic markers CD4, CD8, T19 and B cell. When stained with an anti-
CD8, 57% of the selected cells were positive (Fig. 4.2). Thus capping of surface
antigens as an explanation was excluded.
There is evidence from the use of Dynabeads that surface antigen detachment
can occur during incubation of cells with immunomagnetic beads. On reculturing,
antigen depleted cells can recover their normal levels of surface antigen (Rubbi et
al, 1993). To determine whether the observed contaminating population of cells had
their surface antigens detached through the use of magnetic particles, B cells and
CD4+, CD8+, T19+ T cells were positively removed and the negatively selected cells
cultured for 48 hours. Cultured cells were then stained with phenotypic markers.
Figure 4.3 shows that re-expression of the CD4, CD8, T19 or B cell antigens did
not occur. Unselected efferent cells cultured for 48 hours were used as a control.
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LOG FLUORESCENT INTENSITY
Figure 4.1 Flow cytometric analysis of cells after MACS negative selection for the
CD4 antigen. CD4 positive cells were stained with anti-CD4 FITC conjugated
antibody prior to separation on the MACS (solid line). Unstained cells are
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Figure 4.2 Flow cytometric analysis of paraformaldehyde fixed efferent
lymphocytes after MACS negative selection for the CD8 antigen. The solid line in
each plot represents staining on selected cells with anti-CD8 (S8U-T3), anti-CD4
(SBU-T4), anti-Tl9 (ST197) and anti-B cell (DU2-104). The dashed line





















Figure 4.3 Flow cytometric analysis of the null cell population after culturing for
48 hours. Cells were stained with antibodies to CD4 (ST4), CD8 (E95), T19




This contaminating population of cells appeared to be a real phenomenon and
are henceforth referred to as "null cells". To establish whether null cells are
lymphocytes electron microscopy was carried out. Null cells were selected by
positively removing CD4+, CD8+, T19+ T cells and B cells. Both the negative and
positively stained fractions were recovered. Figure 4.4 shows both the positively
stained and negatively selected cells. Both cells are typical of small lymphocytes
with condensed nuclear chromatin and sparse cytoplasm. The cytoplasm contains
few mitochondria and many ribosomes but otherwise few organelles. One can
conclude that the null cells are indeed lymphocytes. It was also interesting to see
the magnetic beads on the surface of the positively stained cells.
Having established that the null cells are lymphocytes it was decided to stain
them with a range of mAbs available in the department. The data is shown in Figure
4.5. In general the null cells express all the markers common to efferent
lymphocytes. A notable difference is the absence of CD5 expression. Also a large
percentage are LFA1 negative whereas LFA1 positively stains the majority of
efferent lymphocytes. The staining pattern of many of these mAbs on CD4+, CD8+
andy8 T cells are shown in Figure 5.4 a, b & c in Chapter 5.
There is no available mAb to the oc(3 T cell receptor of sheep. However, there
is a hamster anti-human CD3e which crossreacts with the ovine homologue. CD3 is
associated with both the a[3 andy8 TCR and its presence on null cells would imply
the possession of a T cell receptor. The e chain of CD3 is cytoplasmic, therefore for
analysis of expression, cell lysates were prepared and immunoblotted against
HMT3.1. Figure 4.6 shows the CD3e chain (20kD) present in both afferent cell
lysate (positive control) and the null cell lysates. The presence of CD3e indicates
that null cells possess a T cell receptor. The ST6 cell line, which does not express
CD3 was used as a negative control. The 20,100 marker appears as a diffuse band






Figure 4.4 Transmission electron micrograph of (a) a null cell, negatively isolated
and (b) a positively stained lymphocyte selected by MACS. The arrows indicate
the presence of microbeads on the positively selected cell surface.
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Figure 4.6 Immunoblot analysis of sheep CD3e in null cell lysate
(lane 1, 2), afferent cell lysate (lane 3) positive control and ST6
cell lysate (lane 4) negative control. Cell lysates were fractionated
on 12% SDS-PAGE, transferred to nitrocellulose and probed with
HMT3.1 antibody. Molecular weight markers are indicated in the
left of the blot.
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4.2.4 MACS - positive selection
With the negative selection procedure it was not possible to isolate either
CD4+ or CD8+ T cells due to the presence ot null cells. Because a mAb to a unique
marker on null cells was not identified it was not possible to isolate pure
populations of CD4 and CD8 positive T cells by negative selection. To circumvent
this problem, positive selection of both the CD4+ and CD8+ populations of T cells
was carried out. With positively selecting cells >95% purity was regularly
obtained with CD4+ selections and >85% purity with CD8+ selections (Figure 4.7).
Careful selection of mAbs and second layer reagents made it possible to
double stain the selected cells. Both CD4+ and CD8+ T cells were selected by MACS
using biotinylated SBU-T4 and SBU-T8 mAbs which are lgG2a isotype. Green
fluorescent staining was achieved using a range of non-lgG2a isotype mAbs followed
by isotype specific FITC conjugated antisera. Staining in the red channel was
attained using a pan-class II rat derived mAB (SW73.2) detected with a
phycoerythrin conjugated anti-rat isotype specific antisera. This allowed class II
expression to be correlated with a range of other mAbs directly on the T cell
subsets.
Using this procedure, staining patterns of each mAb was established on T cell
subsets from the efferent lymph of unstimulated lymph nodes. Because these cells
have antibody bound magnetic particles, antibody bound streptavidin and antibody
bound phycoerythrin attached to their cell surfaces, it is possible that optimal
binding is sterically hindered. Though a certain level of staining for each antibody
was detected this may not represent the maximum level of antigen expression.
Because T cells show increased expression of class II molecules after in vivo
activation, it was decided to examine whether the described staining regime would
be able to detect the increased levels of class II expression on positively selected
CD4+ cells. The results of this experiment are shown in Figure 4.8. Class II
expression on unselected efferent cells is compared with expression on MACS
selected CD4+ cells, on day 8 of an in vivo immune response. The efferent cells
were stained with anti-class II isotype mAbs (VPM54, VPM36). In parallel, cells
were positively selected with the MACS for SBU-T4 and then singly stained with
either VPM36 or VPM54 and anti-lgG1 conjugated FITC. The purity of the selection











Figure 4.7 Immunofluorescence profile of cells positively selected with the MACS.
Cells were stained with both streptavidin-microbeads and streptavidin-
phycoerythrin and analysed directly on the FACScan. (•*••) represents the CD4
selected cells, ( ) the CD8 selected cells and ( ) unstained cells.
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Figure 4.8 Flow cytometric analysis of MHC class II DR (VPM54) and DQ (VPM36)
expression on unfractionated efferent cells and positively selected CD4 cells from
the same efferent lymph on day 8 of an in vivo immune response. The dashed lines
represent VPM21 staining (negative control).
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The level of staining observed on the unselected cells was not detected on the
positively selected and singly stained cells. These cells have many attachments to
their surface and steric hindrance effects may have precluded the detection of total
surface antigen. Thus use of the MACS in positive selection had to be abandoned.
4.3 Discussion
In this chapter the MACS was evaluated for the separation of ovine CD4 and
CD8 positive T cell subsets. Purified CD4 and CD8 positive T cells were required
for the analysis of activation marker and class II subtype expression by two colour
flow cytometric analysis. Both negative and positive selection of cells was
undertaken and the quality of the separations analysed by flow cytometric staining.
The presence of a novel cell population precluded the use of a negative
selection procedure. The data indicates that the null cells are a novel cell population
and not an artefact of the MACS method. From the EM photograph they appear as
lymphocytes. Lymphocytes comprise T cells bearing either a(i or 78 T cell
receptors, B cells and Natural Killer cells. The ap+T cells comprise both CD4+ and
CD8+ cells for which the null cells were negative. The 78 T cells of sheep bear the
T19 molecule (WC1) which the null cells did not express. Null cells were also
negative for B cell markers. The other cell type that constitute lymphocytes is the
Natural Killer (NK) cell. NK cells have a large granular morphology and lack CD3
expression (Lanier et al, 1986), this precludes null cells as null cells expressed
CD3e and had the morphology of small lymphocytes. A mAb to a unique marker on
null cells would help to phenotype and quantify this population.
From FACS analysis null cells express similar markers to other
lymphocytes when analysed within the small lymphocyte gate. The notable
difference being the lack of CD5 expression. The absence of CD5 is interesting as
CD5 is expressed by all sheep T cells, thymocytes and a proportion of B cells
(Mackay,1988) only on T cell activation is CD5 expression lost (Hopkins and
Dutia, 1990). The absence of CD5 expression, could perhaps imply that the null
cells are activated T cells, however the null cells did not have the morphology of
activated T cells. Because CD5 is expressed on all T cells and thymocytes in sheep,
the lack of expression on null cells may indicate a different ontogeny for these cells.
Indeed, CD4"CD8" ap+T cells have been identified in both mice and humans which do
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not appear to undergo classical positive or negative selection in the thymus and it
has been suggested that they develop extrathymically (Andreu-Sanchez et al, 1991).
In healthy humans the CD4"CD8~ T cells represent small populations of both PBL
and cells of the thymus (Brooks et al, 1993). Functionally, these cells in mice have
been shown to recognize bacteria (Abo et al, 1991) while in humans they recognize
CD1 molecules in association with bacterial products (Porcelli et a/,1992). The
null cell population identified may represent the a(3+ CD4~CD8" T cells of mice and
humans. Further work is required to fully characterize these cells and elucidate
their functional role.
Using a positive selection procedure highly purified cells were separated.
However the positively stained cells could not be further stained for flow
cytometric analysis. As the positively selected cells are bound by magnetic
particles, these molecules may sterically hinder further binding to the cell surface.
Because the cells were fixed in paraformaldehyde prior to purification, this effect
is not due to capping of the antigens. Fluorescent labels are smaller than the
magnetic particles used for MACS which would explain why triple and double
staining can be achieved for flow cytometric analysis. There have been many
reports on the use of MACS for cell separations. However these generally have
involved the positive selection of cells for in vitro cell culture where the presence
of beads has been found not to affect functional assays (Abts et al, 1989; Jacobs et
al, 1993).
Though the MACS could not be used for these studies it did prove to be an
efficient method for isolating cells. When negative selection was employed the
removal of the positively stained cells was almost complete. It was the presence of a
novel cell population that precluded the use of a negative selection procedure. The
positive selection procedure also yielded highly purified cell fractions. Positively
selected cells were unsuitable, as the magnetic particles appeared to affect two
colour flow cytometric analysis. Thus in conclusion, the MACS had limited
capabilities for the required experiments.
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CHAPTER 5 The correlation of class II expression with
activation/adhesion molecule expression on T cell
subsets.
5.1 Introduction
Following in vivo antigenic stimulation, T cells show increased expression
of both DR and DQ class II isotypes. It has been proposed that the pattern of MHC
class II expression may reflect different levels of T cell differentiation and
activation (Dutia et al, 1993a), the DCTDR" phenotype changing to the DQ+DR+
phenotype on activation and the DQ"DR+T cells representing resting recirculating
memory T cells. To examine this proposition the expression of activation/adhesion
molecules and class II subtypes on T cell subsets was studied. Originally it was
hoped to correlate class II expression directly with expression of activation
markers on isolated T cell subsets, however from results described in the previous
chapter this proved problematic. As a consequence the correlation of class II
expression with activation/adhesion marker expression was analysed indirectly by
two colour flow cytometry. Cells were stained for cytometric analysis in one
channel with phenotypic markers (CD4, CD8 and T19) and with activation/adhesion
markers and class II in the second channel.
Secondary antigen challenge mediates a vigorous immune response from
immunologically experienced cells. This enhanced response is due to the
persistence in the host of antigen specific cells and their increased frequency on
stimulation. These memory T cells also exhibit different circulatory behaviour to
virgin cells and the selective expression of an array of adhesion molecules
facilitates their extravasation into specific tissues. Several markers that
distinguish activation states of T cells have been identified. T cells which have not
encountered antigen express high molecular weight isoforms of CD45
(CD45RA/B/C), a low density of both CD44 and (31 -integrin and a high density of
L-selectin. The reciprocal phenotype is displayed by memory/effector T cells
primed to various environmental antigens (CD45RA10, CD44hi and L-selectin'0)
(Sanders et al, 1988; Mackay et al, 1990). In addition, memory phenotype T cells
express higher levels of several adhesion molecules such as ICAM-1, LFA-1, CD2,
LFA-3 and a4p1 integrin (reviewed in Mackay,1993). In this study class II
isotype expression is correlated with the expression of CD45RA, CD44, CD2, LFA-
3, L-selectin and the a4-heterodimers.
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CD45 is a transmembrane glycoprotein whose cytoplasmic domain shows
protein tyrosine phosphatase activity (Tonks et al, 1988). CD45 isoform
expression subdivides T cells into reciprocal subsets expressing either high
molecular weight isoform (CD45RA/B/C) or the low molecular weight isoform
(CD45RO). The CD45RO subset responds in vitro to recall antigens and provides
help for antibody synthesis (Morimoto et al,t 985). The similarities between
species led to the widespread acceptance of high and low molecular weight isoforms
as markers of naive and memory T cells respectively (Mackay,1991). It is now
clear that this distinction is not absolute as reversal of isoform expression on
previously primed cells occurs (Sparshott and Bell,1994). CD45 isoforms have
been shown to regulate signal transduction differentially through the TCR complex.
The high molecular weight isoform enhancing TCR signalling while CD45RO
requires a costimulus to augment cellular proliferation (Chui et al, 1994).
Further evidence from CD45 deficient T cell lines has shown that CD45 expression
is an absolute requirement for TCR signalling (Trowbridge and Thomas,1994).
CD45 isoform expression may be more appropriately described as a marker of
activation state.
CD44 was one of the first molecules employed to distinguish memory
phenotype T cells. Murine T cells can be subdivided into CD44hi andCD44l0
subsets, the CD44hi T cells representing antigen activated cells (Cerottini and
MacDonald,1989). In sheep, CD44|0 T cells in lymphatic vessels are resting cells
whereas the CD44hl cells are effector cells dividing rapidly over a period of days
(Mackay et al, 1990). CD44 interacts with several cell surface and matrix
components, including fibronectin, collagen and hyaluronate (Miyake et al, 1 990).
There is no direct evidence that CD44 binds to the high endothelial venules or
activated endothelium, instead it has been proposed that CD44 functions in
activating other adhesion molecules and the modulation of CD2 has been found
(Herrlich et al,~\ 993).
CD2 is a member of the immunoglobulin superfamily expressed on CD4 and
CD8 T cells. Its counter receptor is LFA-3, which is also a member of the
immunoglobulin super family. The driving force in regulation of cell-cell adhesion
mediated by the CD2/LFA-3 mechanism is T lymphocyte activation. Close cell
contact between circulating cells is opposed by the negative charge of sialic acid.
This repulsive negative charge is reduced on activated T cells. The differences in
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surface charge contributes to different levels of adhesion mediated by CD2/LFA-3
(reviewed in Springer,1990). The CD2/LFA-3 interaction also induces signal
transduction events involved in the regulation of T cell responses. CD2 mediated
activation of human T cells has been shown to induce class II expression (Oshima
and Eckels,1990b). After in vitro activation of naive human T cells increased
expression of CD2 and LFA-3 has been reported (Sanders et al, 1988). Similarily,
it has been found that in vivo activated sheep T cells show increased expression of
CD2 and LFA-3 (Mackay et al, 1 990).
L-selectin was the first identified mediator of lymphocyte homing to
peripheral lymph node HEV (Gallatin et al, 1983). Naive T cells are L-selectin
positive enabling them to enter the lymph node directly from the blood while
memory T cells lack this receptor and reach the lymph node via afferent lymph
draining the tissues. Following activation the down-regulation of L-selectin and
up-regulation of other adhesion molecules on memory T cells suggest that they are
less apt to bind to lymph node FIEV but more prone to bind to other endothelial
surfaces (Mackay,1 991).
The mAb 218 recognizes a4 integrins of which 2 distinct a4-heterodimers
have been identified a4pi(VLA-4) and a4[}7 (Flolzmann and Weissman, 1989).
Memory cells in humans and mice which show a trophism for the gut express the
a4p7 integrin, while a4pi is one of the principal adhesion molecules for
lymphocyte extravasation to inflammatory sites (van Kooyk and Figdor,1993).
Because the frequency of antigen specific lymphocytes is low, continuous
migration through most tissues of the body enhances the likelihood of cells of
appropriate specificity coming into contact with their individual antigen. It has
been proposed that to optimize their efficiency, naive and memory T cells have
different circulatory routes (Mackay,1991). Afferent lymph contains mainly cells
of the memory phenotype while efferent cells contain a mixture of naive and
memory phenotypes (Mackay et al, 1990). To establish staining patterns for each
of the described activation/adhesion markers, staining on both afferent and efferent
lymph cells was established. The staining pattern following activation in the
efferent lymph was then correlated with class II isotype expression. Proliferation
assays and assays for specific antibody (gel diffussion) were carried out to
establish that the animals were adequately primed to antigen.
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5.2 Results
5.2.1 Proliferation and gel diffusion assays.
To establish that the sheep used were responding to antigen, proliferation
assays were conducted on their PBLs. Gel diffusion assays were also conducted to
measure levels of ovalbumin specific antibodies. These results are shown in Figure
5.1. A stimulation index of >6 and an antibody equivalence of -30 pg/ml ovalbumin
was required before the typical kinetic changes that characterize a secondary
immune response were detected. In animals primed with ovalbumin with low
antibody responses and low stimulation index from proliferation assays there were
no observed changes in cell kinetics after antigen challenge to the cannulated node.
This is similar to what has been found in primary immune responses of the sheep
(Hopkins et al, 1993). Sheep were repeatedly stimulated with ovalbumin until an
adequate antibody response was detected. A threshold level of antigen priming
appears to be required.
5.2.2 Changes in efferent lymph following antigen challenge
Antigen challenge to a lymph node leads to pronounced changes in the output
of cells (Hall and Morris,1965). Secondary immune responses were characterized
by cell shutdown within the first 24 hours followed by an increase in lymphocyte
output between 50 and 150 hours (Fig5.2a). By 9/10 days after antigen challenge
cell output and lymph flow had returned to resting levels. Changes in the percentage
ofCD4+, CD8+ andyS T cells following antigen challenge are shown in Figure 5.2b.
The percentage of CD4+ cells increases on days 1, 2 and 3 post antigen challenge
while the percentage of CD8+ cells increases on days 2 to 5. y8 T cell levels
remained constant.
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Proliferative response of PBMC to ovalbumin, human serum albumin
and Con A from two sheep primed to ovalbumin. The proliferative
response is presented as stimulation indices calculated as follows
SI - mean proliferative response with antigen




Gel diffusions assays with sera from the same sheep as in Table
5.1. Ovalbumin at a concentration of 0.5mg/ml was titrated in
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(b) Changes in the percentage staining of CD4+, CD8+ and T19+ efferent cells
following in vivo antigen challenge. Cells were collected from a cannulated lymph
node before and after antigen challenge, stained with SBU-T4, SBU-T8 and CC15
and analysed by flow cytometry.
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5.2.3 Afferent and efferent staining for activation/adhesion markers
Cells of the afferent lymph are described as memory type while in efferent
lymph they are mostly of the naive type (Mackay et al, 1990). Using monoclonal
antibodies to activation/adhesion molecules the staining patterns on both afferent
and efferent lymph was established to distinguish between naive and memory
patterns of staining (Fig 5.3). The CD4+ cells of efferent lymph expressed lower
levels of a4 integrin when compared with afferent CD4+ cells. a4 integrin was
expressed on a higher percentage of afferent CD4+ cells and showed a higher
intensity of staining as evident from the peak channel data. L-selectin expression
showed a reciprocal pattern, decreased expression was observed on afferent cells.
Expression of CD45R was absent on afferent cells whereas 67% of efferent cells
expressed CD45R. This data is consistent with the reported naive and memory
phenotypes of efferent and afferent lymph cells respectively. Differences in CD2,
CD44 and LFA-3 expression levels are not as obvious. Slight variations in levels of
intensity were observed.
The CD8+ T cells were also divided into naive and memory phenotypes. L-
selectin was expressed on 30% afferent CD8+ cells and 93% of efferent CD8+ cells.
a4 integrin was expressed by comparable numbers of CD8+ cells in efferent and
afferent lymph, however the intensity of staining was higher on afferent cells.
Levels of CD45R expression were negligible on afferent CD8+ cells while 87% of
efferent cells were positive. These differences subdivide CD8+ T cells into afferent
memory and efferent naive types. Again differences in expression of CD2, LFA-3
and CD44 were less clear. High levels of CD2"CD8+ cells were observed on both
efferent and afferent lymph. The CD8 molecule is expressed on a proportion of NK
cells and y8 T cells (Mackay et al, 1990) and because y8 T cells do not express the
CD2 molecule, this may account for the high percentage of CD2"CD8+ cells.
The anti-CD45 mAb (73B) used in these studies has been shown to recognize
a high molecular weight isoform, possibly CD45RA. This antibody stains CD4 and
CD8 positive T cells, while staining on y8 (T1 9+) T cells has been shown to be less
than 10% (Dutia et al, 1993b). The data presented confirms this finding for yS T
cells. CD2 is not expressed on yS T cells (Mackay et al, 1988) and the data shows a
negative staining pattern for CD2.
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Figure 5.3
Flow cytometry histograms of double stained efferent cells compared with double
stained afferent lymph cells. Adhesion/activation marker expression (FL1) is
displayed as single histograms gated on (A) CD4+, (B) CD8+ and (C) T19+ T cells
(FL2). Gates were set on the negative control (VPM21) profile for each of the T
cell subsets. The figures represent the percentage positive cells (% pos.) when
compared with the negative control. Peak channel (pk. chan.) data is also shown.

















































































































































Both efferent and afferent 78 T cells express L-selectin at a greater intensity to
CD4+ andCD8+ cells. The peak channel data for L-selectin expression on 78 T cells
reaches 150 compared with 110 for CD8+ cells and 97 for CD4+ cells. Differences
in L-selectin, a4 integrin, LFA-3 and CD44 expression between efferent and
afferent lymph were difficult to discern. 78 T cells in both efferent and afferent
lymph appear to express a memory phenotype based on expression of both CD45R
anda4 integrin.
Overall, CD4 and CD8 positive T cell subsets in afferent lymph expressed a
predominantly memory phenotype while efferent lymph T cells were mainly of the
naive phenotype. Differences between efferent and afferent 78 T cells were not
similarily marked. For comparison class II DR and DQ expression on efferent and
afferent lymph T cell subsets was shown in Figure 3.3 a, b and c. The DR+DQ+
phenotype of afferent CD4+ andCD8+T cells correlating with a memory phenotype
andtheDR'DGT of efferent T cells correlating with a naive phenotype. The DR+DQ"
T cells in efferent lymph may represent a low incidence of memory phenotype cells.
5.2.4 Expression of adhesion/activation markers on T cell subsets
following in vivo stimulation.
Having established the staining patterns for memory and naive cells, these
mAbs were used to follow the events of cellular activation. Antigen was delivered to
the draining area of the cannulated node of antigen primed sheep. Cells were
analysed by flow cytometry gating on small lymphocytes. 10,000 events were
counted for each sample. The proportions of T cell subsets varied during the
immune response and this is reflected in the numbers analysed. For example, when
the numbers of CD4+ T cells were high the proportion of 78 T cells analysed was
reduced. Two sheep were used in this study. Analysis at 4 time points was achieved
for sheep BT169, while analysis at 2 time points was obtained for sheep BT170.
The results are presented for each of the T cell subsets in Fig 5.4 a,b & c and Fig5.5
a,b & c respectively. Class II DR and DQ staining on sheep BT169 was shown in Fig
3.4 a, b and c. Class II DR and DQ staining on BT170 T cells is included in Fig.5.5.
5.2.4.1 CD4+ T cells
During the secondary immune response of sheep BT169, L-selectin
expression showed a bimodal distribution pattern on days 2 and 9, though the
88
percentage positive cells increased on day 2 numbers fell below day 0 values by day
9. Resting levels were restored on day 12. The loss in L-selectin staining intensity
was not as dramatic as that seen in afferent lymph. An increased percentage of CD4+
cells stained with mAb 218 (a4-heterodimers) was observed on day 2. A variable
pattern of CD45R staining was observed throughout the time course. Expression of
CD2 on days 2 and 9 appeared to show a marginal increase in intensity, this was not
reflected by the peak channel data. No variations in LFA-3 and CD44 were
observed.
On the second sheep examined, expression of CD2 and CD44 by day 4 was
increased. L-selectin expression was reduced from 78% on day 0 to 50% on day 4.
CD45R expression was also reduced, 26% on day 0 to 9% on day 4. Though the
percentage a4 integrin positive cells remained the same on days 0 and 4, the cells
collected on day 4 expressed a higher intensity of staining as evident from the peak
channel data (Fig5.5A). From the results of these two sheep, it can be concluded
that CD4+ T cells in efferent lymph show an increased expression of the memory
phenotype on day2/4.
Levels of class II expression on CD4+ T cells also increased over the time
course for both sheep. Sheep BT169 showed increased expression of both DR and DQ
by day 2 with near doubling levels expressed on day 9 (Fig3.4a). By day 12 class II
expression had returned to resting levels.
5.2.4.2 CD8+ T cells
The staining pattern on day 2 for CD8 cells was marked by a higher intensity
of CD2 and LFA-3 expression which is reflected in the peak channel data. No
significant changes in CD44 expression occured (Fig 5.4B). Loss of the CD2"
population on day 2 was coincident with the reduced numbers of T cells analysed
per sample. No significant difference in L-selectin expression occured between day
0 and 2 however the percentage L-selectin positive cells decreased on day 9 and 12.
A dramatic loss of the high intensity CD45R positive cells occured on the second day
and returned to resting levels at each of the other time points. This is in contrast to
CD4+ T cells which showed variable expression of CD45R from day 0-12. The
intensity of a4 integrin staining also increased on day 2.
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CD8+ T cells from sheep BT170, also showed increased intensity of expression for
LFA-3 on day 4. No discernible difference was evident for CD2 staining. CD44
expression appeared to be down-regulated as was CD45R and L-selectin
expression. Decreased levels of a4 integrin expression was observed on day 4.
This is in contrast to the data for CD4+ cells which showed increased expression of
a4 integrin on day 4. The data from both these sheep would indicate that CD8+ T
cells during the secondary immune response show increased expression of the
memory phenotype on day 2/4.
Levels of class II on CD8+ T cells were also up-regulated. Increased DR and
DQ expression was observed on day 2 and reached maximal levels by day 9 for sheep
BT169 (Fig3.4b). Similarily elevated levels of class II expression were observed
on day 4 for sheep BT170.
5.2.4.3 y5 T cells
y5 T cells do not express CD2 or the antigen recognized by the 73B mAb
(anti-CD45R). Stimulation with ovalbumin appeared not to induce discernible
variations in adhesion/activation markers on the circulating y8 T cells. This was
evident from the data of both sheep examined. This correlates with the lack of
difference observed between afferent and efferent lymph.
However increased expression of class II DR and DQ isotypes were observed
in both animals examined. Similar to CD4+ and CD8+ T cells maximal expression
was observed on day 9.
In summary, antigen challenge to the node resulted in increased expression
of the memory phenotype on the circulating CD4 and CD8 positive T cells on day
2/4. This correlated with increased expression of class II molecules on these T
cells. Class II expression remained up-regulated for a longer period. There were
no observed changes in activation/adhesion molecule expression on y5 T cells,
however increased expression of class II did occur.
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Figure 5.4
Expression of adhesion/activation markers on efferent lymph CD4- (A), CD8+ (B)
and T19+ (C) T cells isolated during a secondary immune response to ovalbumin for
sheep BT169. Cells were stained by two colour immunofluorescence and histograms
represent single colour staining on gated CD4+, CD8+ or T19+ small lymphocytes.
VPM21 staining on CD4+, CD8+ and T19+ T cells represents the negative control.
The figures represent the percentage positive cells (% pos.) when compared with
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Figure 5.5
Expression of adhesion/activation markers and class II isotype expression on
efferent lymph CD4+ (A), CD8+ (B) and T19+ (C) T cells isolated during a
secondary immune response to ovalbumin for sheep BT170. Cells were stained by
two colour immunofluorescence and histograms represent single colour staining on
gatedCD4+, CD8+ or T19+ small lymphocytes. VPM21 staining on CD4"\ CD8+ and
T19+ T cells represents the negative control. The figures represent the percentage
positive cells (% pos.) when compared with the negative control. Peak channel
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The association of T cell function with the expression of a unique array of
cell surface determinants has led to a greater understanding of cell trafficking
during immune responses. It has emerged that the migratory routes of
memory/effector cells are different from those of naive precursor cells. T cells
entering the lymph node via afferent lymph are phenotypically memory type, while
those in the efferent lymph which derive mainly from the blood entering the LN
across HEV are mostly naive phenotype (reviewed in Mackay,1993). The studies
described here on afferent and efferent lymph are consistent with these findings.
Using mAbs to a4 integrin, L-selectin and CD45R molecules, differences in their
level of expression defined a reciprocal pair of T cell subsets. T cells of the afferent
lymph were predominantly memory-type (L-selectin", CD45R" oc4-integrinhi)
while in the efferent they were predominantly naive phenotype (L-selectin+,
CD45R+, a4-integrin'°). Only marginal differences in levels of CD44 expression
were observed between afferent and efferent lymphocytes and subdivision into high
and low expressing populations as has been reported by Mackay et al {1 990) was
not carried out. Class II DR and DQ expression on CD4 and CD8 positive T cells
coincides with the memory phenotype. The higher incidence of DR+ DCT T cells in
afferent lymph coincides with the memory phenotype whereas efferent T cells are
mostly class II negative, the DR+DGT T cells may reflect the lower incidence of
memory efferent T cells. This pattern was reflected on CD4+ andCD8+ T cell
subsets.
The administration of antigen to a primed sheep enhances the traffic of
lymphocytes through the regional lymph node. Increased numbers of CD4+ and
CD8+ T cells appeared in the lymph. The composition of efferent lymph was
characterized by an increased proportion of CD4+ T cells during the first 3 days.
This was followed by increased proportions of CD8+ T cells on days 2 to 5. This is
consistent with data published (Bujdoso et al, 1989). Profiles of
activation/adhesion molecules were not obtained on a daily basis to correlate
expression of adhesion/activation markers with exit of CD4 and CD8 positive T cells
from the node.
The CD4 and CD8 positive T cell subsets during the immune response were
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also characterized by increased expression of the memory phenotype markers (on
day 2 for one sheep and day 4 for the second sheep). This is consistent with data
published by Mackay et at, (1992). Variable expression of CD45R was observed
over the time course for sheep BT169, while expression on sheep BT170 decreased.
The significance of this event is not understood and may represent sheep to sheep
variability. The increased expression of both DR and DQ class II molecules on day 2
correlates with the activation/memory phenotype. Elevated levels of
activation/adhesion markers were evident at day 2/4, with the exception of L-
selectin on CD4+ T cells which displayed a memory phenotype until day 9. The
increased expression of class II molecules was observed for up to 9 days following
immune stimulation. Class II expression coincided with the increased expression of
activation markers but the time courses of expression did not correlate. In
comparison with activation/adhesion marker expression, levels of class II
expression remained elevated for a longer period. Class II expression reached
maximal levels on day 9, when activation/adhesion molecules had returned to
resting levels. Because class II expression on T cell subsets was detectable for a
longer period its presence may be indicative of a different functional role.
The panel of activation/adhesion molecules did not subdivide 78 T cells in
afferent and efferent lymph into either memory or naive phenotype T cells
respectively. Changes in the expression of activation/adhesion molecules was also
not observed during the secondary immune response. 78 T cells did however show
increased expression of both class II DR and DQ molecules. Because 78 T cells could
not be identified as either naive or memory phenotye it was not possible to correlate
activation status with class II expression.
No changes in numbers of circulating 78 T cells were observed during the
immune response. 78 T cells appeared not to elicit an immune response to
ovalbumin. In contrast, work published by Mackay et at {1992) reported changes
in 78 T cell numbers following BCG challenge. The failure to detect changes may be a
reflection on the antigen used. In mice, numbers of 78 T cells in the peritoneal
cavity increase following Listeria monocytogenes (an intracellular bacterium)
infection but not after Nippostrongylus brasilensis (an extracellular parasite)
infection (Ferrick et a/,1995). 78 T cells appear to be biased in their recognition
of pathogens. A recent report, argues that 78 T cells have a system for specific T
cell recognition that is alternate to the MHC presented peptide complex of a(3 T cells
(Tanaka et at, 1995). An antigen such as ovalbumin would not be detected by the 78
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T cell whereas small non-peptidic antigens are recognized.
On activation both DR and DQ class II molecules were induced in each of the T
cell subsets. DQ expression showing a marked induction on CD4+ T cells. In sheep
expression of DQ by T cells may be a result of recent activation (Dutia et al, 1 993a)
as has been implicated on human T cells (Oshima and Eckels,1990a). However,
correlations with other activation markers in this study did not provide further
insights into the possibility that DR and DQ may fulfill different functional roles.
In the next chapter the functional significance of class II isotypes will be examined
with regard to cytokine secretion.
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CHAPTER 6 Correlation of MHC class II DR expresssion
with cytokine expression.
6.1 Introduction
T cell activation in response to antigens involves the interaction of multiple
receptor-coreceptor pairs which mediate cell adhesion and signal transduction.
Having examined the correlation of the increased class II expression on activated T
cells with adhesion/activation molecules, the relationship of class II DR expression
with the outcome of signal transduction events is examined in this chapter. Signal
transduction events that occur during antigen recognition by T cells eventually lead
to the expression of cytokines which are mainly responsible for the mediation of
cell function. It is the coordinate production of cytokines which is crucial for the
regulation of an immune response. In the experiments described here, the
relationship between class II DR expression and cytokine expression following
activation was examined.
In recent years it has become evident that the immune response is largely
dependent on the activation of particular subsets of CD4 cells that secrete defined
patterns of cytokines. Initially, Mosmann et a/(1986) subdivided mouse CD4+
helper 1 cell clones on the basis of differences in their cytokine production. The
subsets, termed Th1 and Th2 type T cells, showed distinct, and mutually exclusive,
patterns of cytokine secretion. Th1 cells are defined as IL-2, y-IFN and TNFp
secretors while Th2 cells produce mainly IL-4, IL-5, IL-6 and IL-10. Other
cytokines such as TNFa, IL-3 and GM-CSF are produced by both Th subsets
(reviewed in Mosmann and Coffman,1989; Kelso et al, 1991; Janeway et al, 1 988).
The existence of functional Th1 and Th2 subsets in vivo has been established
using the mouse model of Leishmania major infection. Strains of mice that are
highly susceptible to the parasite develop poor cell mediated immunity and produce
Th2 type cytokines. In contrast, resistant mouse strains develop Th1 responses
(Heinzel et al, 1989). A similar dichotomy has been found in humans using T cell
clones expanded from patients suffering from leprosy. Th1 clones were derived
from healed lesions of patients with tuberculoid leprosy and Th2 clones derived
from patients with lepromatous leprosy (Salgame et al, 1991). The successful
elimination of infectious agent depends on expansion of the appropriate CD4+ T cell
subset. In general Th1 cells are responsible for generating strong cellular
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immunity against intracellular pathogens; Th2 cells promote the development of
humoral responses that direct effector functions using specific antibodies against
extracellular pathogens.
In the murine system Th1 and Th2 cells are repeatedly stimulated memory T
cells that have differentiated from precursor T cells (Thp). Naive Thp cells
produce IL-2 and progress into an intermediate ThO stage in which the cytokines
that characterize both Th1 and Th2 are produced. These cells then terminally
differentiate into Th1/Th2 cells upon repeated antigen stimulation (Street et
al, 1990). Secretion of cytokines following activation is short-lived. Cytokine
production occurs within a few hours. The cell then reverts to a resting state until
further stimulation.
Once induced, the subsequent expansion of Th subsets is facilitated and
regulated by subset specific cytokines. The dominant cytokines responsible for Th1
and Th2 differentiation are IL-12 and IL-4 respectively (reviewed in Paul and
Seder,1994; Trinchieri,1993). IL-12 produced by macrophages in response to
bacteria or parasites is an obligatory factor for Th1 generation and proliferation.
IL-12 acts directly on Th1 cells and indirectly by inducing ylFN production by T
cells and NK cells. ylFN has a positive feedback effect by positively inducing
further IL-12 production. On the other hand, IL-4 generates a Th2 type response
by inhibiting IL-2 receptor expression andylFN production. The Th2 cell products,
IL10 and IL-4, have a negative feedback effect on IL-12 production (D'Andrea et
al, 1993).
Macrophages, NK cells and mast cells have been implicated in the directed
development of the Th phenotype (Kullberg et al, 1992). IL-12 is induced in
macrophages infected with intracellular organisms, while IL-4 directed Th2
development may be through IL-4 production by CD4+ T cells, mast cells and
basophils, y8 T cells may also contribute to the cytokine milieu that influences the
differentiation of antigen specific CD4+ T cells into Th1 or Th2. y5 T cells have
been shown to produce cytokines which are associated with the appropriate Th type
response earlier than CD4 cells during infection (Ferrick et al, 1 995).
The immune response is directed by cytokines. Flowever locally active
hormones (Daynes et al, 1991), antigen dose and antigen specific recognition
(Murray et al, 1994) can also control the functional outcome of immunity. Peptide
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density on APCs has been predicted from MHC haplotype and cell mediated immunity
was found associated with the MHC haplotype that displays high ligand density
presentation in vitro (Murray et al, 1 994).
In sheep, as in humans, activated T cells expressing MHC class II are
associated with cell proliferation and may have a regulatory role in the immune
response. HLA-DR expressed by activated human CD4 T cell clones has been shown
to play a role in signal transduction (Odum et al, 1991). Antibody crosslinking of
DR resulted in an increase in tyrosine phosphorylation and T cell activation. To
understand the potential functional consequences of T cells expressing MHC class II,
the cytokine profiles of unfractionated T cells and class II DR negative T cells
stimulated in vitro was examined. Most of the initial knowledge on the regulation of
cytokine production and the effect of these factors in vitro comes from studies
performed with cell lines and T cell clones. Understanding the regulation and
function of cytokine production by normal immunocompetant cells in in vitro
situations mimicking immune responses, will give important information which
may be more relevant to in vivo physiological function.
PCR (Saiki efa/,1988; Kawasaki et al,~\ 988) is currently the most
sensitive technique for the detection of specific nucleic acid molecules present in
low copy number. Quantitation of RNA can be achieved by coupling reverse
transcription (Krug and Berger,1987) with PCR reactions (RT-PCR). Reverse
transcription is employed to make first strand cDNA which is then used as a
template for further amplification in PCR. Enhanced specificity and sensitivity can
be achieved by hybridizing oligonucleotide DNA probes internal to the primers of
the target sequence. The RT-PCR technique has been successfully applied to the
precise quantitation of mRNA (Wang and Mark,1989) and the combination of RT-
PCR and Northern blotting has allowed the comparison of relative amounts of
specific mRNAs present in syngeneic and allogeneic cardiac transplants (Dallman
et al,1991). Many of the ovine cytokines have now been cloned and so it was
possible to use RT-PCR to provide a semi-quantitative analysis of cytokine mRNA
levels.
Using RT-PCR, the kinetic analysis of ylFN (Th1) production in in vitro
concanavalin A activated efferent cells was established along with IL-6 and IL-10
(Th2) production by an LPS stimulated monocyte enriched cell population. Using
the MACS, T cells were depleted of the MHC class II DR phenotype and the cytokine
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profiles examined in the fractionated and unfractionated T cells following in vitro
specific antigen and mitogen activation.
6.2 Results
6.2.1 Kinetic analysis of cytokine production.
The aim of these experiments was to establish the kinetics of ylFN, IL-6 and
IL-10 production from activated cell populations. ylFN production was assessed in
Con A activated efferent lymphocytes while IL-10 and IL-6 production was analysed
from an LPS activated macrophage enriched population. Cytokines were assessed by
semi-quantitative RT-PCR. An ovine ATPase alpha subunit PCR assay was used
specifically for these studies (Woodall et al, 1994). ATPase is a gene with a
housekeeping function and therefore would be expected to be expressed in all cell
types throughout development. Levels of cytokine expression were normalized with
respect to ATPase expression. This approach gave a semi-quantitative measure of
cytokine gene transcription.
6.2.1.1 Cytokine profiles of Concanavalin A stimulated efferent
cells.
Efferent lymphocytes were cultured at 2 x 106/ml in the presence of
5^g/ml Con A. 10ml cultures containing 2 x 107 cells were harvested prior to the
addition of concanavalin A and 2, 4 and 8 hours following stimulation. The total RNA
recovered was intact as determined by agarose gel electrophoresis (Fig 6.1a) with
clear bands apparent for the 18S and 28S ribosomal RNA. mRNA is present as a
smear between both these bands. cDNA was synthesized and PCR performed for
ylFN, IL-4, IL-10 and ATPase. Aliquots of the PCR reaction were removed after
increasing numbers of cycles and analysed by slot-blot southern hybridisation (Fig
6.2).
The level of expression of ATPase is consistent in the 0, 2 and 8 hour time
points with the gene detectable at 25 cycles in each sample. Expression of ATPase
does not appear until 30 cycles in the 4 hour time point. Taking the ATPase levels
as a measure of the amounts of mRNA per sample there is an increase in ylFN
expression after 2 hours of Con A stimulation, with maximal expression after 4
hours. IL-6 expression also appears after 2 hours, the lack of expression at 4
hours may be coincident with the lower levels of mRNA in this sample.
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A. Analysis of RNA from concanavalin A stimulated efferent lymphocytes at 0, 2. 4
and 8 hour time points. 20gg of total cellular RNA per sample with the exception of
the 2 hour sample which had only 10ug were fractionated on a 1%
agarose/formaldehyde gel and visualised under UV.
B. Analysis of RNA from an alveolar macrophage enriched cell population before
adherence (0), after adherence (0'), and 1. 2, 4 and 13 hours following LPS
stimulation. 10pig of total cellular RNA per sample was fractionated on an
agarose/formaldehyde gel and visualised under UV by ethidium bromide staining.
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Figure 6.2
ATPase.YlFN, IL-6 and IL-10 gene expression in concanavalin A activated efferent
lymphocytes analysed by semi-quantitative RT-PCR. RNA was isolated, cDNA
synthesised and 10pl PCR reaction mix was removed every 5 cycles from 20-40
cycles. PCR product was denatured and blotted directly onto nylon membrane. Blots
were probed with 32P labelled internal oligonucleotide. Product was examined at 0,
2, 4 and 8 hours following concanavalin A activation. -, no cDNA control.
cycle number
20 25 30 35 40
ATPase




35 cycles 40 cycles 35 cycles 40 cycles 35 cycles 40 cycles
Ohrs 0 0.92 0 0 1.52 3.6
2hrs 1.07 2.65 0 0.42 0.7' 2.59
4hrs 1.88 4.09 0 0 0 0.72
8hrs 0.08 1.37 0 0.31 0.49 1.15
Table 6.1
Densitometric assessment of slot-blots shown in Figure 6.2. Values are presented
as multiplication factors of the ATPase levels at each cycle. The data is of a single
experiment.
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There was little difference in the levels of IL-10 mRNA expression between the 0,
2 and 8 hour time points, again the 4 hour time point had a lower level. The data
from the densitometer scan is normalized to ATPase expression per sample in Table
6.1. Values are given as ATPase multiplication factors. This data parallels the
observations described.
6.2.1.2 Cytokine profiles of alveolar macrophage enriched cells
stimulated with LPS
Cells were recovered from ovine lungs as described in Chapter 2 (2.2.3.3).
The recovered cells were set up in culture and macrophages allowed to adhere for 2
hours. The non-adherent cells were removed by washing and LPS at 10pg/mi added
to the remaining macrophage enriched cells. mRNA was harvested from cells before
adherence, after adherence and 1, 2, 4 and 13 hours after LPS stimulation. Fig 6.3
shows a flow cytometric profile and Leishmann stain of the population of cells prior
to adherence. The flow cytometric profile indicates that this was not a homogenous
macrophage population but contained lymphocytes as evident by the smaller size and
granularity. The Leishmann stain shows a majority of macrophages, macrophages
are large with many cytoplasmic granules, whereas lymphocytes have dense nuclei
and sparse cytoplasm. The cells following adherence were not analysed.
There are particular problems in isolating mRNA from macrophages because
of the abundance in lytic granulosomes. Cytokines are known to have AU rich
sequences in the 3' untranslated region, conferring a short half-life on the RNA
(Shaw and Kamen,1986). Therefore, with the disruption of the cellular
microenvironment the RNA must be rapidly recovered. The integrity of the RNA
was assessed under denaturing conditions of agarose gel electrophoresis with good
RNA recovered for each sample (Fig 6.1b).
Figure 6.4 shows the slot-blot southern hybridisation after RT-PCR for IL-
10, IL-6, ylFN and ATPase. ATPase expression was detectable at 25 cycles in each
sample indicating similar levels of mRNA. ylFN levels were measured as a check on
the purity of the population, because macrophages are not known to express ylFN
(Lau,1994). The levels of ylFN were high in the initial samples prior to adherence
when one can expect a large proportion of lymphocytes. Washing removed a
proportion of lymphocytes and this was marked by reduced levels of ylFN. Clearly a
more rigorous procedure of washing is required to remove all lymphocytes and yiFN





(A) Forward scatter and side angle scatter profile of the alveolar lavage cells prior to
adherence to plastic.
(B) Leishmann stain of the same cell poplation.
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Figure 6.4
ATPase.ylFN, IL-6 and IL10 gene expression in LPS activated macrophage enriched
alveolar cell population. Cells were harvested for mRNA and RT-PCR performed.
Analysis was made at various time points following activation with LPS.
represents the cDNA negative control.
20
cycle number
25 30 35 40
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ylFN IL-6 IL-10
35 cycles 40 cycles 35 cycles 40 cycles 35 cycles 40 cycles
0 3.32 7.03 0 0.14 0.23 1.12
0' 0.88 3.45 0 0.68 0.72 0.79
1 3.17 5.52 4.09 7.22 0.2 0.41
2 1.57 4.88 2.89 6.53 0.42 0.49
4 1.99 3.41 2.53 4.48 0.11 0.04
13 0.76 2.32 0 0.47 ND ND
Table 6.2
Densitometric assessment of the slot-blots shown in Figure 6.4.
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The levels of IL-10 show little variation over the time course. IL-6 is produced by
both macrophages and lymphocytes and LPS has a stimulatory effect on both cell
populations. At 0 time point there was very low expression of IL-6 mRNA.
Adherence induces activation of macrophages which was marked by increased iL-6
mRNA expression. On LPS stimulation a clear enhancement in IL-6 mRNA levels
could be detected as early as 1 hour. IL-6 mRNA expression was maximal after 1
hour and by 13 hours was beginning to decline. The data are normalized to ATPase
expression in Table 6.2. As the level of ATPase expression was consistent in each
sample the data can be used comparatively. Overall, IL-6 was dramatically induced
following LPS activation, IL-10 levels showed little variation while ylFNwas
variably expressed.
6.2.2 Activation of unfractionated T cells and DR" T cells.
To examine the role of MHC class II isotype expression on T cells the
cytokine profile of unfractionated T cells was compared with the profile from DR" T
cells stimulated in vitro. Both antigenic and mitogenic stimulation was employed.
6.2.2.1 Antigen stimulation of unfractionated T cells and DR" Tcells.
Efferent lymphocytes from an ovalbumin primed sheep were stimulated in
vitro with ovalbumin using autologous irradiated PBMC as antigen presenting cells
Efferent lymphocytes were MACS purified into a total T cell population and a DR T
cell population (details of these experiments are given in 6.2.2.2). The purified T
cells were established in culture at 2 x 106/ml with irradiated PBMC at a 1:1 ratio
and ovalbumin at 500|jg/ml. RNA was harvested from 4 x 107 cells at various time
points after the addition of antigen. As a control irradiated PBMC were set up in
culture at 4 x 1 07cells/1 Omls and harvested for RNA prior to the addition of
ovalbumin and 24 hours following addition of ovalbumin. RNA was purified, cDNA
synthesized and ATPase primer pair added to the PCR reaction for product detection.
The result is shown in Fig 6.5. Irradiation did not disrupt the levels of mRNA
present in the APCs and ATPase was detectable at both time points in the irradiated
cells. Following these results it was decided to stimulate T cells non-specifically
with Con A to examine cytokine profiles.
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ATPase PCR product fractionated by electrophoresis through an ethidium bromide
agarose gel. Samples are as follows
Lanel and 2, amplified product from 107 efferent cells MACS fractionated into DFT
T cells with autologous irradiated PBMC at a 1:1 ratio. Cells were stimulated with
ovalbumin and analysed at either 0 or 24 hours.
Lane 3 and 4, amplified product from 2x 107 irradiated PBMC at 0 and 24 hours
following the addition of ovalbumin.
Lane 5, 6 and 7, amplified product from 107 unfractionated efferent cells with an
equal number of autologous irradiated PBMC. Cells were stimulated with ovalbumin
and analysed at 0, 4 and 24 hours.
Lane 8 represents the no cDNA control.
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6.2.2.2 Mitogen stimulation of unfractionated T cells and DR" T
cells.
The initial plan was to isolate T cell subsets into DR and DQ expressing
populations using the MACS. However, from the results described in Chapter 4, it
was not possible to isolate T cell subsets negatively. This was due to the lack of a
null cell specific mAb. Positive selection with the MACS was deemed unsuitable, as
antibody binding may affect the resultant cytokine profile. Thus it was decided to
prepare a total T cell population from efferent lymph by negatively removing B
cells, macrophages, monocytes and granulocytes with the MACS. By further
removing DR+ T cells from the isolated T cell population, it was possible to compare
the cytokine profile of the DR" T cell population with the total T cell population.
Isolation of a DQ" T cell population was not examined as DQ is expressed on only a
small percentage of unstimulated T cells.
Lymphocytes were purified from defibrinated blood by hypotonic lysis of the
red blood cells followed by centrifugation over lymphoprep. These cells were used
for MACS purification of a T cell population and a DR" T cell population.
Biotinylated antibodies to granulocytes/monocytes [VPM65 (anti-CD14) & VPM64
(anti-CD16)] and B cells (VPM30) were used to remove these cells, leaving a pure
T cell population. To purify the DR" T cells, biotinylated VPM54 (anti-DRa) was
used to remove DR+ cells. Flow cytometric profiles of the selected cells are shown
in Fig 6.6. The purity of the cells isolated by MACS was >95% as determined by
lack of phycoerythrin expression. The purified cell populations were stained with
neither a pan T cell marker or a DR specific antibody to establish unequivocably
their purity. The selected cell populations were cultured at 2 x 106 cells/ml with
Con A at 5gg/ml. 2 x 107 cells were harvested for RNA extraction at 0, 2, 4 and 16
hours using the total T cell population. As fewer cells were recovered for the DR" T
cell population, 2 x 107 cells were harvested at two time points (0 and 4 hours)
for RNA analysis. Less than 0.3mg RNA was recovered, this was insufficient for
agarose gel electrophoresis. cDNA was synthesized and the genes detected by RT-
PCR. Samples were standardized according to the percent incorporation of 32P-
dCTP, The results of the slot-blot southern hybridization are shown in Fig 6.7 and
the data from densitometric scans is presented in Table 6.3. ATPase was detectable
at 25 cycles in all samples with higher levels in the 0 and 2 hour time points of the
total T cell population. Values shown in Table 6.3 are normalized to ATPase levels.
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Figure 6.6
Flow cytometry histograms of PBMC purified by MACS. T cells were purified by
negative selection using mAbs to B cells (VPM30) and granulocytes/monocytes
(VPM65 & VPM64). The T cells were further purified by removal of the DR+ cells
using VPM54. Positive staining represents the cells stained with both
supramagnetic beads and phycoerythrin. Cells were not gated on their scatter
profiles. The figures indicate the percentage of positively stained cells.
(A) unstained PBMC
(B) cell staining prior to MACS separation,
(C) staining pattern of the negatively selected T cell population,
(D) staining pattern of the negatively selected DFT T cell population.
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Densitometric assesment may not be completely accurate as bands on a blot that
contain large but different amounts of PCR product will appear of the same intensity
even after short exposure on X-ray film. Hence both values at 35 and 40 cycles are
shown.
y IFN mRNA levels increased following Con A activation in the total T cell
population. Over the time course examined there was maximal expression at 16
hours. ylFN levels showed little increase in expression during the first 4 hours.
Likewise, the DR" T cell population showed no marked increase/decrease in ylFN
levels after stimulation. Maximal expression was detected at 16 hours, which is in
contrast to the earlier result of efferent cells which expressed ylFN maximally
after 4 hours of Con A activation.
IL-6 mRNA was detectable 2-16 hours after Con A stimulation in the total T
cell population. The densitometer values at 35 cycles indicate that levels of IL-6
mRNA expression were much lower than that of the other cytokines examined. In
contrast to the total T cell population, there was no induction of IL-6 production in
the DR" T cell population after Con A activation. Con A stimulation induced IL-6
production in the unfractionated T cell population but did not induce IL-6
production in the DR" T cell population.
As IL-6 gave such an interesting result it was decided to look at another Th2
type cytokine and IL-4 was chosen. IL-4 mRNA was detectable in all samples with
increased expression in both populations over 4 hours. The densitometer values
show similar levels of IL-4 after 4 hours in both populations. In the total T cell
population the IL-4 mRNA levels had declined to resting level by 16 hours.
IL-10 mRNA levels showed no variation in levels of expression in either of
the T cell populations. IL-10 expression was detected as early as 30 cycles in each
sample and appeared to be expressed at similar levels throughout. The detectable
oxprossion of IL-10 at 30 cycles would indicate that IL-10 was more highly
expressed than either IL-4 or IL-6.
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Figure 6.7
ylFN, ATPase, IL-10, IL-6 and IL-4 gene expression on MACS purified T
cells and DR- T cells (MACS purification was described in Rgure 6.6).
Cells were cultured and stimulated with concanavalin A. RNA was
extracted from the unfractionated T cells (total DR+) atO, 2, 4, and 16
hours following activation and at 0 and 4 hours following activation in the




































































DR-0 0.2 1 0 0 0 0.01 0.52 0.27
DR-4 0.25 0.71 0 0 0.26 0.23 0.5 0.35
DR+0 0.57 0.95 0 0 0 0.1 0.22 ND
DR+ 2 0.55 0.49 0 0.11 0.09 0.25 0.12 0.22
OR+4 0.49 0.55 0.05 0.17 0.21 0.4 0.23 0.24
DR+ 16 1.31 1.32 0.17 0.45 0 0.00 0.23 0.23
Table 6.3
Densitometric assessment of the slot-blots shown in Figure 6.7.
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6.3 Discussion
In an attempt to understand the functional significance of class II positive T
cells, the cytokine profile of a DR" T cell population was compared with
unfractionated T cells (a proportion of which express the DR isotype). The
interesting finding was that IL-6 is induced on activation only in the total T cell
population and not in the DR" T cell population. Production of IL-6 mRNA
correlated with DR expression by T cells. IL-6 is a cytokine with pleiotrophic
activities. IL-6 is involved in the terminal differentiation of B cells into antibody
producing plasma cells, the induction of acute phase proteins, the
differentiation/activation of T cells and the induction of IL-2 and IL-2 receptor
expression on T cells (reviewed in Akira et a/,1994; Lau,1994). It has also been
found that IL-6 can replace the requirement for APC derived costimulatory signals
for IL-2 secretion and proliferation (Kasahara et al, 1990; Lorre et at, 1990).
It is this last point which may be the key to the significance of IL-6
secretion by the DR positive T lymphocytes. Despite the expression of large
amounts of MHC class II following activation, these cells do not induce antigen
specific T cell proliferation (Hopkins et at, 1993). The increased expression of DR
may act to transduce signals for IL-6 production. The activation and production of
IL-6 may allow the proliferation and differentiation of naive T cells (DR") without
the need for APC stimulation. IL-6 has been shown to induce IL-2 and IL-2
receptor expression. In studies conducted by Odum et al {1993), it was found that
DR expressing T cells showed increased IL-2 receptor expression and IL-2
sensitivity after activation. The production of IL-6 by DR+ T cells may induce IL-2
receptor expression on T cells, thus amplifying the specific immune response
locally.
IL-6 is produced by many cell types (monocytes, macrophages, fibroblasts,
T cells, B cells, granulocytes, mast cells, endothelial cells and osteoblasts) (Akira
et al, 1994) and because the purity of the isolated T cell populations was not
established care must be taken in drawing conclusions from this data. Non T cells
present may have contributed to the production of IL-6.
The subdivision of T cells into Th1 and Th2 types was based on the cytokine
profiles of T cell clones in vitro. The cell population used in this study was derived
from sheep PBL and as such will represent an array of ThO, Th1 and Th2 type cells.
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Theseex vivo cells may display a diversity in their cytokine profiles such that the
Th1/Th2 division represents extremes of the phenotype (Kelso,1995). This may
explain why production of IL-4 mRNA by the DR" T cell population did not correlate
with IL-6 production, both of which are Th2 type cytokines.
Con A activation of efferent cells induced the synthesis of ylFN mRNA and by
4 hours expression was maximal. This is in agreement with work carried out by
Henfrey (1993). In the purified T lymphocyte population isolated from peripheral
blood, Con A did not induce maximal expression of ylFN until much later (16
hours). This is perhaps a consequence of the absence of APC costimulatory signals
in the pure T cell population. Concanavalin A stimulates T cell proliferation in the
absence of MHC molecule recognition. It is presumed to interact directly with the
CD3 complex. In the absence of accessory cells, T cell populations show a
significant reduction in mitogen responsiveness. This is consistent with the need
for accessory cell-derived second signals for optimal proliferative response
(Mueller et al, 1989). The costimulation required is delivered by the APC and
involves the CD80 (B7) molecule on the APC interacting with the CD28 and CTLA-4
receptors on T lymphocytes (Linsley et al, 1991 a & b)
Con A can induce stimulation which may also induce cytokines not detectable
with antigen stimulation. In the experiments described the T cells were activated
nonspecifically with Con A. Attempts to study the cytokine profile following
activation through the TCR proved problematic. It was found that irradiated APCs
produced cytokine specific mRNAs. Thus T cell production of cytokine RNA following
antigen stimulation by inactivated APCs could not be assessed. Perhaps higher
levels of irradiation would destroy the RNA but then such levels may hinder the
ability of the cells to present antigen. Actinomycin D inhibits transcription of RNA
by binding tightly and specifically to double-helical DNA. This prevents it from
being an effective template for RNA synthesis. Use of actinomycin D may have been
a better choice at blocking mRNA synthesis without affecting antigen presentation.
Due to time constraints, I was unable to set up the control experiments for the use
of actinomycin D.
Macrophages produce IL-10 in response to LPS and this has an inhibitory
effect on the LPS induction of other cytokines (Fiorentino et al, 1991). However,
the results described for the alveolar macrophage enriched cell population
stimulated with LPS show low levels of IL-10 production. As this was not a pure
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macrophage population, cytokines induced in the other cells present may have
contributed to the reduced IL-10 levels. ylFN and IL-10 have been found to
regulate each others production and function in a negative manner. Monocyte
depletion from Staphylococcus aureus activated PBMC reduced IL-10 production by
90% and resulted in increased ylFN production (Chomarat et al, 1993). This
possibly explains the results of cytokine mRNA levels observed in the LPS activated
alveolar monocyte enriched cells. The low level of IL-10 mRNA throughout the
time-course may be attributed to the antagonistic effect of ylFN which was highly
expressed. The inhibitory effect of ylFN production on IL-10 production by
macrophages highlights the interplay of cytokines in regulating immune responses.
The IL-10 mRNA levels expressed by the purified T cells in comparison were much
higher, but again showed little variation over the time-course, this may also be
attributed to ylFN down-regulation.
Precise quantitation of nucleic acids by RT-PCR is problematic as the
procedure involves two enzymatic steps with the second PCR step having an
exponential nature. Variations in efficiency of the cDNA synthesis coupled with
variations in amplification efficiency dramatically affect the yield of amplification
product. The use of an internal control template was first described by Chelly et al
(1990) to which target RNA levels can be normalized allowing the direct
comparison of RNA in separate samples. Ovine ATPase was used as an internal
control for sample-to-sample variations in both the RT and PCR reactions in these
experiments. It is ubiquitously expressed and acts to maintain the sodium
potassium ion balance across the plasma membrane playing a fundamental role in
cellular metabolism. However it is not known if there is invariant expression
following activation of cells. It would have been interesting to carry out Northern
blots of the RNA samples and hybridize with labelled double-stranded ATPase probe
to confirm the levels observed with RT-PCR. Such an approach would be more
quantitative and would possibly answer the question of invariance in ATPase
expression.
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CHAPTER 7 Concluding remarks
There are striking differences between species in the expression of MHC
class II on T cells. In humans and rats, T cells express class II only after activation
(Oshima and Eckels,1990a; Broeren et al, 1995), while in the sheep a proportion
of T cells are class II positive and increased expression occurs after activation
(Hopkins et al, 1986 &1993). Equine (Crepaldi et al, 1986), canine (Doveren et
al, 1986) and feline (Rideout et al, 1992) T cells constitutively express class II.
The functional significance of class II positive T cells is unclear. T cells can present
peptide antigens and function as antigen presenting cells in MLR, but their ability to
present soluble antigen is limited by their inability to take up antigen. In humans,
class II positive T cells have been implicated in the induction of anergy (O'Hehir and
Lamb,1990; LaSalle efa/,1992) and in signal transduction (Odum et al, 1991 &
1993). In rats, expression of class II on T cells has been shown to be involved in
T-T cell regulation (Broeren et al, 1994). The work described in this thesis was
conducted to examine the functional significance of class II positive ovine T cells.
Monoclonal antibodies specific for sheep homologues of DQ and DR were
characterized. The amino terminal sequence analysis of the a chains recognized by
VPM36 and VPM54 show a high degree of homology to the DQ and DR a chains in
humans. This allowed the use of these mAbs in the unequivocal identification of the
ovine equivalents of the human DQ and DR locus products. Both mAbs were then used
to correlate T cell expression of class II isotypes with T cell activation status and
cytokine synthesis profiles.
Phenotypic differences between afferent, efferent and peripheral blood show
that afferent lymph T cells are mainly of the memory phenotype, while efferent and
peripheral blood contain a mixture of naive and memory T cell phenotypes (Mackay
et al, 1990). There are no definitive markers of memory or naive T cells and the
expression of activation and adhesion molecules is used to define different cell
phenotypes. Because the relationship of class II expression has not been correlated
with other markers of activation, studies were conducted to correlate these events
on T cell subsets derived from the various immunological compartments. Variable
expression of class II on T cell subsets between afferent and efferent lymph was
found. Afferent T cell subsets (CD4+, CD8+) expressed increased levels of both DR
and DQ when compared with levels of expression on efferent lymphocytes. Afferent
T cells were also characterized as memory phenotype (CD45R", L-selectin'° and
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a4-integrinhi). Thus the DR+DG4" phenotype of afferent CD4+ and CD8+ T cells
correlated with a memory phenotype. The T cells derived from efferent lymph were
predominantly DR'DGr and this correlated with a naive phenotype (CD45R+, L-
selectinhi, a4-integrin'°). The DR+DCT T cells of efferent lymph may reflect a low
incidence of memory efferent T cells. It appears that class II expression correlates
with a memory phenotype on CD4+ and CD8+ T cell subsets.
Studies in humans and sheep report increased expression of class II
molecules after activation (Evans et al, 1978; Ko et al, 1979; Hopkins et al, 1 986).
To further establish the relationship of class II expression with activation status,
class II expression and activation/adhesion marker expression was correlated after
in vivo antigenic challenge.
Antigen challenge to the lymph node has been likened to the events that occur
during inflammation (Mackay et al, 1992). For example, during inflammation the
phenotype of the endothelium is drammatically modified. These changes are due to
the production of inflammatory cytokines IL-1, TNF and ylFN which induce cell
surface expression of adhesion molecules on the endothelia. These events promote
the recruitment of memory lymphocytes to the inflammation site. After antigen
challenge to the node, increased traffic of T cells expressing the memory phenotype
are found to exit the node in the efferent lymph (Mackay et al, 1990). These
obsevations are only detectable in secondary immune responses. The primary
immune response takes time to develop because the novel antigen must be screened
by T cells before establishing a specific response. In contrast, the secondary
response is more rapid due to the presence of specific memory cells. Production of
inflammatory cytokines assist in the tissue selective homing of antigen specific
memory T cells (Mackay et al, 1992) which have a minimal requirement for
costimulation (Bradley et al,t 993).
Consistent with these observations the in vivo secondary immune response
described in this study was characterized by increased proportions of both CD4+ and
CD8+ T cells leaving the node. As increased proportions of CD4+ andCD8+ T cells
exited the node there was a corresponding increase in the expression of the memory
phenotype. Although the expression of class II coincided with the increase in
activation/adhesion molecule expression, class II expression was upregulated on
CD4+ and CD8+ T cells leaving the node for a longer period. These data suggest that
123
the increased expression of adhesion/activation markers correlates with the
increased traffic of T cells through the node. Because class II expression on the T
cell subsets was detectable for a longer period, its presence may be indicative of a
different functional role.
Expression of the class II locus products on y8 T cells was observed on cells
derived from afferent, efferent and peripheral blood. Similar to the results for
CD4+ and CD8+ T cells, levels of expression were higher on afferent lymph than
efferent lymph and peripheral blood y8 T cells, albeit at lower densities throughout.
However, no discernible differences in levels of expression of the
adhesion/activation markers were detected between afferent, efferent and
peripheral blood. Assuming that CD45 expression correlates with activation status
ony8 T cells as it does on ap T cells, the lack of CD45R expression would indicate
that the vast majority of y8 T cells are memory phenotype. The higher levels of
a4-integrin expression are also indicative of a memory phenotype, but the high
levels of L-selectin expression cannot be reconciled with that of a memory
phenotype (a4-integrinhi, L-selectin'0). It was therefore not possible to correlate
class II expression on y8 T cells with activation status.
In several species y8 T cells comprise a major, if not exclusive, T cell
component of epithelial tissues (Allison and Havran,1991). Distribution of y8 T
cells in mice show a strictly epidermal localization (Janeway et al, 1988) while in
sheep the intestinal epithelia and lamina propria are populated with large numbers
of y8 T cells (Hein and Mackay,1991). y8 T cells are believed to be involved in the
protection of these epithelial surfaces. In sheep, spleen and lymph node y8 T cells
localize to the regions of cellular traffic. It appears that y8 T cells home to
epithelial surfaces and return to the blood via the lymph, rather than the blood to
lymph node route of a(3 T cells (Mackay,1991). The unusual pattern of adhesion
molecule expression observed on yS T cells may serve a different circulatory route
to ap T cells. This may account for the differences in surface expression of adhesion
molecules observed on y8 T cells as opposed to ap T cells.
No changes in the proportions of y8 T cells exiting the node were observed
during antigen challenge. This is in contrast to the work of Mackay et al(1 9 92)
which documented increased proportions of y8 T cells exiting the node after BCG
challenge. The failure to detect a similar response in these experiments may be a
reflection on the antigen used. A recent report, argues that y8 T cells have a system
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for specific T cell recognition that is alternate to the MHC presented peptide
complex of a(3 T cells (Tanaka et at, 1995). Thus an antigen such as ovalbumin
would not be detected by the yS T cells whereas small non-peptide antigens of
mycobacterial infections are recognized. The interesting observation for y8 T cells
was the increased levels of class II expression during the immune response. It
would appear that factors present in the lymph node are responsible for the general
upregulation of class II on T cell subsets during the secondary immune response.
The stimuli for the increased expression of class II occur during secondary
immune responses only (Hopkins et at, 1993). Cytokines produced by activated T
cells are possible candidates for the induction of class II expression. ylFN is a
possible candidate as it has been shown to be released into efferent lymph from
antigen activated lymph nodes only during secondary immune responses (Emery et
at, 1 990). ylFN induces the expression of the CIITA gene which is involved in the
control of class II expression (Steimle et at, 1994). As there is no evidence of CIITA
gene binding directly to the promotors of class II, it has been suggested that ylFN
may act as a tissue specific coactivator. Another inducer that has been well studied
is IL-4 which induces a DNA binding activity specific for the distal upstream region
of a class II promotor (Gravallese et at, 1991). However ylFN and IL-4 alone are
not responsible. When purified human T cells were activated, strong proliferation
and IL-2 receptor expression was observed but low levels of class II expression.
Addition of conditioned media resulted in increased surface class II expression but
IL-2, IL-4 or ylFN alone were responsible (Salvadori et at, 1991). Work by
Caplen et a/(1992) has shown that resting T cells can transcribe mRNA for class II
genes but that they do not express the protein product on the cell surface until after
activation. In addition, they suggest that there may be a protein factor which may
negatively influence class II levels in T cells. ylFN may act as the tissue specific
regulator of class II expression on T cells but other factors involved have yet to be
identified. Promotor elements identified on the HLA-DRA, DPA and DQB genes show
differential susceptibility to different cytokines (Kara and Glimcher,1993). Thus
ylFN may control the upregulation of class II on T cells while different cytokines
may be responsible for the differential expression of the class II products.
Expression of MHC class II by APCs functions in the presentation of antigen
to CD4 positive T cells. In addition, MHC class II delivers signals that modulate APC
cell function. Similarily, class II molecules on human T cells have the ability to
function as signal transduction elements. Crosslinking class II molecules induces
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activation of tyrosine kinases and mobilization of intracellular calcium in activated
human T cells (Odum et al, 1991). Crosslinking class II with CD3 induces IL-2,
IL-3, 7IFNandTNFa secretion by T cells (Spertini e/a/,1992). A more recent
study has shown that crosslinking class II molecules on human T cells enhances the
IL-2 proliferative response of DR+ T cells (Odum et al, 1993). This was elicited by
an increase in IL-2 receptor expression on these T cells. It was found that the
response was specific for DR expression, crosslinking DQ had no effect.
In the work presented here it was shown that Con A activation of purified
DR+ T cells induced IL-6 mRNA. The expression of IL-6 mRNA correlated with DR
expression on T cells. IL-6 is a pleiotropic cytokine. One of IL-6's reported
functions is its ability to replace the requirement for APC derived costimulatory
signals for IL-2 secretion and proliferation (Kasahara et al, 1990; Lorre et
al, 1990). Relating this to the work of Odum et al{1993), perhaps activation of
DR+T cells induces IL-6 production which in turn induces IL-2 responsiveness.
This may function to amplify a local immune response. Further studies are
required to test this hypothesis.
Resting ovine T cell subsets express DR and little DQ. On activation DR
expression predominates over DQ. Similarily in humans, DR expression
predominates over DQ expression after activation. Crosslinking DR on human T
cells has been shown to induce T cell sensitivity to IL-2 whereas crosslinking DQ
had no effect (Odum et al, 1993). The cytokine studies conducted in this thesis,
correlated IL-6 mRNA production with T cell DR expression. This may indicate a
functionally distinct immunoregulatory role for DR positive T cells. However, the
expression of DQ was not analysed on these T cells after activation. From the work
ofOdum et al (1993) crosslinking DQ did not lead to IL-2 responsiveness.
Perhaps, DQ expression on T cells may be associated with the induction of anergy
that has been reported when using T cells as APCs (O'Hehir and Lamb,1990; LaSalle
efa/,1992). The differential expression of class II molecules may fulfill distinct
functions in regulating the outcome of T cell activation and further experiments are
required to delineate these functional roles.
Despite the increased expression of class II on T cells these cells do not
induce antigen specific T cell proliferation (Hopkins et al, 1993). However they do
have the capacity to stimulate allogeneic T cells in an MLR (Hopkins et al,t 993).
Furthermore, it was shown that the ability to stimulate allogeneic T cells increases
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during in vivo secondary responses and correlates temporally and quantitatively
with class II expression. The presentation of alloantigens by class II positive T cells
may have significance in the immune response. Indeed many recent studies have
implicated class II expression on T cells with the activation of autoreactive T cells.
It is believed that activated T cells present peptides derived from activation
associated molecules and peptides of the TCR. Broeren et at (1994) have shown that
T cells can process and present their own TCR proteins to anti-TCR peptide-specific
MHC class II restricted CD4+ T cells. T cell regulation of activated T cells also
underlies the principal of T cell vaccination. In patients with multiple sclerosis,
there is an increased frequency of activated MBP reactive T cells (Allegretta et
al, 1990). Vaccination of MS patients with irradiated autologous MBP reactive T
cells induces an MHC restricted T cell response to the MBP reactive T cells (Zhang
et al, 1993). The immunized patients developed cytotoxic CD8+ and CD4+ T cells
that were reactive with MBP-specific clones and this decreased the frequency of
MBP reactive T cells. It was postulated that this response was regulated by a
clonotypic network whereby peptides of the TCR variable region were presented by
T cells themselves. The upregulation of class II on T cells is coincident with the
recently reported internalization/down-regulation of the TCR (Valitutti et
al, 1995). Thus class II expression on T cells may regulate the immune response
through T-T cell interactions (Figure 7.1A).
Class II positive human and rat T cells may regulate T-T cell interactions
but whether this applies for sheep T cells remains to be established. Similar to the
human and rat studies, sheep T cells also express class II on activation. However
the expression of class II on sheep T cells differs from rat and human T cells in that
a proportion of resting T cells are class II positive. The function of class II
expression on resting T cells is unclear (Figure 7.1 B). A T-T cell regulatory role
for ovine T cells may not apply. A T-T cell regulatory role is also questionable in
species that constitutively express class II on their T cells.
It would be interesting to conduct further studies to establish whether ovine
class II positiveT cells have an immunoregulatory role as has been suggested from
rat and human studies. To establish a T-T cell regulatory role for class II positive T
cells assays for autoreactivity (cytotoxicity assays) and anergy induction
(proliferation assays) could be conducted. T cells derived from antigen challenged
node could be tested in such assays using irradiated autologous antigen specific T cell
clones as APCs. The role of class II positive resting T cells could also be assessed in
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such assays. The analysis of peptides presented on class II positive T cells during an
immune response may also delineate their functional role. From purified class II
molecules, bound peptides may be identified by Edman microsequencing. It would
then be interesting to compare the data on peptides analysed from class II positive
activated T cells with that from resting T cells. Such experiments may elucidate the
functional significance of class II expression on resting and activated ovine T cells.
The analysis of peptides presented on DR and DQ molecules may delineate different
functional roles for these molecules. The functional significance of class II positive
T cells is a fascinating subject and further experiments are required to establish
their precise role in the immune system.
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Resting T cell
(which according to model A
does not present TCR peptides)
Figure 7.1 Schematic representation of class II function on ovine T cells.
(A) A model for the function of MHC class II expression on activated antigen
specific T cells. The antigen specific T cell recognizes antigen presented on class II,
this leads to the internalization of its antigen specific TCR and the increased
expression of class II molecules. The TCR is processed in the class II pathway and
presented to an anti-idiotypic T cell. Activation of the anti-idiotypic T cell may
induce anergy or a cytotoxic response. Thus the immune response to antigen is
downregulated.
(B) Resting T cells also express class II which according to model A do not present
TCR peptides. The functional significance of class II expression on resting T cells
has yet to be elucidated.
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Patterns of major histocompatibility complex
class II expression on T cell subsets in different
immunological compartments 1. Expression on
resting T cells*
In this study we have investigated the expression of major histocompatibility
complex (MHC) class II molecules on T cells from various lymphoid compart¬
ments in the sheep. Monoclonal antibodies which react specifically with sheep
MHC class II molecules homologous to the human DQ and DR molecules have
been characterized. These antibodies have been used, together with the
monoclonal antibodies specific for sheep CD4-, CD8- and T19-positiveT cells, to
quantitate DQ and DR expression onT cell subsets in adult and fetal peripheral
blood, afferent lymph, lymph node and efferent lymph. The results show that
expression of class II by T cells depends on the age of the animal and the
physiological location oftheT cell. Infetal blood there is no expression of class II
on CD8+ or T19+ cells and very low expression on CD4+ T cells. In adult
peripheral blood and efferent lymph a significant proportion of cells express DR
but not DQ. A very different situation is found in afferent lymph and the
peripheral lymph node: in afferent lymph the majority of T cells in all three
subsets express both DQ and DR molecules; in the lymph node over 50 % of
T cells express DR and 30% are DQ+. These results suggest that within all T cell
subsets there is a progression from DQ~ DR~ to DQ DR+ and DQ+DR+ which
correlates with physiological stages of T cell differentiation in vivo.
1 Introduction
MHC class II expression by T lymphocytes shows consider¬
able inter-species variation. In humans activated but not
resting T cells are MHC class II-positive [1, 2] whereas in
mice evidence for the expression of class II by T cells is
controversial [3, 4]. All equineT cells constitutively express
class II [5] and studies in sheep suggest that a proportion of
T cells are class H-positive [6]. This is unlike the situation
with dendritic cells and B cells which constitutively express
class II in all species so far examined [7, 8].The significance
of class II expression onT cells is not clear. Class Il-positive
T cells can present peptide antigens and function as antigen
presenting cells in an MLR [9-12] but their ability to
present soluble antigens is limited by their lack of an
efficient mechanism of antigen capture [13].
One approach to understanding the significance of T cell
class II is to characterize its expression on T cell subsets
isolated from different parts of the recirculating lympho¬
cyte pool. This is only possible in sheep where lymphatic
cannulation techniques permit an overall picture of physio¬
logical changes in lymphocyte phenotype and function to
[I 11139]
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be studied.We have chosen to examine phenotypic changes
in class II onT cells because it is known that T cells drawn
from different immunological compartments vary in their
cell surface phenotype. Sheep afferent lymph T cells
express memory cell surface phenotype while efferent
lymph contains T cells of mainly naive phenotype and
peripheral blood contains a mixture of the two phenotypes
[14]. These phenotypic differences include differential
expression of CD45 isoforms and quantitative variation of
expression of LFA-1, LFA-3 and CD2. Whether these
phenotypic differences identify fixed subsets of T cells or
whether they reflect T cells at different stages of activation
as a consequence of their physiological location is not
known. While it is clear that CD45RO+ cells have recall
function in vitro [15, 16], the inflexibility of cell-surface
phenotype has been called into question. In the rat,
CD45RO+ cells can revert to CD45RA"1" [17] and there is
evidence that high levels of expression of LFA-1 can more
properly be regarded as a marker of activation than as a
memory cell marker [18].
In this paper we describe the development of a panel of
monoclonal antibodies which recognize ovine DQ and DR
homologues and use these antibodies to analyze expression
of MHC class II molecules on T cell subsets isolated from
different immunological compartments.The data show that
in sheep there is considerable expression of MHC class II
molecules on small resting T lymphocytes but that the
products of the different loci are differentially expressed in
all compartments. Furthermore, the class II phenotype of
T cells varies significantly between different sites and is
dependent on the age of the animal. These data indicate
that expression of DR correlates with a differentiation state
of T lymphocytes while DQ+ cells appear to represent a
population of recently activated cells. Our results show that
T lymphocyte phenotype is not fixed but is continuously
modulated during recirculation.
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2 Materials and methods Table 1. Monoclonal antibodies used
2.1 Anti-sheep monoclonal antibodies
Two panels of anti-sheep monoclonal antibodies were used
in this study, one defining the major lymphocyte pheno-
types and the other recognizing the sheep MHC class II
locus products. These antibodies are listed in lable 1. The
anti-sheep class II monoclonal antibodies have been de¬
scribed previously [6, 19]. These antibodies react with all
sheep tested (> 30) and appear to react with monomorphic
determinants. VPM30 is a pan-sheep B cell monoclonal
antibody which is not directed against Ig [20]. CC15 is an
anti-bovine T19 monoclonal antibody which recognizes
CD4~CD8~ T cells expressing the gamma/delta T cell
receptor [21], This monoclonal antibody was a generous gift
from Dr. C. Howard. SBUT4 and SBUT8 are specific for
sheep CD4 and CD8 [22],
2.2 Preparation of cells
Sheep aged between 12 and 18 months were obtained from
the Moredun Research Institute, Edinburgh. Prefemoral
afferent lymph was collected by ablation of the prefemoral
lymph node and subsequent cannulation of the efferent
duct [23]. This duct now contains afferent lymph and is
known as a "pseudoafferent". Efferent lymph cells were
obtained by cannulation of the prefemoral efferent lym¬
phatic [24], Animals were allowed at least seven days
post-operative recovery before lymph cells were taken for
examination. Peripheral blood lymphocytes were isolated
from heparinized blood by NH4CI lysis as described by
Mishell and Shiigi [25]. Fetal blood was obtained from
animals at 130 days gestation and lymphocytes were iso¬
lated as described above. Lymph node lymphocytes were
obtained from prefemoral lymph nodes and splenocytes
were prepared from spleens obtained from the local
abbatoir. Cells were teased into suspension and lympho¬
cytes were obtained by centrifugation over Lymphoprep
(Nycomed AS, Oslo, Norway).
2.3 Immunopurification and ELISA analysis of sheep
class II
Immunoglobulin was prepared from anti-sheep class II
monoclonal antibody ascites fluid by caprylic acid precipi¬
tation [26] and linked to Affigel 10 (Bio-Rad, Hemel
Hempstead, GB). Sheep class II molecules were purified
from spleen by affinity chromatography as described pre¬
viously [6], ELISA for detection of purified class II were
carried out as described previously [6], Both antibodies and
antigens were titrated to give optimal concentrations.
2.4 Two-dimensional immunoblot analysis
For the analysis of |3 chains sheep afferent lymph cells were
lysed at a concentration of 8 X 106/ml in 2% (w/v) NP40,
8.5 m urea containing 2% (v/v) 2D Pharmalyte (Sigma
Chemical Company, Poole, Dorset, GB). Cells
(0.4 x 106 - 2 x 106) were fractionated by 2D NEPHGE-
SDS (two-dimensional non-equilibrium pH gradient gel
electrophoresis-SDS) polyacrylamide gel electrophoresis
Antibody Specificity Reference
SW73.2 Anti-sheep MHC II pan |3 chain [19]
VPM36 Anti-sheep MITC II a chain [6]
VPM38 Anti-sheep MHC II a chain [61
VPM41 Anti-sheep MHC II (3 chain [6]
VPM57 Anti-sheep MHC II f> chain unpublished
data
VPM30 Anti-sheep B cell [20]
CC15 Anti-bovine T19 [211
SBUT4 Anti-sheep CD4 [22]
SBUT8 Anti-sheep CDS [22]
using a non-reduced gel in the second dimension [27]. For
the analysis of a chains sheep splenocytes were lysed at the
same concentration in 2% (w/v) NP40, 8.5 m urea, 2%
(v/v) pH 2.5-5 Pharmalyte (Sigma) and fractionated by 2D
IEF-SDS polyacrylamide gel electrophoresis using a non-
reduced gel in the second dimension [28]. The gels were
blotted onto nitrocellulose, blocked with 5 % (w/v) dried
milk powder in PBS and incubated overnight in monoclonal
antibody supernatant. Blots were incubated overnight in
monoclonal antibody supernatant and developed by incu¬
bating in biotinylated anti-mouse Ig (Boehringer Mann¬
heim, East Sussex, GB) or biotinylated anti-rat Ig (Sigma)
followed by streptavidin alkaline phosphatase (Boehringer
Mannheim) and nitroblue tetrazolium/bromochloroindole
phosphate.
2.5 N-terminal sequence analysis of class II molecules
Affinity-purified class II molecules were separated into a
and |3 chains by SDS polyacrylamide gel electrophoresis
using an Applied Biosystems HPEC 230A (Applied Bio-
systems, Warrington, Cheshire, GB). Separation was
achieved on 10% polyacrylamide gels in 75 mm Tris
phosphate pH 7.5 [29].The separated eluted a and |3 chains
were centrifuged onto Problot membrane (Applied Biosys¬
tems) and sequenced by the SERC Protein Sequencing
Facility, University of Aberdeen, GB, on an ABI pulsed
liquid analyzer.
2.6 Flow cytometry
Immunoglobulin of the anti-cell phenotype antibodies,
with the exception of VPM30,was isolated from ascitic fluid
by caprylic acid treatment [26] followed by ammonium
sulfate precipitation. VPM30 IgM was purified by S300
(Pharmacia, Milton Keynes, Bucks. GB) gel filtration
chromatography. Purified Ig were then coupled to biotin
(biotinamidocaproate N-hydroxysuccinamide ester) (Sig¬
ma) at a biotin/Ig ratio of 75 pg/mg. Anti-class II mono¬
clonal antibody Ig were treated similarly but were not
coupled to biotin. The biotinylated anti-cell phenotype
antibodies were detected using streptavidin-phycoerythrin
(SA-PE, Amersham International PLC, Amersham, GB)
and the anti-class II monoclonal antibodies were detected
using the relevant Ig subclass-specific FITC-conjugated
anti-mouse Ig antiserum (The Binding Site, Birmingham,
2884 B. M. Dutia, I. McConnell, K. Bird et al. Eur. J. Immunol. 1993. 23: 2882-2888
GB). Before use, the concentrations of all reagents were
optimized by checkerboard titrations.
Cells (106) of each cell population were stained simulta¬
neously with 50 pi of the appropriate dilution of biotiny-
lated anti-phenotype monoclonal antibody and anti-class II
monoclonal antibody diluted in PBS/0.1% BSA/0.01 M
sodium azide (PBA). After 60-min incubation at 4°C the
cells were washed twice in PBA and incubated for 60 min
with SA-PE and FITC-antiglobulin before final washing
and analysis. Cells (104) live-gated on small lymphocytes
were analyzed by flow cytometry using a Becton Dickinson
FACScan Analyzer (Mountain View, CA). Live gating
using forward scatter (FSC) and side scatter (SSC) para¬
meters was used to distinguish the different cell populations
in afferent and efferent lymph and blood [30]. Linear
amplification was used for the physical parameters (FSC,
SSC) and logarithmic amplification used for the fluores¬
cence parameters (FLl-green, FL2-red). FL1-FL2 and
FL2-FL1 compensation was used to optimize the two-color
analysis. Antibody-negative cells were gated by reference
to biotinylated normal mouse Ig at 10 pg/ml followed by
FITC anti-mouse IgG.
3 Results
3.1 Monoclonal antibodies identify subgroups of sheep
class II
The aim of these experiments was to identify which
anti-sheep class II monoclonal antibodies reacted with
different MHC class II molecules.The panel of monoclonal
antibodies was characterized by immunopurifying the
antigens reacting with each antibody and reacting the
purified antigen with all other monoclonal antibodies by
ELISA. Affinity purification of class II results in both a and
(3 chains being isolated regardless of the chain specificity of
the monoclonal antibodies [19]. Table 2 shows the results of
such an ELISA. OD readings are comparable except with
VPM41 antigen which contains lower levels of antigen than
the other preparations. These data show that there are two
mutually exclusive groups of class II molecules: those
defined by VPM36 and VPM41 (36/41) and those defined
by VPM38 and VPM57 (38/57).
3.2 Two-dimensional gel analysis of sheep class II
In order to further define the different subgroups of sheep









Figure 1. Two-dimensional immunoblots of sheep class II (3
chains. Sheep afferent lymph cell lysates were fractionated by
NEPHGE 2D PAGE, transferred to nitrocellulose and developed
with monoclonal antibodies. (a)SW73.2; (b)VPM57; (c)VPM41.
Arrows indicate spots common to SW73.2 and VPM41 blots which
are not present in VPM57 blots.
was carried out. Fig. 1 shows the sheep class II (3 chain
spots. Fig. la shows the total |3 spots identified by the pan-P
chain rat monoclonal antibody SW73.2, Fig. lb and c show
identical blots probed with VPM57 (lb) or VPM41 (lc).
Arrows in la and c indicate spots which are absent in
Fig. lb. Spots in Fig. lc which are not arrowed are not
resolved from VPM57P spots. The data shows that VPM57
and VPM41 identify different patterns of spots which are
subgroups of total class II. No spots were observed with
either mouse or rat negative control antibodies (data not
shown). Fig. 2 shows the sheep class II a chain spots
identified by VPM36 (2a) and VPM38 (2b). These two
antibodies clearly recognize different molecules.
3.3 N-terminal amino acid analysis of sheep class II
molecules
In order to determine the relationship between the sheep
class II subgroups 36/41 and 38/57 and the subgroups of
human and mouse class II, the N-terminal amino acid
sequence of VPM36 and VPM38 a chains was determined.
Fig. 3 shows the N-terminal amino acid sequence of







NVV/3 ! P 1 II76'» 1 353 II 367 1 560 1 171
VPM36 a 1.339 0.868 0.296 0.091 0.0
VPM41 P 1.712 0.983 0.351 0.076 0.0
VPM38 a 1.558 0.117 0.053 0.889 0.703
VPM57 P 1.392 0.0 0.012 0.685 0.598
a) MHC class II molecules purified by affinity
chromatography with each monoclonal antibody;
appropriate dilutions of each preparation in
PBS/azidc were coated onto an LLISA plate
overnight at 4 "C.
b) Monoclonal antibody used in ELISA; antibodies
were used as 1/40 dilutions of saturated superna¬
tant.
c) OD492 nm with the negative control sub¬
tracted.
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Figure 2. Two-dimensional immunoblots of sheep MHC class II a
chains. Sheep splenocyte lysates were fractionated by IEF 2D
PAGE, transferred to nitrocellulose and developed with mono¬
clonal antibodies. (a)VPM36; (b)VPM38.
VPM36 a and VPM38 a chains compared with human and
mouse sequences [31].TheVPM36achain sequence is close
to that of DQa and I-Aa and the a chain sequence of
VPM38 antigen is homologous to human DRa and mouse
I-Ea.
Figure 3. N-terminal amino acid analysis of (a) VPM36a and (b)
VPM38a chains compared with human DP, DQ and DR and mouse
I-A and I-E a chain sequences. Boxes indicate identity with sheep
sequence; indicates that residues could not be determined;
indicates a gap inserted to maximize alignment. Alternative
residues indicate different allelles for human and mouse sequences.
For sheep sequences alternative residues indicate that more than
one residue was present. Human and mouse sequences taken fom
Travers and McDevitt [31].
These data taken together with the ELISA and 2D blot
data show that we have two mutually exclusive groups of
monoclonal antibodies which define unambiguously the a
(VPM36) and (3 (VPM41) chains of the sheep DQ and the a
(VPM38) and |3 (VPM57) chains of the sheep DR (VPM38
and VPM57) molecules.
3.4 Expression of MHC class II in vivo
Previous experiments had shown that the anti-sheep pan-
class II monoclonal antibody SW73.2 stained 62 ± 5 % of
sheep resting PBMC [20].This is higher than the percentage
which can be accounted for by B cells. Two-color flow
cytometry using SW73.2 and the anti-cell phenotype mono¬
clonal antibodies showed that approximately 50% of the
class II-positive cells are B cells. The remainder of class
ITpositive cells, which express class II at a lower and more
variable level, are 27% CD4+, 16% CD8+ and 13% T19+
(data not shown).This establishes that in the sheep class II
is expressed on small resting T cells.
3.5 Differental expression of MHC class II by T cells
Having shown that peripheral blood resting T cells express
class II we then used the the anti-DQ (VPM36) and
anti-DR (VPM38) monoclonal antibodies to investigate
expression of the individual locus products in vivo. Class II
expression on CD4+, CD8+ and T19+ T cells in afferent
and efferent lymph as well as peripheral blood and in the
lymph node was investigated.To assess the effect of natural
antigenic exposure on class II expression we examined
class II subtype expression on fetal blood lymphocytes.
Fig. 4 shows the expression of DQ and DR molecules on
CD4+ T cells drawn from the five different compartments.
The class II positive population is not a discrete population,
rather variable levels of class II appear to be expressed on
individual T cells leading to the appearance of a con¬
tinuum. These results are consistent over a large number of
animals. The data show that CD4+ T cells from all com¬
partments express DR molecules but the number of
DR+CD4+ T cells varies between the different immunolog¬
ical environments. Approximately 90 % of afferent lymph
CD4+ T cells express DR but only 50 % of lymph node and
30 % of efferent lymph CD4+ T cells are DR+ (Table 3). In
fetal blood around 15 % of CD41 T cells express DR while
in adult sheep (> 1 year of age) 60 % of peripheral blood
CD4+ T cells are DR+. Expression of DQ molecules on
CD4+ T cells differs considerably from DR expression. In
peripheral blood, fetal blood and efferent lymph very few
CD4+ T cells express the DQ molecule. Significant expres¬
sion of DQ is only found in afferent lymph and lymph node
where 80 % and 33 % respectively of CD4+ T cells express
DQ.
Expression of DQ and DR molecules on CD8+ T cells
mirrors the expression on CD4+ T cells with the exception
of fetal blood where there is no detectable expression of
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LOG FLUORESCENCE INTENSITY GREEN (ANTI-CLASS II)
Figure 4. FACScan analysis of lymphocytes from adult sheep peripheral blood (PBMC), afferent lymph, lymph node, efferent lymph and
peripheral blood taken from fetuses at 130 days gestation (fetal PBMC) double-stained with the anti-CD4 monoclonal antibody SBU-T4
and the anti-class II subgroup-specific monoclonal antibodies VPM36 (anti-DQ) and VPM38 (anti-DR). SBU-T4 was coupled to biotin
and detected with streptavidin-labeled phycoerythrin (red fluorescence) and the anti-class II monoclonal antibodies detected with
isotype-specific FITC labeled anti-mouse Ig (green fluorescence).
either locus product on CD8+ T cells (Table 3). In afferent
lymph expression of both locus products is uniformly high.
In adult peripheral blood very few CD8+ T cells express
DQ whereas a significant percentage express DR. The
percentage of CD8+DR+ T cells is, however, higher in
blood than in efferent lymph. In the lymph node 30% of
CD8+ T cells are DQ+ and 50-60 % express DR molecules. 4 Discussion
In contrast to the results with T cells there is no differential
expression of class II molecules on B cells from any of the
lymphoid compartments with all B cells expressing DQ and
DR (data not shown).
MHC class II expression on T19+ T cells is generally lower
than on CD4+ and CD8+ T cells but the pattern is similar
(Table 3). DQ and DR are differentially expressed in all
compartments.Very few T19+ T cells in peripheral blood or
efferent lymph are DQ+ but in afferent lymph and the
lymph node > 50% of cells are DQ+. Fetal T19+ T cells,
which comprise the majority of T cells in fetal blood, are
DQ-DR-.
The aim of these studies was to develop and characterize
monoclonal antibodies which are specific for the sheep
homologues of DQ and DR, and to use these monoclonal
antibodies to link T cell expression ofMHC class IIwith the
recirculation pathways of T cell subsets.
Using a combination of affinity purification and ELISA
analysis we have described four monoclonal antibodies
Table 3. Percentage of T cells from different lymphoid compartments expressing MHC class II DQ and DR molecules3'
PBMC
Tissue compartment










CD4+ DQ 3.5'± 2.8 33.6 ±4.6 11.4 ± 2.5
T cells DR 57.1 ± 8.3 89.1 u 8.3
gs





6.4 ± 3.9 73.8 ± 4.2 30.3 ± 3.2 13.0 ± 2 < 1
T cells DR 51.4 ± 7.3 79.8 ± 6.8
\<6
60.6 ± 6.2
56.5 ± 6.3 38.4 ± 4 < 1
T19+ DQ *<1 48.3 ± 4.7 t ± 3 < 1
T cells DR 35.3 ± 9.3 78.7 ± 4.8 62.3 ± 8.2 19 ±2 < 1
a) Lymphocytes from each tissue were
double-stained with biotinylated anti-
CD4, anti-CD8 or anti-T19 mono¬
clonal antibody and VPM36 (DQ spe¬
cific) or VPM38 (DR specific) mono¬
clonal antibody. T cells were detected
using streptavidin-phycoerythrin and
class II staining was detected using
isotype-specific anti-mouse FITC.
Cells were analyzed by FACScan and
gated to include only small resting
lymphocytes.
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which react with the a or |3 chains of two distinct subgropus
of sheep MHC class II molecules. By a combination of
two-dimensional immunoblot analysis on separated a and |3
chains, together with N-terminal sequence analysis of
affinity-purified class II,we have shown that the monoclon¬
al antibodies VPM 36 and VPM 41 recognize the ovine
homologue ofDQ, whereas the other monoclonal antibod¬
ies VPM 38 and VPM 57 recognize DR. The N-terminal
amino acid analysis of the a chains of the two subgroups
shows that there is a high degree of homology between
ovine a chains and the corresponding a chains in the
human.These monoclonal antibodies can therefore be used
for the unambiguous identification of the ovine equivalents
of the human DQ and DR locus products.
We have established that there are both qualitative and
quantitative differences in T cell subset expression of
class II, depending on age and physiological location of the
cells. Two-color flow cytometry using the monomorphic
anti-sheep class II monoclonal, SW 73.2, and anti-cell
phenotype monoclonals, shows that up to 50 % ofT cells in
blood express class II. These cells originate from normal
healthy animals and are non-activated small lymphocytes.
Although it is difficult to detect de novo synthesis of class II
by theseT cells, data in the accompanying paper [32] shows
that T cells synthesize class II following in vivo activation.
In contrast to the sheep, humanT cells express class II only
after recent activation [1, 2] and equine T cells are 100%
class II-positive, even in the resting state [5],
Using the DR- and DQ-specific monoclonals we have
shown that fetal blood T cells do not express DQ or DR in
either the CD8+ or T19+ T cell subsets, and show low levels
of expression of both DR and DQ only in the CD4+ T cell
subset. By contrast, in adult sheep PBMC there is a
significant level of expression of DR on all T cell subsets.
Despite these elevated levels ofDR onT cell subsets in the
blood, the level of DQ expression is low. Similar results are
found in efferent lymph whereT cells are virtuallyDQ" but
cells from all three subsets express DR albeit at a lower
level than is found in blood. A different T cell class II
phenotype is apparent when the T cell subsets are isolated
either from afferent lymph or the lymph node. In these
compartments the majority of the T cell subsets now
express DQ as well as DR (DQ+DR+).
Phenotypic differences between afferent and efferent
lymph and blood have been documented by Mackay et al.
[14] who used a variety of non-MHC class II markers to
show that afferent lymph contains cells mainly of the
memory phenotype while efferent lymph and blood contain
a mixture of memory and naive pleno types. Based on
numbers alone, the expression of DR onT cells correlates
with a memory phenotype in all compartments. Our
preliminary experiments using three-color FACS analysis
have so far shown that CD45RA+ cells (naive) are
DQ~DR". In humans, expression of DQ by T cells seems
to be a result of recent activation [33] and the data in the
accompanying paper [32] suggests that this also applies to
sheep T cells. Afferent lymph T cells have an activation
profile; they have a high forward and side scatter in FACS
analysis, have a high rate of spontaneous DNA synthesis
[23] and express elevated levels of IL-2R (unpublished
observations). We conclude that the pattern of MHC




Figure 5. Expression of MHC class II molecules on T cells in
different lymphoid compartments. + + + : >60% positive; + + :
30-60% positive; +: 20-30% positive; ±: <10% positive.
T cell differentiation and activation. The DQ"DR" pheno¬
type is typical of antigen-naive fetal T cells.These change to
being DQ~DR+ and DQ+DR+ after exposure to antigen.
The DQ+DR+ phenotype is characteristic of recently
activated T cells present in afferent lymph and node and the
DQ~DR+ T cells represent a resting and recirculating
memory T cell phenotype present in efferent lymph and
blood (Fig. 5).
These data also establish that there is considerable plastic¬
ity of T cell phenotype. The migration of lymphocytes
across endothelia into tissues (e.g. skin or lymph node) is a
multistep process requiring adhesion, activation of P2
integrins on the lymphocyte surface and trans-endothelial
migration [34, 35]. Crucially this process requires activa¬
tion which occurs via endothelium/T cell interaction or
endothial-derived factors. High levels of DQ and DR in
afferent lymph may therefore be a consequence of this
activation. The explanation for the low level of DQ
expression in efferent lymph may reflect the fact these cells
do not appear in efferent lymph until about 30 h after they
have crossed the endothelium [36] and by this time they
have reverted to a DQ~DR+ phenotype. In rats,T cells can
revert their phenotype from CD45RO+ to CD45RA+ [17]
and we propose that the reversion from DQ+DR+ to
DQ"DR+ is another example of modulation of T cell
phenotype which occurs at different stages in the recircu¬
lation pathway. The functional significance of differential
expression of MHC class II on T cells is discussed in the
accompanying paper [32].
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